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ABSTRACT 
Exposure assessment for incident ingestion of polycyclic aromatic hydrocarbon (PAH) 
contaminated soil typically assumes an absorption factor of 100%.  However, gastro-intestinal 
(GI) absorption of PAHs from soil is known to be less than 100% and will vary based on the soil.  
The research herein investigates factors affecting desorption of soil PAHs and absorption into 
mammalian systemic circulation in order to develop an in vitro bioaccessibility model that is 
predictive of in vivo bioavailability, aka the absorption factor.  In vivo bioavailability is 
determined using the juvenile swine model, a mammalian system, to determine PAH soil 
bioavailability. The Fed organic estimation of the human simulation test (FOREhST) is the in 
vitro model compared against in vivo bioavailability.  The hypotheses of this thesis are (1) PAH 
bioavailability can be partially explained by chemical partitioning, as measured by fugacity 
capacity, (2) PAH bioaccessibility measurements are dependent upon energetic input of the 
model, (3) PAHs interact with each other influencing partitioning, bioaccessibility and 
bioavailability, and (4) PAH-PAH interactions at the cellular level, using an intestinal porcine 
enterocyte cell line (IPEC-J2), alter partitioning into cellular components and rates of 
metabolism affecting bioavailability measurements. 
 Within a soil, fugacity predicts PAH exposure (Exposure = 0.21 log Fugacity + 0.68, r2 = 
0.96, p < 0.005, n=14), however between soils, fugacity does not predict plasma content of PAH 
compounds, with the exception of benzo(a)pyrene.  Soil fugacity capacity predicts the PAH soil 
concentration for all five PAHs with an average slope of 0.30 (μg PAH g-1soil) Pa-1 and r2’s of 
0.64-0.73.  As a result of soil fugacity capacity predicting soil concentration, soil fugacity 
capacity was correlated to PAH bioavailability for these historically contaminated soils, with r2's 
of 0.45-0.66, however benzo(k)fluoranthene and benzo(a)pyrene had much weaker correlations 
with r2 values of 0.13 and 0.14, respectively.  These findings suggest that soil and chemical 
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dependent properties of fugacity and fugacity capacity can partially explain the variability 
associated with PAH exposure, soil concentration and bioavailability. 
Shaking method significantly affected PAH bioaccessibility in the FOREhST model, with 
PAH desorption from the high energy FOREhST an order of magnitude greater compared to the 
low energy FOREhST.  PAH-PAH interactions significantly influenced PAH bioavailability and 
when these interactions were used in a linear model, the model predicted benzo(a)anthracene 
bioavailability with a slope of 1 and r2 of 0.66 and for benzo(a)pyrene bioavailability has a slope 
of 1 and r2 of 0.65.  When spiking low levels of benzo(a)anthracene into the FOREhST model 
with soil, a significant increase (p < 0.05) in bioaccessibile benzo(a)pyrene was observed.  When 
spiking low levels of fluoranthene into the FOREhST model with soil, no significant differences 
in benzo(a)anthracene was observed. 
Co-exposure of IPEC-J2 cells to fluoranthene/benzo(a)anthracene mixture significant 
increases the partitioning to media, opposed to partitioning to cellular components.  Furthermore, 
a fluoranthene/benzo(a)anthracene mixture significantly increases the metabolism of 
benzo(a)anthracene from media when compared to solo exposure of benzo(a)anthracene. 
Notably, a chrysene/fluoranthene/benzo(a)anthracene mixture results in a significant increase of 
benzo(a)anthracene partitioning to media while no significant difference in the disappearance of 
benzo(a)anthracene  from media was observed compared to solo benzo(a)anthracene exposure.  
Co-exposure of IPE-J2 cells to benzo(a)anthracene/benzo(a)pyrene mixture significantly 
increases the partitioning to media compared to solo benzo(a)pyrene exposure but no significant 
difference in benzo(a)pyrene metabolism.  
PAH in vivo bioavailability is a function of a multitude of factors, including but not limited to 
PAH mixtures influencing PAH partitioning to soil, simulated intestinal fluid, and cellular 
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components, and PAH mixtures influencing their own relative metabolism.  By accounting for 
the partitioning effects of PAH mixtures through the use of statistical modelling tools, co-inertia 
(COIA) and structural equation modelling (SEM), better in vitro predictions are made.  PAHs 
mixtures influence PAH cellular partitioning and metabolism, influencing PAH bioavailability, 
however the simple 3 PAH mixtures used here may not wholly explain the complicated cellular 
interactions influencing partitioning and metabolism. 
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1 INTRODUCTION 
Polycyclic aromatic hydrocarbon (PAH) soil contamination is a world-wide problem due to 
incidental ingestion of soil and the carcinogenic nature of PAHs.  Risk assessors often assume an 
absorption factor of 100% for exposure assessment, however this is a conservative estimate, as 
gastro-intestinal (GI) absorption is known to vary based on the soil.  In vivo animal 
bioavailability models are the gold standard for determining the PAH soil absorption factor, but 
these models are costly, time consuming, and ethically difficult to be used repeatedly.  In vitro 
bioaccessibility models measure the amount of contaminant solubilized into simulated GI fluids, 
therefore they do not share the negatives of in vivo modeling and theoretically are a conservative 
estimate of in vivo bioavailability.  Ideally, in vitro would replace in vivo models, but currently in 
vivo bioavailability across many soils cannot be predicted by in vitro models.  The primary 
factors affecting PAH soil desorption between many soils is currently unknown. A confounding 
issue with PAH bioavailability is that PAHs are subject to metabolism via cytochrome P450 
(CYP) enzymes which are highly conserved enzymes across species and tissues.  Specific PAHs 
induce CYP enzymes and can increase the relative rate of metabolism based on the mixture of 
PAHs present, potentially altering the bioavailability measurements.  While in vivo 
bioavailability models are affected by metabolism, in vitro bioaccessibility models typically do 
not contain biotic metabolizing components, and therefore do not account for metabolism.  The 
research of this PhD thesis investigates factors influencing PAH desorption from soil in order to 
create an in vitro model that is predictive of in vivo bioavailability and to investigate the role of 
cellular PAH metabolism on bioavailability based on PAH mixture.  
 2 
1.1 Objectives and Hypotheses 
The global objective of this PhD research was to investigate the primary factors responsible 
for PAH desorption from soil in order to improve the accuracy of in vitro models predicting in 
vivo bioavailability.  Over the course of the global objective stated, four sub hypotheses are 
evaluated: (1) PAH bioavailability can be partially explained by chemical partitioning, as 
measured by fugacity capacity, (2) PAH bioaccessibility measurements are dependent upon 
energetic input of the model, (3) PAHs interact with each other influencing partitioning, 
bioaccessibility and bioavailability, and (4) PAH-PAH interactions at the cellular level alter rates 
of metabolism affecting bioavailability measurements. 
For the first hypothesis, the fugacity capacity of 11 PAHs across 14 soils was determined and 
compared to the in vivo exposure to swine and presented in Chapter 3 (Predicting Polycyclic 
Aromatic Hydrocarbon Bioavailability to Mammals from Incidentally Ingested Soils using 
Partitioning and Fugacity).  To investigate the second hypothesis, bioaccessibility of the 14 soils 
was determined using two shaking methods and presented in Chapter 4 (In vitro Prediction of 
Polycyclic Aromatic Hydrocarbon Bioavailability of 14 Different Incidentally Ingested Soils in 
Juvenile Swine).  The third hypothesis of PAH-PAH interactions was investigated using co-
inertia analysis and is also presented in Chapter 4.  Lastly, to test the fourth hypothesis, an 
intestinal cell line was exposed to various PAH mixtures and is presented in Chapter 5 
(Polycyclic Aromatic Hydrocarbon Mixtures Effects on Metabolism and Binding to Cellular 
Components).  Chapter 6 discusses future directions and implications associated with the current 
findings. 
 3 
 
2 LITERATURE REVIEW 
2.1 Polycyclic Aromatic Hydrocarbons 
Polycyclic aromatic hydrocarbons are a large class of hydrophobic ubiquitous environmental 
contaminants consisting of two or more fused benzene rings. There are over 100 known 
individual PAH compounds, however the focus of the research presented here is limited to 12 
compounds selected within the US EPA priority 16 PAHs, namely: phenanthrene, anthracene, 
pyrene, fluoranthene, benzo(a)anthracene, chrysene, benzo(b)fluoranthene, 
benzo(k)fluoranthene, benzo(a)pyrene, benzo(ghi)perylene, dibenzo(ah)anthracene, and 
indeno(123-cd)pyrene.  Notably, phenanthrene and anthracene are typically classified as lower 
molecular weight (LMW) PAHs as they contain a series of three fused benzene rings, while 
pyrene, fluoranthene, benzo(a)anthracene, chrysene, benzo(b)fluoranthene, 
benzo(k)fluoranthene, benzo(a)pyrene, benzo(ghi)perylene, dibenzo(ah)anthracene, and 
indeno(123-cd)pyrene are typically classified as heavy molecular weight (HMW) PAHs as they 
contain a series of four or more fused benzene rings (Figure 2.1).  The aforementioned PAHs are 
chosen as they are routinely analyzed for and have been widely studied.  Additional PAHs that 
are not included in the USEPA priority 16 PAHs include nitro, alkyl, and oxy-PAH derivatives.      
The source of many PAHs are broadly classified into either pyrogenic, products of incomplete 
combustion of organic matter, or petrogenic, by-products of petroleum processes. Specific 
sources of PAHs result in the production of PAHs at different ratios (Galarneau 2008; Li et al. 
2003; Tobiszewski and Namiesnik 2012; Zhang et al. 2005).  For example, pyrogenic sources 
generally have a higher contribution of HMW PAHs (4 and 5 rings) while petrogenic sources 
generally have a higher contribution of LMW PAHs (2 and 3 rings) (Zhang et al. 2005).  More 
specifically, (Ravindra et al. 2008) has found that a fluorene to pyrene ratio (fluorene / (fluorene 
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Figure 2.1 Structure of twelve common parent PAH compounds.
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+ pyrene)) greater than 0.5 is attributed to petrol emissions, while a ratio of less than 0.5 is 
attributed to diesel emissions.  Additional PAH ratios reported in the literature for source 
appointment include anthracene and phenanthrene, benzo(a)anthracene and chrysene, 
benzo(a)pyrene and benzo(e)pyrene, and indeno(123-cd)pyrene and benzo(ghi)perylene 
(Tobiszewski and Namiesnik 2012).  Principal component analysis and canonical analysis are the 
primarily statistical tools used to decipher the source appointment based on the PAH ratios and 
the typical sources include combustion of fossil fuels, grass, wood, and coal (Tobiszewski and 
Namiesnik 2012).  
PAHs are a broad class of hydrophobic contaminants and there are large differences in their 
physiochemical properties including but not limited to solubility, vapor pressure, octanol-water 
partitioning coefficient (Kow), and molecular weight.  As a result of these differences in 
physiochemical properties each individual PAH will behave somewhat differently, however 
despite these differences, the 12 PAHs selected here have a relatively low solubility and vapor 
pressure with relatively high Kow values.   
Due to the physiochemical properties of PAHs, soil is a major repository for PAHs.  
Estimated by Wild and Jones (1995), 90% of the total environmental PAHs in Great Britain are 
stored in the soil.  PAHs will accumulate in soil over time, whereas the low water solubility of 
PAHs limits the concentration in water. Pyrogenic sources of PAHs, such as residential heating, 
vehicular emissions, coal combustion, and forest fires, emit PAHs into the atmosphere.  
Depending on the physiochemical properties of the PAH, the fate and transport PAHs in the 
atmosphere will change, however atmospheric deposition via rainfall or gravimetric settling 
transfers a substantial amount of atmospheric PAHs to the soil (Wilcke 2000).  Direct PAH soil 
contamination results from industrial sites associated with the following activities (primarily 
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petrogenic in nature): gasworks, fuel processing, coke production, asphalt production, coal tar 
production, and wood preservation (Wild and Jones 1995).  
2.1.1 Human Exposure to Polycyclic Aromatic Hydrocarbons 
Human exposure to environmental contaminants occur through ingestion, inhalation or dermal 
absorption.  Ingestion of PAHs can be from ingestion of PAH contaminated drinking water, 
contaminated food, and incidental ingestion of contaminated soil.  Inhalation of PAHs can be 
from the inhalation of gaseous PAHs, however it is more common to inhale PAHs adhered to 
airborne particulate matter (e.g. dust or re-suspended soil).  A prominent source of PAH 
exposure is through the inhalation of cigarette smoke, especially when individuals voluntarily 
inhale freshly combusted organic material deep into the lungs (Band et al. 2002). Occupational 
exposure is another important source for PAH exposure and exposure is primarily through 
inhalation, however dermal absorption can also be important (Boffetta et al. 1997; Brandt et al. 
2003). Dermal absorption can occur from water (bathing or showering), soil (typically adhered to 
hands) or from consumer products.  Of the three exposure routes, ingestion is typically the 
dominant exposure pathway as PAH concentration in the air is relatively small with dermal 
absorption relevant in certain situations (CCME 2010; James et al. 2012).  Ingestion of 
contaminated food has consistently been found to be the most significant exposure route to 
humans (Bansal and Kim 2015; Domingo and Nadal 2015; Phillips 1999; Yebra-Pimentel et al. 
2015).  Whereas PAH transfer into cereal grains and vegetables from soil and water is limited, 
the relative PAH concentration and composition found in food is primarily linked to the cooking 
process (e.g. baked, grilled or barbequed) and the type of food being cooked (Bansal and Kim 
2015; Domingo and Nadal 2015; Phillips 1999).  Outside of individuals voluntarily inhaling 
cigarette smoke, consuming grilled or barbequed food, and occupational exposure, incidental 
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ingestion of PAH contaminated soil is one of the main drivers of human health risk assessment 
from environmental media.     
2.1.2 Effects Characterization of Polycyclic Aromatic Hydrocarbons 
The human health effects of PAHs have been well documented over the years (CCME 2010; 
Kim et al. 2013; ATSDR 1995).  As a broad class of contaminant, PAHs exhibit carcinogenic, 
teratogenic, genotoxic, mutagenic, systemic, immunological, neurological, reproductive, and 
developmental effects (CCME 2010; Kim et al. 2013; ATSDR 1995).  From this list of PAH 
exposure effects, the most sensitive endpoint is believed to be the carcinogenic mechanism of 
action, which drives the Canadian Soil Quality Guideline value of 0.6 mg kg-1 (mg PAH per kg 
bodyweight) and 5.3 mg kg-1 corresponding to an incremental lifetime cancer risk of 10-6 and 10-
5 (CCME 2010).   
Three well recognized mechanisms of PAH carcinogenic action include 1) PAH metabolism 
to epoxides and diol epoxides, 2) metabolism of PAH radical cations and 3) PAH metabolism 
into quinone intermediates (Penning et al. 1999; Ramesh et al. 2004). The formation of the 
aforementioned compounds leads to interactions with DNA, epoxides forming DNA adducts 
causing mutations, radical cations forming DNA adducts resulting in depurination, and quinones 
which can form DNA adducts resulting in depurination or by creating reactive oxygen species 
which subsequently attack DNA (Cavalieri and Rogan 1995; Harvey 1996; Penning et al. 1999; 
Singh et al. 2007).   
Select PAHs elicit immunological responses, with immunosuppression relevant to the 
carcinogenic endpoint.  While the three aforementioned carcinogenic mechanisms of action 
represent the initiation phase of carcinogenesis, immunosuppression acts via promotion of 
carcinogenesis.  The immune response from PAH exposure is similar to the carcinogenic 
response, such that the effects require metabolic activation.   Not all PAHs exhibit 
 8 
immunosuppressive effects, whereas White et al. (1985) found that anthracene and chrysene 
were not immunosuppressive in mice, other HMW PAHs such as benzo(a)anthracene, 
benzo(a)pyrene, dibenzo(ah)anthracene, and a less routinely used PAH, 7,12-
dimethylbenzo(a)anthracene, had significant immunosuppression.  Benzo(a)pyrene and 7,12-
dimethylbenzo(a)anthracene are regularly used to study immune effects and they have the 
potential to suppress B cell lymphopoiesis (Hardin et al. 1992), inhibit differentiation of blood 
monocytes into macrophages (Van Grevenynghe et al. 2003), decrease spleen and thymus weight 
(Miyata et al. 2001), and damage bone marrow subsequently depleting lymphocytes (Galvan et 
al. 2005).  Taken together the aforementioned effects all influence the immune system, and 
thereby contribute to the promotion of carcinogenesis. 
2.1.2.1 Activation/Detoxification of Polycyclic Aromatic Hydrocarbons 
    Associated with PAH carcinogenicity is the aryl hydrocarbon receptor (AhR).  Many PAHs 
induce various phase I and phase II enzymes and it is likely that they act through the AhR 
(Lampen et al. 2004; Mathieu et al. 2001; Ramesh et al. 2004; Vakharia et al. 2001). Select 
PAHs bind to the AhR receptor and heterodimerize with the aryl hydrocarbon nuclear 
translocator (ARNT) and pass into the nuclear membrane to complex with the xenobiotics 
regulatory element (XRE) to illicit a biochemical response from the cell (Androutsopoulos et al. 
2009; Rowlands and Gustafsson 1997). The AhR pathway induces phase I CYP enzymes, 
predominately CYP1A and CYP1B (Androutsopoulos et al. 2009; Ramesh et al. 2004) as well as 
phase II enzymes, sulfotransferases (SULTs), uridine 5'-diphospho-glucuronosyltransferases 
(UGTs), glutathione S-transferases (GSTs) (Buesen et al. 2003; Hessel et al. 2013). Generation 
of epoxide and quinone species occur as a result of phase I metabolism, whereas the products of 
phase II metabolism are much less hydrophobic and therefore are readily excreted (Ramesh et al. 
2004).    
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Metabolism of PAHs by phase I enzymes, such as CYP1A1, is known to produce oxygenated 
reactive intermediates which are carcinogenic (Ramesh et al. 2004), but overall CYP1A1 plays a 
protective role against PAH toxicity (Nebert and Dieter 2000; Uno et al. 2004).  For example, 
Uno et al. 2004 performed an in vivo B(a)P dosing study using mice, where oral B(a)P exposure 
to Cyp1a1 (-/-) knockout mice lead to lethality whereas there were no overt signs of toxicity to 
Cyp1a1 (+/+) mice.  Furthermore, Uno et al. (2004) shows that there was four times more B(a)P 
in circulating blood in Cyp1a1 (-/-) mice and a 4 times slower clearance rate.  In agreement with 
Uno et al. (2004), Arlt et al. (2008) found that Cyp1a1 (-/-) mice resulted in slower clearance of 
B(a)P compared to Cyp1a1 (+/-) mice, further, Cyp1a1 (-/-) mice had higher hepatic DNA 
adduct levels (4-fold) compared to Cyp1a1 (+/-) mice.  PAH carcinogenesis requires metabolic 
activation and although cancer is not an ideal outcome, it is a likely a preferable outcome relative 
to lethality when there is no metabolic activation. 
2.2 Bioavailability/Bioaccessibility in Human Health Risk Assessment 
In human health risk assessment bioavailability/bioaccessibility measurements are used to 
better characterize exposure estimates.  Typically a conservative estimate of 100% relative 
bioavailability is used, however the default assumption of 100% relative bioavailability can 
potentially lead to overestimating the risk to human health (Richardson et al. 2006).  Within the 
context of risk assessment the term relative bioavailability refers to the bioavailability relative to 
the media from which the guideline In vitro bioaccessibility models estimate the contaminant 
fraction solubilized into simulated GI fluids that can potentially be absorbed by the GI 
epithelium.  In theory the solubilized fraction from in vitro bioaccessibility models should be a 
conservative estimate of bioavailability, as the entire soluble fraction will not be absorbed, 
however Juhasz et al. (2014a) noted that this is not always the case.  Ideally, in vitro 
bioaccessibility models would be used for human health risk assessments as in vivo 
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bioavailability models are comparatively time-consuming and costly  (Rees et al. 2009).  
Additionally there is also the ethical issue of euthanasia of animals for the purpose of 
characterizing human health risk, as there are currently many contaminated sites and there will 
continue to be more sites caused through incidental release of pollutants.  In vitro 
bioaccessibility models need to be validated against in vivo bioavailability models.  In the case of 
exposure to contaminants found in soil, such as PAHs, the in vitro models need to be validated 
across many soils with contrasting soil properties.   
2.2.1 In vivo Bioavailability  
Currently, three animal models are commonly used to calculate mammalian oral 
bioavailability: juvenile swine (Casteel et al. 1997), monkey (Roberts et al. 2007), and mouse/rat 
(Budinsky et al. 2008; Smith et al. 2011).  Three advantages of using swine include 1) their 
anatomically similar GI tracts (Patterson et al. 2008), 2) similar nutritional requirements (Cooper 
et al. 1997) as humans and 3) swine are routinely used as livestock.  Historically monkeys have 
been used as they are non-human primates, and their physiology is similar to humans (Ikegami et 
al. 2003; Kararli 1995). However, there are ethical complications of using monkeys for 
bioavailability studies and typically they are not used.  Lastly, the rat/mouse model is the most 
commonly used for bioavailability studies (Ramesh et al. 2004), as there is relative lower cost of 
housing and maintenance when compared to swine or monkeys. 
 Defining in vivo bioavailability is a complicated process that is dependent upon the 
nature of the toxicant.  For example, for arsenic in vivo bioavailability, typically urine and feces 
are analyzed, as arsenic is primarily excreted via the urine (Buchet et al. 1981).  For lead 
bioavailability, bone, blood, liver and kidney have been collected (Schroder et al. 2004).    For 
PAHs, oral bioavailability is defined as the fraction of a compound that reaches the systemic 
circulation (Ruby et al. 1999); therefore, multiple studies have directly sampled from the 
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systemic circulation and analyzed whole blood or plasma (Budinsky et al. 2008; James et al. 
2011; Rees et al. 2009).  In contrast, Juhasz et al. (2014b) analyzed parent PAH compound 
recovered in the feces to estimate bioavailability. The oral bioavailable fraction of PAHs pass 
through the intestinal epithelium and is absorbed into either the bloodstream or the lymphatic 
system; for PAHs the bloodstream is the dominant pathway (Busbee et al. 1990; Laher et al. 
1983).  Kinetic desorption of PAHs from soil and subsequent absorption into systemic 
circulation is a time dependent process.  As such, area under the plasma concentration-time curve 
(AUC) analysis can be used as it integrates the contaminant plasma concentration over multiple 
time points to estimate the total body burden over an extended period of time (Rees et al. 2009; 
Van Schooten et al. 1997).   
2.2.2 In vitro bioaccessibility 
In vitro bioaccessibility models are designed to mimic the chemical and physiological 
conditions present in the human GI tract.  Common in vitro bioaccessibility models include, but 
are not limited to: Physiological Based Extraction Test (PBET) (Ruby et al. 1996), Simulator of 
the Human Intestinal Microbial Ecosystem (SHIME) (Van de Wiele et al. 2004), Ohio State 
University In vitro Gastrointestinal method (OSU-IVG) (Basta et al. 2007), Fed ORganic 
Estimation human Simulation Test (FOREhST) (Cave et al. 2010; Juhasz et al. 2014b), Relative 
Bioaccessibility Leaching Procedure (RBALP) (Drexler and Brattin 2007), Simplified Based 
Extraction Test (SBET) (Juhasz et al. 2008) and TNO Gastrointestinal Model (TIM) (Minekus et 
al. 1995). The majority of in vitro digestion models follow the same basic doctrine using 
standardized values for temperature, peristaltic mixing, pH, liquid-to-solid ratio, and transit times 
(Oomen et al. 2002). Temperature (37°C) is the only consistent value used across various models 
(Drexler and Brattin 2007; Oomen et al. 2002; Van de Wiele et al. 2007).  Peristaltic mixing has 
been simulated with magnetic stir bars (Van de Wiele et al. 2004), end-over-end rotation  
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(Drexler and Brattin 2007), mixing of an inert gas directly into simulated fluids (Ruby et al. 
1996), or horizontal shaking (Laird et al. 2007).  The pH used for the various in vitro models in 
the stomach compartment range between 1.3 (Ruby et al. 1993) to 4.0 (Oomen et al. 2002), in the 
intestinal compartment range between 6.5 (Laird et al. 2007) to 7.8 (Oomen et al. 2002), while in 
the colon compartment it ranges between 5.6 to 5.9 (Laird et al. 2007).  Liquid-to-solid ratios 
previously had a large discrepancy between models ranging between 10:1 (Ruby et al. 1993) to 
5000:1 (Hamel et al. 1998); however current models favour using 100:1 ratio (Cave et al. 2010; 
James et al. 2011; Tilston et al. 2011a). Transit times for the gastric stages range between 1 to 3 
hours (Oomen et al. 2002), whereas intestinal stages range between 2 to 6 hours (Oomen et al. 
2002), and colon stages range between 8 hours (Tilston et al. 2011a) and last up to 18 hours 
(Laird et al. 2007).   In a comparison between five in vitro digestion models for arsenic, 
cadmium and lead bioaccessibility, Oomen et al. (2002) identifies pH, residence time, liquid to 
solid ratios, filtration process, fed state, and bile concentrations as factors responsible for 
discrepancies between models.  Similarly, Van de Wiele et al. (2007) found that fed vs fasted 
state and liquid to solid ratios were the main factors resulting in differences in lead 
bioaccessibility between five in vitro models.    
One of the most notable differences between in vitro models is the number of compartments 
utilized and the relative chemical composition of each of these compartments.  Less complex 
models such as the RBALP, contain only a single compartment consisting of a 0.4M glycine 
solution acidified to a pH of 1.5 (Drexler and Brattin 2007).  The FOREhST is a slightly more 
complex model, totaling three compartments, where the simulated fluids consists of  25 various 
inorganic, organic or additional compounds (Cave et al. 2010) and the pH is modified at every 
stage. The TIM method is likely the most complex mechanical method as it is a dynamic model 
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that simulates the transit through the GI tract utilizing computer controlled transit times and 
secretion rates (Minekus et al. 1995). 
Oftentimes, to improve the utility of bioaccessibility models modifications to the original 
design are implemented.  Modifying an in vitro model occurs either to improve the accuracy of 
the model or to eliminate unnecessary steps for particular contaminants.  When measuring PAH 
bioaccessibility, James et al. (2011) added an intestinal stage to the RBALP model, as well, in 
this same study a C18 membrane was added as a lipophilic sink.  Similarly for PAH 
bioaccessibility, Tilston et al. (2011b) added a colon compartment to the PBET.  Conversely, 
Juhasz et al. (2008) eliminated the intestinal stage in the SBET because arsenic bioaccessibility 
is greatest in the gastric stage.  As another form of lipophilic sink, Gouliarmou and Mayer (2012) 
added silicone rods to the PBET model to influence partitioning and simplify the extracting 
procedure. Notably, ethyl vinyl acetate (EVA) thin films (Minhas et al. 2006; Vasiluk et al. 
2007) and tenax beads (Li et al. 2015) have also been used as a lipophilic sink for PAH in vitro 
bioaccessibility. 
In this thesis, the FOREhST model is chosen and modified to determine the in vitro 
bioaccessibility across multiple soils.  The FOREhST model is an adaption of the fed state 
methods developed by the RIVM - The Netherlands National Institute for Public Health and the 
Environment (Versantvoort et al. 2004) and is intended for organic contaminants (Cave et al. 
2010).  The three compartments of the FOREhST model include saliva, gastric, and intestinal.  
The simulated fluids of each stage consist of inorganic salts (e.g. KCl, NaOH, or NaH2PO4), 
organic reagents (e.g. urea, bile, or pancreatin) that mimic the physiological conditions at each 
stage (Table 2.1).   The fed state utilizes freeze dried porridge (~ 0.8 g), sunflower oil (50 µL), 
and 2.45 mL milli-Q water.  If necessary the pH of the supernatant solution is adjusted at each 
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stage with NaOH or HCL to match the following conditions: saliva – 6.5 ± 0.5, stomach – 1.4 ± 
0.3, intestinal – 6.3 ± 0.5. After the addition of each fluid, bottles are capped and incubated in a 
water bath (37°C) with end over end rotation (30 rpm).  The transit time for the saliva phase is 5 
minutes, while the gastric and small intestinal phases are 2 hours each.   
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Table 2.1 Components of FOREhST fluids 
Reagent Concentration  
(mg l-) 
Compartment Organic/Inorganic/ 
Additional 
KCl 1792 Saliva Inorganic 
NaH2PO4 1776 Saliva Inorganic 
KSCN 400 Saliva Inorganic 
Na2SO4 1140 Saliva Inorganic 
NaCl 596 Saliva Inorganic 
NaOH 144 Saliva Inorganic 
Urea 400 Saliva Organic 
Amylase 145 Saliva Additional 
Mucin 50 Saliva Additional 
Uric Acid 15 Saliva Additional 
NaCl 5504 Gastric  Inorganic 
NaH2PO4 533 Gastric Inorganic 
KCl 1649 Gastric Inorganic 
CaCl2 799 Gastric Inorganic 
NH4Cl 612 Gastric Inorganic 
HCl 8.3 ml of 37% HCl Gastric Inorganic 
Glucose 1300 Gastric Organic 
Glucuronic acid 40 Gastric Organic 
Urea 170 Gastric Organic 
Glucoaminehydrochloride 660 Gastric Organic 
Bovine Serum Albumin 1000 Gastric Additional 
Mucin 3000 Gastric Additional 
Pepsin 1000 Gastric Additional 
NaCl 14024 Duodenal  Inorganic 
NaHCO3 11214 Duodenal Inorganic 
KH2PO4 160 Duodenal Inorganic 
KCl 1129 Duodenal Inorganic 
MgCl2 100 Duodenal Inorganic 
HCl 180 µl of 37% HCl Duodenal Inorganic 
Urea 200 Duodenal Organic 
CaCl2 200 Duodenal Additional 
Bovine Serum Albumin 1000 Duodenal Additional 
Pancreatin 3000 Duodenal Additional 
Lipase 500 Duodenal Additional 
NaCl 10518 Bile Inorganic 
NHCO3 11570 Bile Inorganic 
KCl 753 Bile Inorganic 
HCl 180 µl of 37% HCl Bile Inorganic 
Urea 500 Bile Organic 
CaCl2 222 Bile Additional 
Bovine Serum Albumin 1800 Bile Additional 
Bile 6000 Bile Additional 
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2.3 Fugacity 
A common way to view fugacity is as the thermodynamic equivalent to chemical potential. 
Lewis (1901) developed the concept of fugacity as an alternative to chemical potential when 
working with chemicals in multiple phases. Fugacity is a partial pressure and is measured in 
units of pressure such as pascals (Pa) or mm mercury (mm Hg).  According to Lewis (1901), 
when a chemical present in one phase comes in contact with a second phase the chemical will 
have a tendency to escape to the second phase.  This escaping tendency can be viewed as a 
pressure exerted by the chemical and therefore fugacity can be measured as a partial pressure.  
Lewis developed fugacity as it requires less rigorous calculations than using chemical potential 
and furthermore it consolidates the units of multiple phases.  Whereas a chemicals’ concentration 
in air, water and soil are measured in µg m-3 and µg L-, and µg g-, respectively, within the 
fugacity concept, units of concentration are unilaterally expressed as mol m-3.    
For many years, fugacity wasn’t widely used until Mackay (1979) took interest and 
investigated the usefulness of fugacity.  To summarize the relevant findings of Mackay (1979), it 
is generalized that fugacity calculations are most appropriate for persistent environmental 
chemicals and that at low concentrations, the concentration of most chemicals are linearly related 
to fugacity.    The relationship between concentration and fugacity is as follows:  
𝐶𝑝 =   𝐹 × 𝑍𝑝                   (Eqn 2.1) 
Where Cp = chemical concentration within a phase (mol m
-3), F = fugacity or escaping 
tendency (Pa), and Zp = fugacity capacity of the phase (mol m
-3 Pa-).  Notably, fugacity acts as a 
partial pressure and has units of Pa.  Within the fugacity concept, when every phase obtains the 
same fugacity the system reaches equilibrium (Lewis 1901).  Furthermore, the concept of 
fugacity functions such that a chemical will move from an area of high fugacity to an area of low 
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fugacity, similar to how chemicals move from a state of high resting energy to low resting 
energy. The fugacity capacity is akin to solubility as the fugacity capacity refers to the ability of 
a phase to absorb a chemical.  Alternatively, fugacity capacity can be viewed as the potential of a 
medium to dissolve a chemical.   
Applying the fugacity concept in practice can mainly be attributed to the work of MacKay 
(1979), Mackay and Patterson (1981), and Mackay and Patterson (1982).  From the 
aforementioned articles, fugacity mainly applied to multimedia fate and transport models 
(MFTMs) (Kawamoto et al. 2001; MacLeod and Mackay 1999; MacLeod et al. 2001; Toose et 
al. 2004; Wania et al. 2006).  Despite the popular use in MFTMs, Mackay (2004) states that the 
most valuable application of fugacity is the ability to explain bioconcentration, bioaccumulation, 
and biomagnification.  Essentially, Mackay (2004) argues that fugacity can be used to explain an 
organism’s exposure based on interactions with contaminants in environmental media. To 
support the ideas of Mackay (2004), Gobas et al. (1993) found that fugacity can explain 
intestinal absorption and biomagnification of organochlorines in both fish and humans.  
Conversely, Kelly et al. (2004) indicates that there are multiple factors outside of fugacity that 
influence the bioaccumulative potential of various commercial chemicals.  Fugacity modelling 
does have limitations, and Mackay (1979) acknowledges that fugacity modelling does not allow 
for heterogeneity within a phase, such as changing soil parameters across a large ecoregion.  A 
second major drawback is the assumption of first-order kinetics for many major processes within 
the model.  Non-first order kinetics or nonlinear sorption isotherms can be accounted for within 
fugacity modelling, however the resulting complexity of the model may not be worth it (Mackay 
1979).  Lastly, fugacity modelling works best for persistent environmental chemicals at low 
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concentrations, therefore chemicals that are rapidly degraded, ionize into multiple forms, and are 
present in large quantities will not follow the linear relationship describe by Eqn 2.1. 
2.4 Cell Cultures and Environmental Contaminants 
Cell cultures can be used to examine the biochemical response resulting from exposure to 
environmental contaminants. Cell cultures can be used to examine a variety of biochemical 
responses, including but not limited to bioavailability, absorption, adsorption, metabolism, 
apical-basolateral transport, cytotoxicity, and interactions with probiotics and bacteria (Cencic 
and Langerholc 2010; Langerholc et al. 2011; Ramesh et al. 2004; Sergent et al. 2008).  For 
biochemical responses to PAHs, human cell lines such as the human colon carcinoma (Caco-2) 
(Oomen et al. 2001; Vasiluk et al. 2007), human hepatoma (HepG2) (Bessette et al. 2005; 
Vakharia et al. 2001; Wu et al. 2003), and human breast cancer (T-47D) (Spink et al. 2002; Wu 
et al. 2003) are routinely used.  It is important to note that these cell lines are of carcinogenic 
origin and as a result may show a significant alteration to various physiological properties related 
to cell functionality (Cencic and Langerholc 2010).    
The caco-2 cell line has the most versatile uses regarding exposure to environmental 
contaminants.  In a sense, caco-2 cells can be considered an in vitro digestion model, as it is used 
to measure the absorption and transport of contaminants (Minhas et al. 2006; Vasiluk et al. 
2007).  A sophisticated use of the caco-2 cells for bioaccessibility is to dose caco-2 cells with 
extracts from the simulated intestinal fluids of an in vitro digestion model (Oomen et al. 2001).  
Notably, this isn’t the perfect replication of GI conditions, and highlighted by (Cui et al. 2016) 
the model lacks goblet cells which produce mucus to further interact with absorption.  When 
using caco-2 cells in this manner, the cells are grown on culture plates of mixed cellulose esters 
(Oomen et al. 2001) or polycarbonate cell culture inserts (Vasiluk et al. 2007), both consisting of 
high pore density (~ 0.4 µm).  Cells are incubated for three to four weeks until maximum 
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confluency is reached and cells differentiate into mature cells with distinct apical and basolateral 
domains (Oomen et al. 2001; Vasiluk et al. 2007).  The caco-2 cells are exposed to a 1:1 mixture 
of simulated intestinal fluid containing PAHs and culture medium on the apical side.  To assess 
bioaccessibility, measurements of PAH concentration are taken from the cells, as well as the 
apical and basolateral compartments over the course of 24 hours.       
Intestinal metabolism of PAHs has the potential to influence the bioavailability of PAHs 
(Buesen et al. 2003).  The bioavailability of individual PAHs can be dependent upon their 
lipophilicity (Cavret and Feidt 2005; Laher et al. 1983; Rahman et al. 1986) and CYP enzymes 
generally metabolize PAHs into less lipophilic compounds (Ramesh et al. 2004).  Using caco-2 
cells it has been demonstrated that PAH mixtures, PAH mixtures with metals, PAH mixtures 
with CYP inhibitors all influence PAH metabolism and subsequent bioavailability (Buesen et al. 
2002; Buesen et al. 2003; Cavret and Feidt 2005; Hessel and Lampen 2010).   
The intestinal porcine enterocyte cell line (IPEC-J2) is a non-transformed, permanent 
intestinal cell line isolated from the jejunal epithelium of a neonatal unsuckled piglet 
(Berschneider 1989).  The IPEC-J2 cells mimic the processes of human intestinal epithelium 
closer than any other cell line of non-human origin and therefore is an ideal cell line for 
modelling human epithelial intestinal processes (Brosnahan and Brown 2012; Vergauwen 2015).  
Furthermore, a porcine intestinal cell line is the best representation of porcine intestinal 
absorption and metabolism when comparing to porcine bioavailability from soil. To date the cell 
line has reached over 100 passages without significant changes in cell growth or transport 
characteristics (GonzalezVallina et al. 1996; Vergauwen 2015).  The IPEC-J2 cell line has been 
characterized mainly for immune responses, i.e. interleukins, tumour necrosis factor, nuclear 
factor kappa beta, major histocompatibility complexes, transforming growth factors (Brosnahan 
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and Brown 2012; Mariani et al. 2009; Schierack et al. 2006).  Despite the IPEC-J2 cell line not 
being characterized for CYP enzymes, Hansen et al. (2000) confirms that porcine duodenal 
enterocytes contain CYP enzymes and that they are appropriate for studies investigating 
intestinal metabolism.  Furthermore, IPEC-J2 is also established as an ideal cell line for 
investigating oxidative stress (Vergauwen et al. 2015).  
Typical dosing for a cell culture involves the mixing of the contaminant of concern with an 
appropriate solvent for both the media and contaminant.  For example, metals can simply be 
dissolved in water and mixed with cell media. Whereas organic contaminants are dissolved in 
dimethyl sulfoxide (DMSO) and then mixed with cell media.  To ensure that the solvent does not 
influence experimental results, solvent controls are included in the experimental design for both 
cytotoxicity and for the experimental endpoint.  Typical volume for solvent controls do not 
exceed 1% of the total media volume, i.e. 1µL of solvent in 100 µL media dosing, and ideally are 
as low as 0.01% (Berridge et al. 1996; Shimada et al. 2008; Vakharia et al. 2001).  A major issue 
with cell culture exposure to organic contaminants is loss due to evaporation and 
adsorption/absorption to the sides of the plastic wells (Schreiber et al. 2008; Tanneberger et al. 
2010).  In an attempt to minimize the evaporative losses, sealplate, or adhesive tape can be 
applied (Schreiber et al. 2008; Vakharia et al. 2001). For sorption to the walls of plates, one can 
simply measure the recovery from plates made of different material, as Schreiber et al. (2008) 
found that a plexiglass plate prevented phenanthrene losses to 28% over a 48 hour period 
opposed to 94% losses from polystrene.  An alternative method of dosing cell cultures is passive 
dosing.  Passive dosing can be accomplished by loading a polymer such as silicone with the 
target chemical at high concentrations to maintain equilibrium with the dosing media (Gilbert et 
al. 2015; Kramer et al. 2010).  Passive dosing relies on partitioning between the solid phase, 
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dosing polymer, and the liquid phase, cell media.  With established partitioning parameters a 
high concentration in the solid phase will maintain a steady concentration of target contaminant 
in the liquid phase (Gilbert et al. 2015; Kramer et al. 2010).  Therefore, when evaopartive or 
sorption losses occur, additional chemical will partition from polymer and maintain a constant 
concentration within the cell media (Kramer et al. 2010).   
Taken together, cell cultures and the specialized techniques developed for cell cultures, allow 
for measuring cellular absorption, transportation, metabolism, and bioaccessibility of various 
chemicals which can be directly applicable to making in vivo to in vitro correlations.    
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3 PREDICTING POLYCYCLIC AROMATIC HYDROCARBON BIOAVAILABILITY TO 
MAMMALS FROM INCIDENTALLY INGESTED SOILS USING PARTITIONING AND 
FUGACITY 
3.1 Preface 
The following chapter has been accepted as a peer-reviewed article in the journal 
Environmental Science & Technology with the following co-authors: 
Rachel Peters (University of Saskatchewan) – involved with experimental design, data 
analysis, and editorial; 
Mark Cave (British Geological Survey) – involved with experimental design, statistical 
analysis, and editorial; 
Mark Wickstrom (University of Saskatchewan) – involved with experimental design and 
editorial; 
Eric Lamb (University of Saskatchewan) – aided with statistical analysis and editorial; 
Steven D Siciliano (University of Saskatchewan) – supervisor involved with all aspects of 
project oversight. 
As the lead author, Kyle James, was involved in every aspect of the article.  More specially, 
Kyle was preformed approximately 30% of the animal work (feeding, dosing, and sampling), 
30% of the lab work (chemical extraction), 50% of the data analysis and 95% of the manuscript 
writing. 
James K, Peters RE, Cave MR, Wickstrom M, Lamb EG, Siciliano SD. 2016. Predicting 
polycyclic aromatic hydrocarbon bioavailability to mammals from incidentally ingested soils 
using partitioning and fugacity. Environmental Science & Technology 50:1338-1346. DOI: 
10.1021/acs.est.5b05317 
This chapter focuses on how chemical partitioning, via fugacity, influences PAH 
bioavailability from soil.  The objective of the chapter was to explore how soil properties may 
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explain PAH bioavailability from soil and to examine inter-correlations between soil properties, 
chemical properties, and soil bioavailability.  Fugacity capacity of 11 PAHs was determined for 
14 soils and compared against in vivo PAH bioavailability to juvenile swine.  The 14 soils 
collected had a wide range of PAH contamination as well as soil physiological characteristics to 
represent various exposure scenarios.  The research suggests that both soil and chemical 
properties influence in vivo bioavailability.    
3.2 Abstract 
Soil and dust ingestion is one of the major human exposure pathways to contaminated soil; 
however, pollutant transfer from ingested substances to humans cannot currently be confidently 
predicted. Soil polycyclic aromatic hydrocarbon (PAH) bioavailability is likely dependent upon 
properties linked to chemical potential and partitioning such as fugacity, fugacity capacity, soil 
organic carbon and partitioning to simulated intestinal fluids.  We estimated the oral PAH 
bioavailability of 19 historically contaminated soils fed to juvenile swine.  Between soils, 
fugacity does not predict PAH blood content, with the exception of benzo(a)pyrene.  In contrast, 
between individual PAHs, fugacity predicts PAH blood content (Area under the Curve = 0.47 log 
Fugacity + 0.34, r2 = 0.68, p < 0.005, n = 14). Soil fugacity capacity predicts PAH soil 
concentration with an average slope of 0.30 (μg PAH g-1soil) Pa-1 and r2’s of 0.61-0.73.  Because 
PAH blood content was independent of soil concentration, soil fugacity correlated to PAH 
bioavailability via soil fugacity’s link to soil concentration. In conclusion, fugacity predicts PAH 
uptake from a soil into blood.   However, something other than partitioning is critical to explain 
the differences in PAH uptake into blood between soils. The kinetically constrained desorption 
of PAHs from carbonaceous geosorbents, i.e. black carbon, coupled with the short transit time in 
the gastro-intestinal tract, may explain differences between soils.   Alternatively, soil, chyme and 
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ileum biochemical interactions may be specific to each PAH, which would explain why fugacity 
predicts the blood uptake of some PAHs, such as benzo(a)pyrene, but not others. 
3.3 Introduction 
How do pollutants move from soil to our blood?   Such a question is what drove us to 
collect 19 contaminated soils from across the world and feed these soils to swine.  This question 
is essential to answer because the transfer of pollutants from soil to blood following ingestion 
can be the dominant pathway for human exposure at contaminated sites.  For example, 
incidentally ingesting soil exposes humans to 100 times more carcinogens than inhaling air 
particles (James et al. 2012). Yet, we have still not developed an acceptable model to quantify 
movement of carcinogens, such as polyaromatic hydrocarbons (PAHs), from an ingested particle 
to the human bloodstream. 
In his pivotal 1979 paper titled “Finding Fugacity Feasible”, Professor Don Mackay 
popularized the use of fugacity to characterize how pollutant movement occurs between 
environment phases and organisms (Mackay 1979). PAH uptake into human cells (Caco-2) 
(Minhas et al. 2006; Vasiluk et al. 2007) and PAH uptake into juvenile swine blood (James et al. 
2011) can be predicted using fugacity.  But using a mouse model, Juhasz et al. (2014b) could not 
use fugacity to model uptake. Fugacity modelling can be done at both equilibrium and non-
equilibrium as well as steady state and non-steady state.  Minhas et al. (2006) and Vasiluk et al. 
(2007) calculate fugacity by measuring concentrations over a time course allowing for fugacity 
calculations at equilibrium and non-equilibrium, whereas Juhasz et al. (2014b), like us, did not 
measure fugacity, instead used published Koc/Kow to calculate fugacity.  Minhas et al. (2007)
 
reports that steady state conditions between soil and aqueous phase (simulated intestinal fluids) 
is reached after 2 hours. Notably, the mean transit time through the stomach (~1.5 hours) and 
 25 
small intestines (~3.5 hours) equates to ~5 hours (Madsen 1992), suggesting that steady state 
conditions are reasonable for modelling gastro-intestinal uptake.   
At environmentally relevant concentrations, the concentration (Cphase) of a compound is 
linearly related to fugacity (f) via the fugacity capacity (Zphase). 
Cphase  =  Zphase×f           (Eqn 3.1) 
Mackay (1979) derived the soil fugacity capacity (Zsoil) of a compound to be: 
Zsoil =  Zwater × soil organic carbon × Koc × soil particle density      (Eqn 3.2) 
Where Zwater is calculated as solubility divided by vapour pressure. Assuming a constant 
soil-organic carbon partitioning coefficient (Koc) between soils allows one to calculate fugacity 
capacity by determining soil organic carbon content.  Routinely, our group and others, would use 
this assumption because it provided useful results (Cachada et al. 2014; James et al. 2011; Juhasz 
et al. 2014b; Mackay and Fraser 2000). Results from Hawthorne et al. (2006) suggest that Koc 
values are not constant between sediments. Across 114 PAH contaminated sediments, Koc values 
for individual PAHs ranged between 2 and 3 orders of magnitude.  Hence, the ability of fugacity 
models to predict blood uptake may be linked to using a more precise estimate of soil fugacity 
capacity.  To achieve this, one needs to experimentally determine Koc.  Koc is the soil-water 
partitioning coefficient (Kd) normalized to organic carbon content: 
Koc = Kd ÷ soil organic carbon          (Eqn 3.3) 
Substituting equation 3.3 into equation 3.2 we obtain equation 3.4 which eliminates soil 
organic carbon from the fugacity capacity equation. 
Zsoil =  Zwater ×  Kd × soil particle density         (Eqn 3.4) 
Therefore, if Zwater and soil particle density remain relatively constant, soil fugacity 
capacity is primarily dictated by Kd, which can be directly estimated.  
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But our intestines contain intestinal fluid rather than the pure water used to estimate Kd. 
Intestines contain ingested particles suspended in fluids and these fluids differ in their 
lipophilicity from pure water.  Hence, estimating Ksim, i.e. the partitioning between soil and a 
synthetic intestinal fluid, should further improve the precision of estimating fugacity for ingested 
particles (Cave et al. 2014).  Improved estimates of fugacity ought to enhance calculations of 
PAH bioavailability based on partitioning theory. 
Here, we define bioavailability as the fraction of an administered dose that is present in 
systemic circulation for a specific time frame (Semple et al. 2003), in our case 48 hours.  One 
can estimate PAH bioavailability by measuring urinary metabolites, PAHs in feces, and PAHs or 
metabolites in blood (see review by Ramesh et al. (2004)). The use of blood concentrations of 
parent compounds is criticized because ingested PAHs enter the body via the portal vein, where 
many PAHs are metabolized by liver enzymes.  A series of recent papers (Shimada and 
Guengerich 2006; Uno et al. 2004) explored how AhR activity, which signals various PAH 
metabolizing enzymes (Ioannides and Lewis 2004), is linked to toxicity.  Hepatic toxicity and 
detoxification depend on metabolism by CYP enzymes yet systemic parent PAH compounds 
cause non-hepatic toxicity.  Thus, parent PAHs that reach systemic circulation are what can 
cause non-hepatic toxicity. This does not suggest that metabolites do not cause toxicity in 
systemic circulation, only that the majority of systemic toxicity is likely the result of parent 
compounds metabolizing to reactive species at the site of toxic effect. Thus parent PAHs in the 
blood provide a meaningful estimate of bioavailability because these PAHs are what pose a risk 
to the remainder of the body, i.e. not the liver or small intestine which are directly exposed to 
PAHs and metabolites during ingestion.   
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Mice, rats and juvenile swine are common animal models used for bioavailability 
research.  The mouse model has several advantages over the swine model, namely less dilution 
into body volume of ingested PAHs (thereby lowering the detection limit of bioavailability 
studies), and that some cancer slope factors are derived from mouse based studies (Culp et al. 
1998).  However, there are certain limits to the mouse model compared to juvenile swine models.  
For example, the mouse AhR is ~10 times more sensitive than the human AhR to AhR ligands 
such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (Flaveny and Perdew 2009), whereas the 
swine AhR is comparable to human AhR for benzo(a)pyrene and TCDD (Lesca et al. 1994).  
Further, the juvenile swine’s digestive tract is very similar to human toddlers (Miller and Ullrey 
1987; Patterson et al. 2008), typically the critical human receptor of concern.   In this study, we 
wished to characterize how toxicokinetics and digestive physiology influenced PAH uptake from 
soil.  Thus, juvenile swine are a good animal model for this purpose. 
In the core of the manuscript, we focus on the results of five carcinogenic PAHs.  
Because of their carcinogenicity, these five PAHs are drivers of the majority of contaminated 
soil risk assessments.   Similar results were obtained with another six PAHs, but with less 
emphasize on their results.  Other PAHs were not robustly or routinely detected and thus, not 
included in our discussion.   
3.4 Materials 
3.4.1 Soils 
A total of 19 soils contaminated with hydrocarbons were obtained from sites in the United 
Kingdom (n = 12), Canada (n = 5) and Sweden  (n = 2), as described previously in James et al. 
(2011) and Cave et al. (2010). Soil pH, soil organic carbon content, and particle size were 
analyzed as previously described by Siciliano et al. (2009).    
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3.4.2 PAH Soil Extraction 
The extraction of PAHs from each soil sample was prepared by weighing approximately 2 g 
of soil into a pre-cleaned 50 mL Teflon centrifuge tube.  To the tube a 5 mL of a 6:1 (v/v) mix of 
methanol: toluene was added and the tube was sealed with Teflon lid.  The vial was gently 
shaken to suspend the contents and then sonicated in an ultrasonic bath for 2 hours at 50°C.  To 
separate the supernatant solution, the tubes were centrifuged at ~ 3000 rpm (1000 g) for 15 min 
and filtered through Whatman GMF 0.45 μm filters into a 15 mL amber glass vial.  A 0.15 mL 
aliquot of the solvent extract was diluted with 1.35 mL acetonitrile into labeled 2 mL amber 
HPLC vials and kept at -20°C until analysis. For the quantification of PAHs from soil a sand 
matrix spike was analyzed every ten samples and the average recovery ranges from 77% to 94% 
with a standard deviation of 12%. Benzo(b)chrysene, present only in very low concentrations in 
the environmental samples, was added as an internal standard and the recovery ranged between 
90-110% with a standard deviation of 11%. 
3.4.3 Bioavailability of Ingested PAHs to Swine 
Female Landrace cross swine (8 week-old; ~20kg) were obtained and housed at the 
Prairie Swine Centre near Saskatoon, Saskatchewan.  The animals were housed in individual 
pens (1.5 x 1.0 x 1.0 m) to prevent cross contamination and for ease of sampling and exposure. 
The diet consists of standard grower ration, two meals a day, with total daily intake rate limited 
to 4% body weight.   Drinking water was provided ad libitum via self-activated watering nozzles 
present in each pen.  Swine were allowed to acclimate for one week prior to dosing and were 
trained daily to eat a dough ball treat consisting of molasses, flour, oats and pig feed as described 
by Casteel et al. (1997). 
 Swine were randomly allocated into treatment groups (n = 6) each week for five weeks.  
At the start of each week the pigs were weighed and fed accordingly.  Treatment groups 
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consisted of 1 of 19 soils individually mixed into dough balls, 40 μg of each 16 priority PAHs 
intra venous (IV) dose in a glycerol tri-octanoate vehicle (each week), and control group 
receiving no PAH dose.  In subsequent weeks, groups were crossed over such that each group 
was assessed as a control and IV dose at some point during the experiment.  Controls were used 
to quantify background levels and IV dose groups were used to ensure consistency between 
treatment groups over progressive weeks. 
 Blood samples were collected from the jugular vein at 2, 4, 6, and 8 hours post exposure 
where n = 4 for each treatment group, while at 0, 12, 24, and 48 hours post exposure, n = 3 for 
each treatment group.  Blood samples were collected from each animal a maximum of five times 
per week to preserve the integrity of the veins for subsequent weeks. Approximately 10-15 mL 
of blood was collected using heparinized vacutainer tubes, which prevents the blood from 
coagulating.  Plasma was separated from the blood within one hour after sampling by 
centrifuging at ~ 3000 rpm (1000 g) for 15 minutes and was stored after decanting at -20˚C until 
solid phase extraction.  PAH tissue concentrations have also been collected and are reported in 
Peters et al. (2015). 
 PAH bioavailability was calculated according to the following equation 
Bioavailability (%) =
AUCSoil Dose 48 H (µg)
PAH administered from soil (µg)
× 100%           (Eqn 3.5) 
 AUCSoil Dose 48 H was determined using area under the plasma concentration curve (AUC) 
analysis over a 48 hour period and PAH administered was the amount of PAHs in contaminated 
soil (μg g-1).  Area under the curve calculations used the plasma concentration time course for 
each compound in individual pigs. AUC was calculated to the 48 hour time point with the MESS 
package (Ekstrom and Ekstrom 2012) in statistical program R (R Core Team 2013) using the 
trapezoidal rule and thus, AUC units convert from μg g-1 48h-1 to μg g-1.   
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3.4.4 PAH Plasma Extraction 
The extraction of PAHs from plasma follow the procedures of James et al. (2011) with minor 
modifications.  To remove impurities from plasma, all samples were extracted using Waters 
Oasis HLB solid phase extraction columns (waters Corporation, Milford MA).  Approximately 5 
mL of plasma was diluted with 0.1 M nitric acid (1:2 plasma: nitric acid) and sonicated for 15 
min in an ultra-sonic bath.  The columns were conditioned with 2 mL of Milli-Q water and then 
with 2 mL methanol.  Approximately 5 mL of acidified plasma was run through the column, 
rinsed with 2 mL of methanol and was eluted with 9 mL of acetonitrile.  The eluate was 
evaporated to near dryness, re-suspended in 2 mL of acetonitrile, and filtered through Whatman 
GMF 0.45 μm filters into labeled 2 mL amber HPLC vials and kept at -20°C until analysis. 
Plasma samples were analyzed in duplicate and the value reported was the average of duplicate 
samples.  In addition, for every 10 samples, we assessed a blank and a matrix spike.  For the 
quantification of PAHs in plasma extracted by SPE columns, a matrix spike was analyzed every 
ten samples using control plasma and the average recovery ranges from 60% to 75% for 
individual PAHs with the highest standard deviation of 6.3% for a PAH.  The average recovery 
of PAHs recovered in plasma separated from whole blood ranged from 43% to 59% compared to 
PAHs recovered from whole blood.  Plasma values have been corrected to reflect recovery from 
whole blood and matrix spike recovery from plasma. 
3.4.5 Simulated Fluids 
The simulated fluids used here follows the composition of the Fed ORganic Estimation 
human Simulation Test (FOREhST) described by Cave et al. (2010).  To summarize, the 
simulated fluids of the FOREhST model mimic the physiological conditions of the human 
gastro-intestinal tract during the fed state.  There are three stages which include saliva, gastric 
and intestinal (duodenal and bile) phases where the temperature was held constant at 37°C. 
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3.4.6 Soil-Water and Soil-Simulated Fluid Partitioning Coefficient (Kd and Ksim) 
The Kd was determined by weighing approximately 3 g of soil into pre-cleaned 50 mL Teflon 
centrifuge tubes.  To the tube, 8 mL of de-ionized water was added and the tubes were sealed and 
placed into a shaker at ~ 30 rpm (0.1 g) for a period of fourteen days.  To separate the 
supernatant solution, tubes were centrifuged at ~3000 rpm (1000 g) for 15 minutes and the 
overlaying water was decanted and filtered through Whatman GMF 0.45 μm filters into 15 mL 
amber vials.  Approximately 1 mL of toluene was added to the water and the mixture was 
evaporated to near dryness and re-suspended in 2 mL of acetonitrile and transferred into labeled 
2 mL amber HPLC vials.  The leftover soil pellet was air-dried overnight and the PAHs 
remaining in soil were extracted using a 6:1 mix of methanol: toluene in an ultrasonic bath for 2 
hours at 50°C.  To separate the supernatant solution, the tubes were centrifuged at ~ 2000 rpm 
(600 g) for 15 min and were filtered through Whatman GMF 0.45 μm filters into a 15 mL amber 
glass vial.  A 0.15 mL aliquot of the methanol: toluene mixture was diluted with 1.35 mL 
acetonitrile into labeled 2 mL amber HPLC vials and kept at -20°C until analysis.  The Ksim was 
determined similarly to the Kd, except only 0.3 g of soil was used with 30 mL of simulated fluids 
to mimic the procedures of Cave et al. (2010). 
 The Kd and Ksim was calculated by dividing the PAH concentration remaining in the soil 
by the concentration of PAHs in the water and simulated fluids, respectively. 
3.4.7 Fugacity Analysis 
The soil fugacity capacity (Zsoil) was calculated as described by Mackay (2001). 
Solubility and vapour pressure (i.e. Zwater) for each PAH are the median values obtained from 
Mackay et al. (2006). Fugacity capacity was calculated using equation 3.4 and measured Kd 
values.  Soil particle density was assumed to be 2.65.    
Zsoil =  Zwater ×  𝐾𝑑 × soil particle density         (Eqn 3.4) 
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3.4.8 HPLC 
Prepared PAH samples were analyzed using an Agilent 1260 Infinity High Pressure 
Liquid Chromatography coupled with Fluorescence Detection (HPLC-FD) (Marriott et al. 1993). 
A 10 μL aliquot was injected onto an Agilent PAH Pursuit column (3 μm particle size, 100mm 
length, and 4.6 mm internal diameter) guarded with an Agilent Pursuit C18 MetaGuard (3 μm 
particle size, 2mm internal diameter). The column temperature was maintained at 25°C for the 
duration of the 25 min run.  The mobile phase consists of acetonitrile and water with a flow rate 
of 1.5 mL min-1.  At the start of the run the solvent gradient was 60:40 acetonitrile: water, 
gradually increases to 95:5 acetonitrile: water at 20 m, and was held constant until the end of the 
run.  The fluorescence detector employs a constant excitation wavelength of 260 nm and four 
emission wavelengths of 350, 420, 440, and 500 nm.  Detection limits for anthracene was 0.70 
pg µL, fluoranthene was 1.71 pg µL, pyrene 0.43 pg µL, benzo(a)anthracene was 2.45 pg µL, 
chrysene was 5.27 pg µL, benzo(b)fluoranthene was 5.58, benzo(k)fluoranthene was 2.77 pg µL, 
benzo(a)pyrene was 13.02 pg µL, dibenzo(ah)anthracene was 7.79 pg µL, benzo(ghi)perylene 
was 1.78 pg µL, and indeno(123-cd)pyrene was 1.80 pg µL. 
3.4.9 Statistical Analysis 
We selected regression analysis for our estimates of the nature of the relationship 
between blood content, bioavailability and soil fugacity because (i) we wished to imply causality 
and (ii) the variation in soil concentration, measured soil fugacity, or soil fugacity capacity was 
much less than that associated with bioavailability or blood content.  Where the variability of the 
x-axis exceeds the variability on the y-axis 95% confidence intervals are provided. Regression 
analyses were performed in SigmaPlot (version 10.0).   
Structure equation modeling (SEM) was performed using R software (R Core Team 
2013) and the 'lavaan' (Rosseel 2012)  package. SEM is a statistical approach similar to path 
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analysis and is used for testing hypotheses where the relationships between many variables are 
confounded by inter-correlations (Lamb et al. 2011). Soil organic carbon content was removed 
from the fugacity capacity equation (see equation 3.4) however soil organic carbon is known to 
influence both partitioning (Chiou et al. 1998) and soil PAH concentration (Tang et al. 2005).  
Furthermore, Kd and Ksim were correlated due to similar experimental conditions.  Using SEM, 
the influence of soil organic carbon on partitioning and soil concentration can be accounted for, 
while simultaneously accounting for the correlation between Kd and Ksim. The initial SEM was 
set up with soil organic carbon as an endogenous variable. Direct paths from soil organic carbon 
to soil PAH and simulated fluid partitioning were included because soil organic carbon is known 
to influence partitioning (Chiou et al. 1998) and soil concentration (Tang et al. 2005).  Soil 
simulated fluid partitioning and soil fugacity capacity are inherently related due to partitioning 
(Cave et al. 2014; Chiou et al. 1998). Soil fugacity was then included as a direct cause of soil 
PAH concentration based on results generated within.  Finally, all four variables, soil organic 
carbon, soil fugacity capacity, soil simulated fluid partitioning and soil PAH concentration were 
included as direct causes of PAH exposure. PAH exposure (AUC48 plasma content) was 
calculated with R software with the 'MESS' (Ekstrom and Ekstrom 2012) package using the 
trapezoidal rule.   
The assumptions of normality were tested using the Shapiro-Wilk test.  All data that were 
not normally distributed were typically log-normally distributed therefore they were log-
transformed prior to analysis.  Data which were not log-normally distributed were transformed to 
normality using box-cox transformations.     
3.5 Results 
The in vivo bioavailability estimates of the 5 PAH compounds analyzed from the 19 soils 
were largely below 30% with an average bioavailability of 12% for benzo(a)anthracene, 11% for 
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chrysene, 29% for benzo(b)fluoranthene, 27% for benzo(k)fluoranthene, and 21% for 
benzo(a)pyrene. Five of the soils, COT1-COT5, had very low PAH soil concentrations, ranging 
from 0.008 to 0.02 μg/g (Table 3.1).  Because of low soil PAH concentrations in these soils, a 
non-detect in plasma led to bioavailability of 0% whereas a detection in plasma led to 
bioavailability of 100%. BGS2 was the only other soil that had a 0% bioavailability for 
benzo(k)fluoranthene. Trimming these samples from the data set, results in lower average 
bioavailability of 12% for benzo(a)anthracene, 11% for chrysene, 8.8% for 
benzo(b)fluoranthene, 6.5% for benzo(k)fluoranthene, 4.4% for benzo(a)pyrene.  The soil 
concentration and bioavailability of anthracene, fluoranthene, pyrene, dibenzo(ah)anthracene, 
benzo(ghi)perylene, and indeno(123-cd)pyrene are presented in Table A1.   
  
3
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Table 3.1 Physiochemical properties and PAH bioavailability soils used in this study 
 Particle Size (%)   Soil Concentration (μg/g) Bioavailability (%) 
 Sand Silt + Clay OC1 pH B(a)A2 CHR2 B(b)F2 B(k)F2 B(a)P2 B(a)A2 CHR2 B(b)F2 B(k)F2 B(a)P2 
BGS1 84 16 1.3 6.7 1.5 1.4 3.7 2.0 2.5 38 10 27 32 11 
BGS2 77 23 8.8 6.7 23 27 84 22 56 2.5 8.6 3.45 0 0.8 
BGS3 54 46 8.2 6.5 19 24 86 22 35 7.1 6.9 4.9 3.1 2.1 
BGS4 67 33 6.8 n/a 50 49 101 33 61 6.2 11 4.8 0.3 2.6 
BGS5 57 43 3.3 n/a 18 18 46 16 18 14 19 7.0 3.9 0.7 
BGS6 59 41 12 6.5 19 26 40 14 17 5.4 6.3 6.7 0.8 4.1 
BGS7 49 51 7.8 6.6 6.8 11 22 8 10 31 27 8.5 1.9 9.1 
BGS8 70 30 13 2.0 32 39 80 19 25 8.8 14 6.6 4.0 0.5 
BGS9 38 62 3.9 6.2 16 16 36 13 22 9.1 14 5.2 0.9 0.3 
BGS10 90 10 4.8 6.3 75 86 77 32 41 6.5 4.5 6.9 6.5 13 
BGS11 39 61 4.9 6.3 54 60 73 29 48 1.3 9.8 4.5 0.3 14 
BGS12 63 37 33 n/a 390 340 410 160 290 0.2 0.007 0.2 0.01 0.1 
WP1 42 58 2.4 5.7 51 45 39 15 18 3.2 4.2 9.6 26 2.0 
GW2 59 41 4.6 6.7 3.7 4.0 5.7 2.2 4.5 40 22 29 4.9 1.4 
COT1   0.8 7.1 ND ND <LOQ 0.004 ND - - - 0 - 
COT2   0.9 6.8 <LOQ <LOQ 0.02 0.002 0.005 - - 100 100 100 
COT3   0.7 6.8 ND ND 0.02 0.004 ND - - 100 100 - 
COT4   0.8 6.8 <LOQ <LOQ 0.01 0.01 0.09 - - 100 100 100 
COT5   1.6 6.8 ND <LOQ 0.008 0.008 0.02 - - 100 100  100 
Average3 60 40 6.3 6.3 57 56 61 21 41 12 11 8.8 6.5 4.4 
Geometric 
Mean3 
59 36 3.7 6.1 25 27 7.5 2.0 5.0 6.2 6.2 5.8 1.7 2.0 
Standard 
Deviation3 
16 16 7.9 1.4 100 86 94 36 67 14 7.4 8.3 10 5.1 
1Organic carbon reported as percent (w/w). 
2Abbreviations are as follows: B(a)A is benzo(a)anthracene, CHR is chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is 
benzo(k)fluoranthene, and B(a)P is benzo(a)pyrene 
3The average, geometric mean and standard deviation values for bioavailability do not include the 5 COT soils 
ND indicates a non-detection of PAH in soil 
<LOQ indicates a value below the limit of quantification 
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As a pre-requisite to calculating fugacity capacity, we determined the partitioning 
coefficients.  As expected, between soils, the PAH partitioning coefficient between soils and 
water (Kd) varied over five orders of magnitude.   For example, for benzo(a)pyrene, the log Kd 
varied between 1.34 and 5.05 (Table A2).  In contrast, between PAHs within a soil, log Kd 
values varied at most one order of magnitude.    
Partitioning between simulated intestinal fluid (Ksim) and soils remained relatively similar 
between soils.  For example, for benzo(a)pyrene, the log Ksim only varied between 1.59 and 2.97.  
The Ksim between PAHs was also relatively similar with Ksim varying slightly less than an order 
of magnitude within a soil (Table A3).   The two measures of partitioning were not linked to one 
another across soils.   For example, Kd and Ksim did not correlate (r < 0.1) for all PAHs, except 
benzo(a)pyrene in which Kd and Ksim were negatively correlated (r = -0.43, p < 0.05). 
Soil fugacity capacity predicts, with an average slope of 0.30 with standard error of the 
slopes between 0.054-0.073, soil PAH concentration (r2 between 0.61-0.73, p <0.001) (Figure 
3.1).  The average soil fugacity capacity for these soils was 1.4 ± 0.70x109 mol m-3 Pa-1 for 
benzo(a)anthracene, 1.3 ± 0.60x109 mol m-3 Pa-1 for chrysene, 1.2 ± 0.52x107 mol m-3 Pa-1 for 
benzo(b)fluoranthene, 7.5 ± 2.9x109 mol m-3 Pa-1 for benzo(k)fluoranthene, and 5.0 ± 2.0x108 
mol m-3 Pa-1 for benzo(a)pyrene (mean ± SE) with an average soil concentration of 55 ± 27μg  g-
1 for benzo(a)anthracene, 53 ± 23μg  g-1 for chrysene, 79 ± 27μg  g-1 for benzo(b)fluoranthene, 
28 ± 11μg  g-1 for benzo(k)fluoranthene, and 46 ± 19 μg  g-1 for benzo(a)pyrene (mean  ± SE).   
Soil PAH concentrations were normally distributed between ~1-100 µg/g between the soils for 
five PAHs with the exception of BGS 12, which has soil PAH concentrations between 160-490 
µg/g.
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Figure 3.1 Comparison between soil concentration (top) or log bioavailability (bottom) and soil fugacity capacity of five PAHs in 
14 soils historically contaminated with hydrocarbons. Lines indicates line of best fit. Data points represent the mean (n =6) of 
mammalian bioavailability and (n=3) estimates of soil concentration or (n=3) estimates of fugacity capacity.  Fugacity capacity was 
calculated using experimentally determined Kd values. Bioavailability was calculated as the quotient of Area under the Curve (μg 
PAHs recovered in plasma per gram of soil over a 48 hour time period) divided by the total amount of PAHs in the dosed soil 
multiplied by 100%. Error bars represent the standard error of the mean and were obscured for soil concentration and fugacity 
capacity. 
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 =0.61 p < 0.001
Log [Soil] = 0.31 * Log Zsoil - 0.09
r
2
 =0.73 p < 0.0001
Log [Soil] = 0.31 * Log Zsoil + 0.74
r
2
 =0.64 p < 0.001
Log [Soil] = 0.31 * Log Zsoil + 0.12
r
2
 = 0.71 p < 0.002
Log [Soil] = 0.25 * Log Zsoil - 0.15
r
2
 =0.62, p < 0.001
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Soil fugacity capacity correlated strongly with PAH bioavailability (Figure 3.1). 
However as the Kow of the PAH increases, the relationship between the soil fugacity capacity and 
bioavailability declines in strength.  For example, soil fugacity explains ca. 60% of the variation 
between soils for low Kow PAHs but explained variance decreases remarkably down to ca. 13% 
for benzo(k)fluoranthene or benzo(a)pyrene.   In contrast with soil fugacity capacity, the Ksim 
was not as closely linked to bioavailability, however as the Kow of PAHs increase the correlation 
with Ksim increases, but not by a significant amount (Figure A2).  Notably, neither PAH fugacity 
(Figure A3) nor PAH fugacity capacity (Figure 3.2) correlated to AUC48 (area under the 
plasma concentration time curve over a 48 hour time period) with the exception of 
benzo(a)pyrene which had a weak to moderate correlation (r2 ~ 0.4-0.5). As soil concentration, 
fugacity, soil organic carbon and partitioning coefficients are all inter-correlated, we used 
structural equation modeling (SEM) to assess the strength of individual parameters.  Specifically, 
we investigated if soil organic carbon, fugacity capacity (estimated by Kd), Ksim, and/or soil PAH 
content was linked to PAH exposure.  Our conceptualized causal network adequately represented 
the data with our SEMs having low chi-squared values (acceptable model parameters) and highly 
non-significant P values (individual analysis was not significantly different than the model) 
(Table 3.2).  Therefore, considering that PAH exposure was not directly correlated to soil 
organic carbon, soil PAH concentration, fugacity capacity or Ksim (Figure 3.2; Table A4), the 
relationship of soil fugacity capacity predicting bioavailability was merely a consequence of soil 
fugacity capacity predicting soil PAH concentration (Figure 3.1). Thus, correlations between 
soil fugacity capacity and soil concentrations were non-causal and should not be used in a 
predictive fashion.   There was one exception to this indirect correlation, the soil fugacity 
capacity of benzo(a)pyrene’s blood content were strongly (P<0.001) and tightly (a slope of 0.78) 
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linked to fugacity capacity (Figure 3.2).   In only one case, anthracene, the partitioning between 
soil and simulated intestinal fluid (Ksim) was causally linked to blood content (Table 3.6). 
Notably, soil organic carbon also predicts soil PAH concentration, but not as well as soil fugacity 
capacity, as indicated by the standardized coefficient (Table 3.2; Figure 3.2). 
 
 
Figure 3.2 Diagram of the structure equation model (SEM) for the relationships between soil 
fugacity capacity, PAH soil concentration, soil-simulated fluid partitioning soil organic carbon 
and PAH exposure.  Single headed arrows indicate that a change in the variable at the tail causes 
a direct change to the variable at the head.  Double headed errors indicate non-directed causality.  
Dashed lines indicate a non-significant (P>0.05) path, whereas red arrows indicate a negative 
relationship.  Arrow width corresponds to the strength of the relationship between variables with 
standardized coefficients provided for significant paths. 
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 Table 3.2 Summary of Significant Collinear Data 
 
PAH 
Model Parameters Significant 
Relationship 
P value 
Standardized 
Coefficient Chi-square DF P-Value 
Benzo(a)anthracene 3.4 2 0.18 
Zsoil predicts [Soil] 0.001 0.80 
OC predicts [Soil] 0.035 0.30 
Chrysene 3.2 2 0.20 
Zsoil predicts [Soil] 0.001 0.79 
OC predicts [Soil] 0.004 0.37 
Benzo(b)fluoranthene 3.7 2 0.15 
Zsoil predicts [Soil] 0.001 0.69 
OC predicts [Soil] 0.001 0.55 
Benzo(k)fluoranthene 3.0 2 0.22 
Zsoil predicts [Soil] 0.001 0.69 
OC predicts [Soil] 0.001 0.50 
Benzo(a)pyrene 3.0 2 0.23 
Zsoil predicts [Soil] 0.001 0.67 
OC predicts [Soil] 0.001 0.51 
Zsoil predicts AUC48 0.001 0.78 
OC predicts AUC48 0.010 -0.46 
1Abbreviations are as follows: Zsoil is the soil fugacity capacity, [Soil] is the soil PAH 
concentration, OC is the soil organic carbon, and AUC48 is the area under the curve exposure up 
to 48hours 
 
Averaged across 14 soils, the fugacity of 11 PAH compounds predicts the AUC48 of 
individual PAHs (Figure 3.3).  As the fugacity of PAHs within a soil increases, the AUC48 
increases proportionally (r2 = 0.68, p<0.005) with a slope of 0.47 Log fugacity. The average log 
fugacity of PAHs between soils was 1.49 ± 0.29 nPa for anthracene, 2.47 ± 0.28 nPa for 
fluoranthene, 1.59 ± 0.25 nPa for pyrene, 0.62 ± 0.18 nPa for benzo(a)anthracene, 0.57 ± 0.18 
nPa for chrysene, 2.25 ± 0.23 nPa for benzo(b)fluoranthene, 0.16 ± 0.06 nPa for 
benzo(k)fluoranthene, and 0.58 ± 0.14 nPa for benzo(a)pyrene 0.27 ± 0.16 nPa for 
dibenzo(ah)anthracene, 0.40 ± 0.22 nPa for benzo(ghi)perylene, 0.76 ± 0.24 nPa for indeno(123-
cd)pyrene.  However, for individual soils this relationship was not consistent for all fourteen 
soils.  For example, for 4 of the 14 soils (BGS2, BGS3, BGS10, and BGS11) there was not a 
strong correlation between the AUC48 and fugacity of individual PAH compounds with r2 values 
between 0.01-0.09, whereas the remaining ten soils had individual r2 values between 0.18 and 
0.65. 
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Figure 3.3 Regression between the Area Under the Curve exposure in μg PAH recovered per 
gram of soil against the fugacity of individual PAHs averaged across all 14 soils historically 
contaminated with hydrocarbons. Fugacity units were reported in nano-fugacity or 10-9 Pa and 
was calculated from soil concentration and soil fugacity capacity. Error bars represent the 
standard error of this mean. Dotted lines represent the 95% confidence intervals. Abbreviations 
are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is 
benzo(a)anthracene, CHR is chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is 
benzo(k)fluoranthene, and B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, B(g)P is 
benzo(ghi)perylene, and IND is indeno(123-cd)pyrene. 
3.6 Discussion 
Our study dosing juvenile swine with PAH-contaminated soils shows that although soil 
properties influenced soil PAH concentration (Figure 3.6), they did not reliably predict the 48-h 
plasma AUC. The only exception to this was benzo(a)pyrene.  Using soil fugacity capacity 
predicts 40% of the variation in benzo(a)pyrene blood content (Log (AUC) =0.16 * Log (Zsoil) - 
0.9: r2=0.41, p<0.05, n=14).  Further, all measures of bioavailability incorporate soil PAH 
concentration, typically as a denominator. Thus, if we use any soil property such as fugacity, 
fugacity capacity or Kd / Koc / Ksim, to predict bioavailability, we cannot be certain if the 
predictive link was merely due to co-linearity with soil concentration or if it was truly a 
predictive link.   Structural equation modeling unraveled this knot of causality and revealed that 
soil properties predict soil concentration, not uptake into the blood, barring benzo(a)pyrene.  We 
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are not surprised by this result; fugacity superbly predicts soil, water and atmospheric 
concentrations as demonstrated by 40 years of research. In our study we use partitioning to pure 
water (Kd) and simulated intestinal fluid (Ksim) to explain mammalian exposure because typical 
exposure to contaminated soil occurs via ingestion of the soil particles that adhere to hands or are 
partially inhaled.  Hence, partitioning was occurring between the soil particle and intestinal fluid, 
i.e. there was minimal partitioning between ingested soil and groundwater.  For estimating the 
terrestrial fate of PAHs at a contaminated site, pure water is not well suited for partitioning 
estimates because partitioning is dependent upon site specific criteria such as the dissolved 
organic carbon and ionic strength of solution (Duan and Naidu 2013; Gouliarmou et al. 2012) 
Mammalian internal exposure displayed no linkage to external exposure according to the 
partitioning behavior of soil bound PAHs. The inability of partitioning to explain differences 
between soils leads one to question, what other soil properties might influence mammalian PAH 
uptake. Soil texture may be one such clue.  Duan et al. (2014) suggest that the bioavailability of 
benzo(a)pyrene was correlated to fine particle associated carbon (calculated as (% silt + % 
clay)/soil organic carbon).   In our current study, no relationship exists between any PAHs and 
the fine particle associated carbon (Figure A4). Thus, soil texture may not be the key factor. 
In model digestive systems, fugacity has a mixed record of predicting PAH release. 
Fugacity underestimates bioavailability in mice fed, aged spiked soils (Juhasz et al. 2014b).  
Conversely, James et al. (2011) predicted swine uptake using fugacity.  In James et al. (2011) 
uptake was expressed in benzo(a)pyrene equivalents, which was benzo(a)pyrene driven.  In the 
present study, benzo(a)pyrene was the only PAH where fugacity capacity was linked to 
exposure, thus explaining the success of our previous work (James et al. 2011) in linking fugacity 
but not the present results. Minhas et al. (2006) spiked chrysene into soil and Vasiluk et al. 
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(2007) spiked benzo(a)pyrene into pristine soil and used a field contaminated sediment. The use 
of a single PAH is problematic because the solubility of a single compound in simulated fluids is 
variable compared to the solubility of PAH mixtures. Juhasz et al.(2014b)  PAH mixtures exhibit 
an intriguing dynamic with solubility and Chun et al. (2002) reports solubility of phenanthrene 
was enhanced in the presence of naphthalene yet reduced in the presence of pyrene.  Chun et al. 
(2002) speculate that more hydrophobic compounds have greater solubility as they are held in 
the core of the micelle whereas less hydrophobic compounds are only solubilized in the 
interfacial medium, thus limiting solubility.  However, the solubility experiments of Chun et al. 
(2002) used PAH concentrations at excess rates of solubility which are much greater than 
environmentally relevant concentrations.  Minhas et al. (2006) and Vasiluk et al. (2007) report 
that the fugacity gradient drove PAH release in model digestive systems, however these were in 
vitro systems consisting of soil, aqueous phase and either EVA thin films or Caco-2 cells and the 
results are not surprising.  What is particularly interesting from Vasiluk et al. (2007) was that 
both a low and high organic matter soil (11% and 29%) were spiked with the same concentration 
of [14C]-benzo(a)pyrene and while the low organic matter soil released more [14C]-
benzo(a)pyrene at 5 hours, there was no significant difference of the [14C]-benzo(a)pyrene in 
either EVA thin film or Caco-2 cells at equilibrium (~12 hours).  These results suggest that a 
fugacity gradient was more prominent under non-equilibrium conditions and that partitioning 
measurements, i.e. Kd and Ksim, would be most appropriate at physiologically relevant times, i.e. 
non-equilibrium over equilibrium.      
  The early work on black carbon’s role in PAH bioavailability (Pignatello and Xing 
1996), has been refined (Burgess and Lohmann 2004) and developed into the dual-mode sorption 
concept (Cornelissen et al. 2005).   Soil sorption of organic compounds follows either absorption 
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to amorphous organic matter or adsorption to carbonaceous geosorbents.  Absorption to 
amorphous organic matter follows linear, non-competitive binding with fast desorption kinetics 
whereas adsorption to carbonaceous geosorbents (i.e. black carbon, kerogen, unburned coal and 
coke) follows non-linear, competitive binding with slow desorption kinetics. Fugacity 
predictions of soil concentrations incorporate both modes of sorption but are ill suited for 
estimating desorption in a short time frame.  The lack of a (linear) correlation implies these 
PAHs are extensively bound to carbonaceous geosorbents and exposure will be dictated as a 
function of desorption rate constant specific to carbon source (Tang et al. 2006).  Further, the 
competitive binding aspect of carbonaceous geosorbents may further explain differences between 
PAHs.     
The soil-water and soil-simulated fluid partitioning coefficients are complementary 
pieces in the bioavailability puzzle.  In our experiments, Kd (fugacity capacity) effectively 
predicted soil concentration but not bioavailability.  If kinetics drive soil bioavailability, Ksim can 
model these short term kinetics and hydrophobic restraints (Kd vs Ksim) occurring in the 
mammalian gastrointestinal tract.  Kinetic release depends upon the energetic inputs associated 
with simulated fluids such as ambient temperature, shaking method, and relative concentration of 
intestinal components (Oomen et al. 2002; Tang et al. 2006).  Thus, Ksim can be estimated under 
conditions similar to gastrointestinal release in terms of energetic inputs.  In this case, it may be 
worthwhile to consider estimating Ksim in dynamic in vitro digestion models such as ‘TIM’ 
(Oomen et al. 2002).  Alternatively, the estimation of uptake of PAHs from soil into blood may 
require more sophisticated models than, the simple, first-order fugacity model used here. 
Systemic parent PAH compounds are responsible for non-hepatic and non-intestinal 
toxicity (Shimada and Guengerich 2006; Uno et al. 2004).  Metabolites internal to the organ of 
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interest, are responsible for organ toxicity, thus measuring metabolites at the site of toxic action 
would alter our bioavailability estimates.  However we are unsure how one could measure 
internal organ metabolites over a time course in a non-lethal manner.  In contrast, assessing 
biomarkers of exposure such as a CYP1A1 induction may be an alternative method of assessing 
exposure.  For example, using three PAH contaminated soils Roos et al. (2002) found that 
hepatic CYP 1A1 induction in mini-pigs appeared to correlate with five and six ring PAH 
content of soils, but no correlation was found with total PAH content.  This suggests that these 
biomarkers of exposure may be an alternative means of assessing bioavailability.  Although, 
other soil compounds, such as metals interact with the systems CYP (Kaminsky 2006; Vakharia 
et al. 2001) confounding the use of these biomarkers for soil bioavailability studies.   
Lastly, PAH metabolism is specific to each PAH and increased metabolism leads to increased 
bioavailability (Cavret and Feidt 2005). 
 By predicting soil concentration, fugacity explains up to 65% of the variation in PAH 
bioavailability in historically contaminated soils.  In reality, one is simply predicting soil 
concentration based on partitioning, or essentially, confirming the fugacity ideas outlined by 
Mackay in 1979.  We speculate that due to the short transit times, the soil-PAH-chyme-ileum 
system does not come to equilibrium.  As a consequence, the kinetic limitations of PAH 
desorption from carbonaceous geosorbents may be the critical driver of PAH bioavailability 
between soils.  A Ksim specifically designed to mimic the energetic inputs that occur on the 
mammalian gut, may allow us to use partitioning predict bioavailability between soils. 
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PREFACE 
4 IN VITRO PREDICTION OF POLYCYCLIC AROMATIC HYDROCARBON 
BIOAVAILABILITY OF 14 DIFFERENT INCIDENTALLY INGESTED SOILS IN 
JUVENILE SWINE 
4.1 Preface 
The following chapter has been accepted as a peer-reviewed article in the journal Science of 
the Total Environment with the following co-authors: 
Rachel Peters (University of Saskatchewan) – involved with experimental design, data 
analysis, and editorial; 
Mark Cave (British Geological Survey) – involved with experimental design, statistical 
analysis, and editorial; 
Mark Wickstrom (University of Saskatchewan) – involved with experimental design and 
editorial; 
Steven Siciliano (University of Saskatchewan) – supervisor involved with all aspects of 
project oversight. 
As the lead author, Kyle James, was involved in every aspect of the article.  Kyle performed 
approximately 30% of the animal work (feeding, handling, dosing, and sampling), 100% of the 
in vitro bioaccessibility testing, 100% of the data analysis, and 95% of the manuscript writing. 
James K, Peters RE, Cave MR, Wickstrom M, Siciliano SD. 2018. In vitro prediction of 
polycyclic aromatic hydrocarbon bioavailability of 14 different incidentally ingested soils in 
juvenile swine. Science of The Total Environment 618:682-689.  
The main focus of the chapter is to evaluate how energetics and co-inertia analysis  
(COAI) can be used to improve in vitro estimations of in vivo PAH bioavailability. Specifically, 
a high and low energetic shaking method was used for in vitro bioaccessibility testing to 
compare the relative PAH release from soil.  Building on the results of Chapter 3, where 
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correlations to PAH soil concentration does not correlate to PAH exposure, the high and low 
shaking methods are compared to soil concentration and in vivo bioavailability. Due to the 
predictability of PAH bioavailability between PAHs in Chapter 3, COIA is used to account for 
PAH interactions affecting partitioning to create a predictive model of PAH bioavailability. To 
confirm PAH interactions influencing partitioning, and by extension bioavailability and 
bioaccessibility, additional PAHs were spiked into in vitro bioaccessibility tests to examine PAH 
release from soil. 
4.2 Abstract 
Predicting mammalian bioavailability of PAH mixtures from in vitro bioaccessibility 
results has proven to be an elusive goal. In an attempt to improve in vitro predictions of PAH soil 
bioavailability we investigated how energetic input influences PAH bioaccessibility by using a 
high and low energetic shaking method. Co-inertia analysis (COIA), and Structural Equation 
Modeling (SEM) were also used to examine PAH-PAH interactions during ingestion. PAH 
bioaccessibility was determined from 14 historically contaminated soils using the fed organic 
estimation of the human simulation test (FOREhST) with inclusion of a silicone rod as a sorption 
sink and compared to bioavailability estimates from the juvenile swine model. Shaking method 
significantly affected PAH bioaccessibility in the FOREhST model, with PAH desorption from 
the high energy FOREhST almost an order of magnitude greater compared to the low energy 
FOREhST. PAH-PAH interactions significantly influenced PAH bioavailability and when these 
interactions were used in a linear model, the model predicted benzo(a)anthracene bioavailability 
with an slope of 1 and r2 of 0.66 and for benzo(a)pyrene bioavailability has a slope of 1 and r2 of 
0.65. Lastly, to confirm the effects as determined by COIA and SEM, we spiked low levels of 
benzo(a)anthracene into historically contaminated soils, and observed a significant increase in 
benzo(a)pyrene bioaccessibility. By accounting for PAH interactions, and reducing the 
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energetics of in vitro extractions, we were able to use bioaccessibility to predict bioavailability 
across 14 historically contaminated soils. Our work suggests that future work on PAH 
bioavailability and bioaccessibility should focus on the dynamics of how the matrix of PAHs 
present in the soil interact with mammalian systems. Such interactions should not only include 
the chemical interactions discussed here but also the interactions of PAH mixtures with 
mammalian uptake systems. 
4.3 Introduction 
Polycyclic aromatic hydrocarbons (PAHS) are carcinogenic compounds produced from 
incomplete combustion of organic material.  Due to their relatively low solubility and vapour 
pressure PAHs will accumulate in soil over time and humans are exposed to PAHs through the 
incidental ingestion of PAH contaminated soil.  The default assumption for exposure assessment 
is that all of the ingested PAHs have been solubilised and absorbed (i.e. 100% bioavailable) from 
the gastrointestinal tract, however a significant fraction of PAHs are strongly bound to soil 
constituents and are not released within the gastrointestinal tract (James et al. 2016; Juhasz et al. 
2014b).   
PAH bioavailability from soil is estimated by monitoring uptake of PAHs into the 
bloodstream of a model organism, e.g. mice, swine or rats.  Animals should, ethically, not be 
used for routine site assessments and thus, substantial effort has gone into developing in vitro 
bioaccessibility models to predict bioavailability.   Current models for organic contaminants 
include Physiologically Based Extraction Test (PBET) (Gouliarmou et al. 2013; Li et al. 2015; 
Ruby et al. 2002), Colon-extended PBET (Tilston et al. 2011a), Fed Organic Estimation human 
Simulation Test (FOREhST) (Cave et al. 2010; Juhasz et al. 2014b), Relative Bioaccessibility 
Leaching Procedure (RBALP) (James et al. 2011), as well as simulation of the human intestinal 
microbial ecosystem (SHIME) (Cave et al. 2010).  To ensure that hydrophobic organic 
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contaminant soil release is not limited to the compound solubility for the simulated intestinal 
fluids, a sorption sink such as C18 membranes (Hurdzan et al. 2008; James et al. 2011), tenax 
beads (Li et al. 2015), ethyl vinyl acetate thin films (Vasiluk et al. 2007), and silicone rods 
(Gouliarmou and Mayer 2012) are incorporated into the models.  These models can often predict 
the bioavailability of different PAHs within a soil (James et al. 2016), but typically are not 
successful in estimating bioavailability between soils.  
Juhasz et al. (2014a) noted that maximizing estimated bioaccessibility is not necessarily 
the most conservative measure of bioavailability (i.e. bioaccessibility can be less that 
bioavailability).  Bioaccessibility is dependent upon the desorption conditions within the in vitro 
model, i.e. shaking method, temperature, desorption media, and desorption time (Oomen et al. 
2002; Reichenberg and Mayer 2006).  PAH release in in vitro models  is linked to the activation 
energy of the desorption process (Enell et al. 2005) as well as organic matter composition 
(Crampon et al. 2014; Zhang et al. 2010).  PAHs bind to either amorphous organic matter with 
non-competitive fast desorption kinetics or to carbonaceous geosorbents with competitive slow 
desorption kinetics (Cornelissen et al. 2005).  A typical soil has both amorphous and 
carbonaceous geosorbents and regardless of carbon type, longer desorption times typically lead 
to greater desorption (Oomen et al. 2002).  The RBALP model, which utilizes end-over-end 
rotation, can be coupled with a lipid sink and leads to high PAH release from soil (James et al. 
2011).  Under such conditions, PAH bioaccessibility closely tracks PAH soil concentration but 
not PAH bioavailability (James et al. 2011).    In vitro models that use reduced energetic input, 
such as the TIM model (Van de Wiele et al. 2007), will result in lower PAH release and perhaps 
this release is linked more closely to bioavailability.  Our rationale for this hypothesis is that the 
current generation of in vitro models assumes that maximizing bioaccessibility will better predict 
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bioavailability.   While possible, our experience is that these in vitro approaches closely mirror 
chemical activity but not bioavailability.  Hence, we modified the existing FOREhST model to 
reduce energetic inputs during extraction and compared this release to in vivo bioavailability 
results.         
PAHs are present as mixtures and depending on the source of the PAHs, e.g. pyrogenic, 
petrogenic, etc., the relative ratios of each PAH will change (Tobiszewski and Namiesnik 2012).  
The nature of this PAH mixture is a major factor influencing PAH 
bioaccessibility/bioavailability (Juhasz et al. 2016).  It is thought that these mixture effects occur 
because PAHs interact with other PAHs and influence their partitioning behavior.  For example, 
phenanthrene solubility in various surfactants was enhanced in the presence of naphthalene yet 
reduced in the presence of pyrene (Chun et al. 2002). Benzo(a)pyrene concentrations in gut 
fluids increased in the presence of cholesterol (137%), phenanthrene (154%),  lecithin (140%) 
and hexadeconal (232%) (Voparil et al. 2003).  Given that PAHs interact with each other, it is 
likely that linking PAH bioaccessibility to PAH bioavailability between soils requires that we 
explicitly link the matrices of PAH accessibility to PAH bioavailability.   
Co-inertia analysis is statistical method developed to study the common structure of 
multiple sets of paired data (Thioulouse 2011).  Co-inertia analysis is a non-directional approach 
to identify individual variables within each matrix that influence the other corresponding matrix 
and is well suited to situations where the number of samples is low relative to the number of 
predictor variables. Here we use co-inertia to identify key PAHs in the bioaccessibility matrix 
that are influencing other PAHs in the bioavailability matrix.   However, co-inertia analysis is 
largely an exploratory statistical approach, and thus we tested if these PAHs were significantly 
influencing bioavailability using structural equation modelling.  Structural equation modelling 
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(SEM) is well suited for assessing a hypothesis that links collinear variables in a causal network 
to predict a dependent variable (Lamb et al. 2011).  Furthermore, unlike multiple regression 
approach, structural equation modelling explicitly accounts for collinearity and thus, allows one 
to estimate, not only the significance, but the strength of a relationship linking predictors (such 
as the bioaccessibility of single PAHs) to the bioavailability of a PAH.  
Our goal here was to combine the concepts of bioaccessibility and bioavailability as 
outlined by Juhasz et al. (2014a) and Reichenberg and Mayer (2006), with explicit multivariate 
predictive approaches, to develop a numerical prediction of bioavailability based on a widely 
adopted bioaccessibility protocol.  We then evaluated the robustness of this prediction by spiking 
PAHs into water or soil and confirming that the drivers identified by the multivariate approaches 
were indeed occurring in in vitro settings.   
4.4 Materials and Methods 
4.4.1 Soils 
A total of 14 PAH contaminated soils have been collected from the United Kingdom (n = 
12) and Sweden (n =2) as previously described by Cave et al. (2010) and James et al. (2011). 
Soil pH, organic carbon, and particle size were analyzed as previously described by Siciliano et 
al. (2009). 
4.4.2 Sorptive sink 
Silicone rods, poly(dimethylsiloxane) (PDMS), were chosen to act as a PAH sorption 
sink as they have established partitioning properties for PAHs and have been previously used for 
in vitro bioaccessibility testing (Gouliarmou et al. 2013; Juhasz et al. 2016).  The silicone rod 
(Altec, Cornwall, United Kingdom) has a diameter of 2.87-3.13 with a mass of 8.0 g m-3.  To 
prepare the silicone rods for experimental use, the procedures of Gouliarmou and Mayer (2012) 
were followed, where the silicone was cleaned by soaking once overnight with ethyl acetate, 
 52 
three times overnight with methanol, 3 times overnight with acetone, and 4 times overnight with 
Milli-Q water.   
4.4.3 FOREhST Shaking Method/Energetic Input 
To investigate the effects of energetic inputs two shaking methods were employed.  The 
first was the standard high energy FOREhST where 125 mL glass bottles were rotated 30 rpm 
end-over-end inside of a water bath held at 37°C. The second method uses a less aggressive 
process to create a massaging motion that utilizes 2 – 1.5” rotating spherical balls moving back 
and forth horizontally (Figure B1). Modified polytetrafluoroethylene (PTFE) bags (5”x4”- 5.0 
Mil thick, Welch Fluorocarbon, Dover, New Hampshire) were used with this lower energy 
method, as their inherent flexibility allows for a massaging technique.  In the low energy method, 
the FOREhST fluids were warmed up to 37°C prior to use and cool down to 28-32°C after 2 
hours. 
The FOREhST model described here follows the detailed procedures of Cave et al. 
(2010). The FOREhST model is an adaption of the fed state methods developed by the RIVM - 
The Netherlands National Institute for Public Health and the Environment (Versantvoort and 
Rompelberg 2004) and is intended for organic contaminants (Cave et al. 2010).  The fed state is 
the most conservative estimate of bioaccessibility for organic contaminants (Oomen et al. 2000).  
The compartments of the FOREhST model are saliva, gastric and intestinal, which consist of 
simulated fluids modeled to the physiochemical conditions present at each stage.  
To each experimental unit, 0.3 g of contaminated soil was added, followed by 
approximately 0.8 g of HIPP creamy porridge™, 2.45 mL of deionized water, 50 µL sunflower 
oil, and 1 m silicone rod.  Saliva fluid, 4.5 mL, was added to each unit and shaken for 5 min.  
Afterwards, 9 mL of gastric fluid was added and incubated for 2 hours.  Finally, 9 mL of 
duodenal fluid and 4.5 mL of bile fluid were added, followed by an additional 2 hour incubation.       
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Post incubation, silicone rods were removed from the extraction units, washed with Milli-
Q water and gently dried with lint free tissue paper.  PAHs were extracted by soaking silicone 
rods in approximately 50 mL of acetone twice for 24 hours (Gouliarmou and Mayer 2012).  The 
100 mL acetone was evaporated using nitrogen gas to near dryness, re-constituted into 1.8 mL of 
acetonitrile into 2 mL HPLC vials and stored at -20°C until analysis. 
4.4.4 Co-Solubility Experiments 
Phenanthrene (96%), pyrene (98%), and benzo(k)fluoranthene (99%) were obtained from 
Sigma Aldrich, while benzo(a)pyrene was obtained from MRI Global.  Bioaccessibility 
experiments were conducted using de-ionized water and bile fluid.  Bile fluid was prepared by 
dissolving 12.5 g L-1 bile and 6 g L-1 NaHCO3
- into de-ionized water.  To each experimental unit, 
1 m of silicone rod was inserted into a 125 mL amber glass jar.  To the jar, approximately 35 ± 5 
mg of PAH was added, followed by 100 mL of either de-ionized water or bile fluid. Notably, the 
solubility limits of these PAHs in water was less than 1.2 mg L-1(ATSDR 1995).  The amber jar 
was then gently shaken on a horizontal shaker for 4 hours, the time was chosen to be 
representative of the gastric and intestinal transit time of the FOREhST model.   
4.4.5 Low Energy FOREhST Spiking 
The low energy FOREhST was repeated for five soils and spiked with 
benzo(a)anthracene (99%, Sigma-Aldrich) or fluoranthene (99%, Sigma-Aldrich) dissolved in 
100 µL of acetonitrile. The spiking consisted of five concentrations for each benzo(a)anthracene 
and fluoranthene.  Soils were also spiked with 100 µL of clean acetonitrile as a solvent control.  
Spiking solution was added directly to the FOREhST media, in the mixture containing soil, 
water, food, saliva and silicone rod.  
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4.4.6 In vivo Swine Oral Bioavailability 
The oral bioavailability and area under the plasma concentration curve over a 48 hour 
time period (AUC48) of PAHs to swine has been previously reported in section 3.2.3 
Bioavailability of  Ingested PAHs to Swine. 
4.4.7 Quality Assurance - Quality Control  
To quantify the PAH recovery from soil, a sand matrix spike was added every 10 samples 
and the average recovery ranges from 77% to 94% with a standard deviation of 12%.  
Benzo(b)chrysene was present at very low concentrations in all soils and was used as an internal 
standard and the recovery ranged from 90% to 110% with a standard deviation of 11%.  For the 
in vitro digestors, a blank sample (no soil) was included every 8 samples.  Average blank 
samples recovered a range of 0 to 120 pg from the high energy FOREhST, 110 to 810 pg from 
the low energy FOREhST, and 0 to 120 pg from the low energy FOREhST spiked with 
acetonitrile.  Residual PAHs adhering to PTFE bags range from 0 to 1400 pg.  
4.4.8 Statistical analysis 
4.4.8.1 Co-Inertia Modelling 
Co-Inertia analysis (COIA) was performed using R software (R Core Team 2013) and the 
“ade4” (Dray and Dufour 2007) package. Co-inertia analysis developed by Doledec and Chessel 
(1994) was reviewed by Thioulouse (2011) and compared with canonical correspondence 
analysis  by Dray et al. (2003)  Co-inertia analysis is an alternative method to canonical 
correspondence analysis when number of samples is low relative to the number of predictor 
variables.  Co-inertia analysis investigates the common structure of paired data tables by 
maximizing the covariance of the row scores between the tables.  High co-inertia occurs when 
simultaneously high values (or inverse) occur in both tables, whereas low co-inertia occurs either 
when they vary independently or they do not vary.  Thus, high scores indicate that parameters, 
 55 
such as a specific PAH, were concordant between two sets of data tables, whereas low scores 
indicate that these specific PAHs were discordant (or in other words, PAHs behaving 
dissimilarly between the two data tables, which in this case would be the soil concentration data 
table consisting of different soils versus different PAHs bioaccessibility compared to the data 
table of different PAH’s bioavailability).   
PAHs have the ability to interact with each other and affect the solubility of each other, 
and in the environment PAHs are present as mixtures.  When investigating the bioavailability of 
PAHs it is likely that the bioavailability of one PAH will affect the bioavailability of another, the 
same can be said for bioaccessibility; however the goal was to use bioaccessibility to predict 
bioavailability.  In addition to bioaccessibility, other environmental variables such as soil PAH 
concentration, organic matter, soil texture, and soil metal concentrations may be used as 
predictive variables of PAH bioavailability. In one table there is bioavailability of individual 
PAHs, in columns, by soil samples, in rows.  In another table there are the predictor variables, 
including bioaccessibility of individual PAHs, as well as PAH concentration , organic matter, 
soil texture, and soil metal concentrations, in columns, by the same soil samples in rows.   
The two data sets were first studied separately with Principal Components Analysis 
(PCA), and eventually analyzed as PCA-PCA COIA.  In a PCA-PCA COIA, the two PCA’s on 
the original two data sets reduces their dimensionalities by selecting the dominant components 
(axes).  COIA uses the principle components from each data set and merges the complied data 
into a new multidimensional space such that the covariance between axes of each data set is 
maximized.  The data tables were not transformed prior to analysis. 
4.4.8.2 Model Selection 
Co-inertia analysis provides the primary components for predicting PAH bioavailability. 
Using the results from co-inertia analysis, a general linear model is constructed consisting of the 
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dependent variable, AUC48PAH, being regressed on by FOREhSTPAH, [soil]PAH, and the top five 
variables as given by co-inertia analysis.  Non-significant variables were then stepwise removed 
using the “stepAIC” function from the “MASS” package (Venables and Ripley 2002) with R 
software (R Core Team 2013) until the best final model was chosen.  The “stepAIC” function 
was combined with an ANOVA to examine significant differences between model fits based on 
Akaike Information Criterion (AIC).  Model residuals were plotted against predicted values and 
visually inspected as per Osborne and Waters (2002) to ensure homoscedasticity.   
4.4.8.3 Structure Equation Modelling 
Structure equation modelling was performed using R software (R Core Team 2013) with 
the additional “laavan” (Rosseel 2012) package.  SEM is a statistical method akin to path 
analysis which allows for testing of hypotheses were the relationship is confounded by many 
variables inter-correlated.  The application of SEM was to determine the relative strength of the 
coefficient that each predictor variable has on the dependent variable in the presence of 
collinearity. After removing non-significant variables, SEM was used to account for collinearity 
between variables and to determine the path coefficients. The structure equation model was built 
similarly as outlined by James et al. (2016), where there was a high degree of collinearity 
between predictor variables, such as between bioaccessible FOREhST PAHs, they are set to co-
vary.  Where one predictor variable predicts another, such as total organic carbon predicting soil 
PAH concentration, the model reads PAH soil concentration was regressed on by total organic 
carbon.  Finally, each predictor variable was included as a direct cause of AUC48PAH.  A detailed 
SEM diagram complete with all relative pathways is available in Appendix B (Figure B6). 
4.5 Results 
In the standard high energy FOREhST model the PAH release correlates moderately to 
strongly (r2 between 0.43-0.62) with soil concentration (Figure 4.1), whereas no correlation was 
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found between the low energy FOREhST and soil concentration (Figure B2).  The average 
bioaccessibility (mean ± standard deviation in parentheses) from the high energy FOREhST was 
23% (8.0 ± 9.5 µg) for benzo(a)anthracene, 29% (9.2 ± 8.1 µg) for chrysene, 20% (11 ± 7.9 µg)  
for benzo(b)fluoranthene, 21% (4.4 ± 2.7 µg) for benzo(k)fluoranthene, and 13% (5.6 ± 5.8 µg) 
for benzo(a)pyrene while the average bioavailability from the low energy FOREhST was 3.7% 
(0.76 ± 0.65 µg) for benzo(a)anthracene, 5.0% (1.2 ± 0.96 µg) for chrysene, 3.0% (0.99 ± 0.58 
µg) for benzo(b)fluoranthene, 3.4% (0.38 ± 0.24 µg) for benzo(k)fluoranthene, 1.6% (0.41 ± 
0.30 µg) for benzo(a)pyrene.  Individual PAH bioaccessibility for each soil is available for both 
the high and low energy FOREhST in Appendix B (Table B3 and Table B4). 
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Figure 4.1 Comparison between FOREhST PAH release and soil concentration of five PAHs in 14 soils historically contaminated 
with hydrocarbons.  Lines indicate line of best fit.  Data points represent the mean (n=3) for FOREhST PAH release and error bars 
represent the standard error of this mean.  
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Between soils, neither the low or high energy FOREhST model predicts in vivo AUC48 
juvenile swine exposure for individual PAHs (Figure B3).  However, within a soil, both the low 
and high energy FOREhST predict in vivo AUC48 exposure between PAHs (Figure 4.2). Within 
a soil, desorption of PAHs was predictable likely due to the physiochemical properties of the 
PAH, as such they desorb from soil at a relative rate, however between soils, the PAH release 
cannot be predicted. The low energy FOREhST predicts exposure between PAHs with a slope of 
1.9 (r2 = 0.64, p < 0.01) while the high energy FOREhST predicts exposure between PAHs with 
a slope of 0.34 (r2 = 0.81, p < 0.005).   Notably, the energetic input does not appear to affect all 
PAHs equally.  In Figure 4.2, the high energy FOREhST does not accurately predict anthracene, 
fluoranthene and pyrene AUC48, however the only outlier in the low energy FOREhST model 
was fluoranthene.  PAH bioavailability data is provided in supplemental material (Table B2).   
Co-Inertia Analysis 
The PCA on PAH bioavailability reduces the data set to six principal components that 
explain 94.9% of the variance (Table B5) while the PCA on predictor variables (PAH 
bioaccessibility, PAH soil concentration, and soil properties) reduces the data set to five 
principle components that explain 90.2% of the variance (Table B6).  COIA indicates that the 
primary variables predicting PAH in vivo exposure were FOREhST release of chrysene, 
fluoranthene, anthracene, and benzo(a)anthracene, followed by soil arsenic concentration, and 
then FOREhST release of pyrene and benzo(k)fluoranthene.  The relative rankings of the 
individual predictor variables were determined using the ‘Strength’ of the predictive vector as 
determined by the canonical weights of COIA (Table B7; Figure B5).   
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Figure 4.2 Regression between in vivo swine PAH area under the plasma concentration curve 
over 48 hours in units of µg PAH recovered in plasma per gram of soil ingested  (AUC48) 
against in vitro FORE(h)ST PAH release in Low energy (left) and High energy (right). Each data 
point represents the mean bioavailability of a single PAH from 14 soils historically contaminated 
with PAHs and error bars were the standard error of this mean.  Abbreviations are as follows: 
ANT is anthracene, FLU is fluoranthene, and PYR is pyrene. 
Model Selection 
The top five variables given from COIA predicting PAH in vivo exposure were 
FOREhST release of chrysene, fluoranthene, anthracene, and benzo(a)anthracene, followed by 
soil arsenic concentration.  We evaluated these variables as well as soil concentration and 
FOREhST release of the individual PAH (either benzo(a)anthracene or benzo(a)pyrene) for their 
ability to predict bioavailability. After removing non-significant predictor variables, the most 
parsimonious model for benzo(a)anthracene AUC48 includes FOREhST release of 
benzo(a)anthracene, fluoranthene and chrysene, while the most parsimonious model for 
benzo(a)pyrene AUC48 includes FOREhST release of benzo(a)pyrene and benzo(a)anthracene 
(Figure 4.3).  COIA does not evaluate information criterion and thus, will identify multiple 
predictors, whereas stepwise regression eliminates predictors based on their information content.  
When combining significant predictor variables into a general linear model (B(a)AAUC48 ~ 
B(a)AFOR + FLUFOR + CHRFOR), the predicted AUC48 values were compared to observed 
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AUC48 resulting in a slope of 1.0, r2 of 0.66, and p <0.0005.  For benzo(a)pyrene, the general 
linear model predicts observed AUC48 with a slope of 1.0, r2 of 0.65, and p <0.0005.  
 
Figure 4.3 Comparison of observed AUC48 (area under the 48 hr plasma concentration 
curve) versus linear model predicted AUC for benzo(a)anthracene and benzo(a)pyrene PAHs 
(top) and the corresponding coefficient for each predictor variable (bottom).  Coefficients were 
determined using structure equation modelling.    Data points for observed AUC48 represent the 
mean of 6 measurements while error bars represent the standard error of this mean.     
Abbreviations are as follows: B(a)A is benzo(a)anthracene, CHR is chrysene, FLU is 
fluoranthene, and B(a)P is benzo(a)pyrene. 
Structure Equation Modelling  
Our hypothesized causal network linking bioaccessibility to bioavailability was 
congruent (P = 0.11 for benzo(a)anthracene and P = 0.13 for benzo(a)pyrene) with the data 
(Table B8).  A non-significant P value for a SEM indicates the likelihood that a completely 
random models fits the data better than the hypothesized causal network.   Other SEM fit values, 
e.g. CFI and RMSE, all indicate that the SEM represented the data reasonably well (Figure B6).  
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Only PAH bioaccessibility and not soil organic carbon content were significant predictors of 
bioavailability (Table B8).   The standardized coefficients, used for comparing within a model, 
predicting benzo(a)anthracene AUC48 given by structure equation modelling were -1.8 for 
FOREhST benzo(a)anthracene, -0.29 for FOREhST chrysene, and 2.5 for FOREhST 
fluoranthene.  The standardized coefficients predicting benzo(a)pyrene AUC48 were -0.56 for 
FOREhST benzo(a)pyrene and 1.0 for FOREhST benzo(a)anthracene.  The SEM coefficients 
suggest that benzo(a)anthracene and fluoranthene counter-act each other in predicting 
benzo(a)anthracene bioavailability.  In contrast, benzo(a)anthracene and benzo(a)pyrene counter-
act each other in predicting benzo(a)pyrene bioavailability. 
Co-solubility 
In the absence of soil (i.e. only water or bile), PAHs significantly decreased the 
bioaccessibility of other PAHs.  The amount of benzo(a)pyrene solubilized in 100 mL of de-
ionized water was 94 ± 14 µg (mean ±SE), was reduced to 39 ± 15 µg in the presence of 
phenanthrene, significantly (p<0.05) reduced to 15 ± 4.8 µg in the presence of phenanthrene and 
pyrene, and 13 ± 6.1 µg in the presence of phenanthrene, pyrene and benzo(k)fluoranthene 
(Figure 4.4).  The amount of bioaccessibile benzo(a)pyrene in 100 mL of simulated bile fluid 
was 36 ± 17 µg, and was significantly (p<0.05) reduced to 8.0 ± 2.5 µg in the presence of 
phenanthrene, 1.3 ± 2.1 µg in the presence of phenanthrene and pyrene, and 8.1 ± 2.1 µg in the 
presence of phenanthrene, pyrene and benzo(k)fluoranthene (Figure 4.4).  
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Figure 4.4 Bioaccessible fraction of benzo(a)pyrene in either water or bile in the presence of 
other PAHs.  Approximately 30 mg of each PAH was added to the respective treatment which 
was above the solubility limit for the PAHs. Abbreviations are as follows: B(a)P is 
benzo(a)pyrene, PHEN is phenanthrene, PYR is pyrene, and B(k)F is benzo(k)fluoranthene.  * 
indicates a significant (p<0.05) difference from bioaccessibility in the presence of only 
benzo(a)pyrene, i.e. only benzo(a)pyrene by itself. 
 
Low-Energy FOREhST of Spiked Field Contaminated Soils 
In contrast to the results in water and bile, PAH interactions in the presence of soil can 
increase the bioaccessibility of other PAHs.  Benzo(a)anthracene was spiked into the low energy 
FOREhST model at 0, 0.38, 0.75, 1.5, 3.0 and 6.0 µg, resulting in a significant increase (p < 
0.05) in the amount of benzo(a)pyrene bioaccessibility when spiking 3.0 and 6.0 µg 
benzo(a)anthracene (Figure 4.5).  Fluoranthene was spiked into the low energy FOREhST model 
at 0, 2.3, 4.5, 9.0, 18 and 36 µg, resulting in no significant difference in benzo(a)anthracene 
bioaccessibility (Figure 4.5).  
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Figure 4.5 Top – Amount of benzo(a)pyrene released from soil in FOREhST fluids in the 
presence of increasing amounts of benzo(a)anthracene.  Bottom – Amount of benzo(a)anthracene 
released in the presences of increasing amounts of fluoranthene. Each bar was the mean release 
from 5 soils and error bars represent the error of this measurement with the entire experiment 
duplicated.  .  ‘*’ denotes a significant difference from acetonitrile control spike at p < 0.05. 
4.6 Discussion 
The FOREhST model successfully predicts 66% of the variance in benzo(a)anthracene 
and 65% of the variance in benzo(a)pyrene internal exposure across 14 soils polluted with a 
mixture of PAHs.  To our knowledge, this was the first successful application of in vitro digestor 
results to estimate PAH bioavailability across multiple soils.  We achieved this by: (i) 
incorporating PAH-PAH interactions into the predictive algorithm, and (ii) altering the energetic 
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input of the in vitro digestors.  We were led to these modifications by building on key concepts 
outlined by Reichenberg and Mayer (2006) that chemical activity, bioaccessibility and 
bioavailability are conceptually distinct.  Specifically, bioaccessibility was a combination of 
chemical activity and solubility, and thus, human in vitro digestors should not be designed to 
solely estimate chemical activity because factors, other than chemical activity, can influence 
bioaccessibility.           
At environmentally relevant concentrations, PAH-PAH interactions can influence 
bioaccessibility and bioavailability. Phenanthrene, pyrene, and benzo(a)pyrene were used based 
on previous work that demonstrated the importance of this PAH-PAH interactions (Chun et al. 
2002; Voparil et al. 2003).  For example, Chun et al. (2002), attribute the change in PAH 
solubility from PAH-PAH interactions to PAH-micelle interactions. Using benzo(a)pyrene and 
phenanthrene in both artificial sea water and Arenicola marina gut fluid, Voparil et al. (2003) 
found that phenanthrene did not significantly change the benzo(a)pyrene concentration in the 
artificial sea water, whereas benzo(a)pyrene concentration was increased to 154% in Arenicola 
marina gut fluid in the presence of phenanthrene, alluding to the importance of the PAH-micelle 
interaction.  Using phenanthrene, pyrene and fluoranthene with various surfactants and water, 
Prak and Pritchard (2002) found that PAH-micelle interactions was a significant factor but also 
that PAH-PAH interactions influenced the water solubility of fluoranthene.  
Typically PAH-PAH experiments are in reduced mixtures of only 1 to 3 PAHs, e.g. Chun 
et al. (2002), Voparil et al. (2003), Prak and Pritchard (2002), etc.  In contrast, our dosed soils 
contained more than 11 PAHs.   Thus, an alternate numerical method was needed to incorporate 
PAH-PAH interactions because we were comparing two matrices, bioaccessibility and 
bioavailability which contained 14 soils by 11 PAHs.   Co-inertia analysis is one such method.  
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We used co-inertia to link the matrix of PAH bioaccessibility with PAH internal exposure and 
identified that FOREhST release of chrysene, fluoranthene, anthracene, and benzo(a)anthracene 
were the principle components governing PAH uptake in vivo.  For benzo(a)pyrene, we confirm 
that benzo(a)anthracene influences benzo(a)pyrene soil bioaccessibility.  In contrast, 
fluoranthene does not increase benzo(a)anthracene soil bioaccessibility as predicted by statistical 
modelling bioaccessibility (Figure 4.5).  Notably, PAH-PAH interactions are not limited to just 
desorption (White et al. 1999) and solubility (Chun et al. 2002; Prak and Pritchard 2002; Voparil 
et al. 2003), as PAH interactions are also relevant with cellular responses.  DNA damage to 
HepG2 cells is modulated based on specific binary PAHs mixtures (Tarantini et al. 2011).  
Furthermore, induction of PAH metabolizing enzymes, CYP1A1 and CYP1A2, are dependent 
upon exposure to specific PAHs (Vakharia et al. 2001). 
The collinearity of individual PAH bioavailabilities or bioaccessibilities likely reflects 
fundamental chemical-chemical interactions.  PAHs with similar molecular weight, ring number, 
and structure have strong influences on each other.  For example, Liu et al. (2013) reports a 
significant correlation for PAH soil concentration of all 16 PAHs examined but a stronger 
correlation for PAHs of similar molecular weight. Similarly, the PAH ratio of compounds w used 
in PAH source appointment because ratios of similar PAHs are consistently found based on 
source (Tobiszewski and Namiesnik 2012; Yunker et al. 2002). Although our results suggest the 
importance of chrysene, fluoranthene, benzo(a)anthracene, this may be limited to our sample set 
of 14 soils.  In other soils, factors such as PAH source (Juhasz et al. 2016; Tobiszewski and 
Namiesnik 2012; Yunker et al. 2002), PAH concentration, sorption sink (Vasiluk et al. 2007), 
desorption media (Oomen et al. 2002; Reichenberg and Mayer 2006), soil physio-chemical 
properties (Cornelissen et al. 2005), dietary constituents (Voparil et al. 2003), and co-
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contaminants (Voparil et al. 2003) may further influence the partitioning dynamic of PAHs and 
thus, may influence the equations describing the link between in vitro bioaccessibility and in vivo 
internal exposure.  
Energetic input through shaking method was responsible for up to 99% of PAHs released 
from in vitro models. PAH release from the low energy FOREhST was between 0.66% 
(anthracene) and 31 % (fluoranthene) with an average of 19% between PAHs compared to the 
high energy FOREhST.  PAH kinetic desorption from soil will be dependent upon the energy of 
the system, both kinetic and thermal, interacting with the PAH-soil binding media, amorphous 
organic matter and carbonaceous geosorbents.  Given the limited desorption time of the 
FOREhST model, i.e. 4 hours, the majority of desorbed PAHs were likely bound to the rapidly 
desorbing amorphous organic matter as opposed to the slowly desorbing recalcitrant 
carbonaceous geosorbents.  However, these rapidly released PAHs from amorphous geosorbents 
may in turn, influence PAH release from carbonaceous geosorbents.  For example, White et al. 
(1999) observed that freshly spiked anthracene or pyrene into soil leads to increased aged 
phenanthrene extraction by a mild solvent and increased biodegradation, suggesting that PAHs 
compete for and interact at the slow desorption sites of carbonaceous geosorbents.  Within the 
FOREhST model, it is uncertain if a similar interaction is occurring between the rapidly 
desorbed PAHs competing with the recalcitrant PAHs to influence bioaccessibility.   If this 
interaction is occurring, this may explain the energetic disparity between the low and high 
energy FOREhST with PAH desorbed from amorphous organic matter in the high energy 
FOREhST increasing PAH desorption rate from the carbonaceous geosorbents.  In either case the 
high energy FOREhST desorbs PAHs at a rate such that there is a strong correlation to soil PAH 
concentration, and we’ve repeatedly observed that soil concentration does not correlate with 
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bioavailability (James et al. 2011; James et al. 2016).  As a product of the desorption kinetics and 
desorption time of in vitro models, energetic input becomes a dominant factor linking PAH 
desorption from soil in an in vitro model to mammalian PAH uptake into the blood stream.  Yet 
oddly, this factor has not been identified in the round robins of in vitro digestor performance that 
have been performed previously (Oomen et al. 2002; Van de Wiele et al. 2007).  Notably, the 
energetic input does not appear to affect all PAHs equally.  In Figure 4.5, the high energy 
FOREhST does not accurately predict anthracene, fluoranthene and pyrene AUC48, whereas 
only fluoranthene was not predicted in the low energy FOREhST model.  Suggesting that for 
these relatively lower molecular weight PAHs, energetic input was not a dominant factor. 
When considered as single contaminants, PAH bioaccessibility and bioavailability was 
strongly linked to soil characteristics (Duan et al. 2014; Minhas et al. 2006; Vasiluk et al. 2007).  
When considered as a mixture, PAH-PAH interactions dominate.   Our work suggests that future 
work on PAH bioavailability and bioaccessibility should focus on the dynamics of how the 
matrix of PAHs present in the soil interact with mammalian systems.   Such interactions should 
not only include the chemical interactions discussed here but also the interactions of PAH 
mixtures with mammalian uptake systems.    
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5 POLYCYCLIC AROMATIC HYDROCARBON MIXTURES: EFFECTS ON 
METABOLISM AND BINDING TO CELLULAR COMPONENTS 
5.1 Preface 
The following chapter has been prepared in the style of a peer-reviewed journal article with 
the Steven D Siciliano as a co-author.  Currently the chapter has not been submitted to a peer-
reviewed journal, but would ideally be submitted to Environmental Toxicology and Chemistry.  
Steven Siciliano (University of Saskatchewan) – supervisor involved with all aspects of 
project oversight. 
As the lead author, Kyle James, performed 100% of the lab work, 100% of the data analysis, 
and 95% of the manuscript writing. 
In the following chapter PAH biochemical interactions are investigated using an intestinal 
porcine cell line (IPEC-J2).  Building on the results founded in Chapter 3, where PAH 
bioavailability was dependent upon soil and PAH physiochemical properties, and furthered 
examined in Chapter 4 where accounting for PAH physiochemical interactions improves 
predictions of PAH bioavailability, Chapter 5 investigates PAH mixtures from a biochemical 
persepctive.  In Chapter 5, IPEC-J2 cells were exposed to PAH mixtures outlined in Chapter 4 to 
investigate the same PAH mixtures from a biochemical perspective.  Biochemical measurement 
endpoints included metabolism and cellular partitioning of PAHs.  The research suggests that 
while PAH interactions will affect PAH cellular partitioning and metabolism, they did not 
consistently agree with predicted values from co-inertia analysis and structure equation 
modelling found in Chapter 4.  
5.2 Abstract 
PAH interactions influence partitioning between soil and simulated intestinal fluid, 
affecting PAH release from soil and improving predictions of PAH bioavailability.  In an attempt 
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to provide further insight regarding PAH interactions, an intestinal porcine enterocyte cell line 
(IPEC-J2) was exposed to PAH mixtures to investigate the relative rate of PAH metabolism and 
PAH partitioning to cellular components. When IPEC-J2 cells are exposed to a 
benzo(a)anthracene/fluoranthene mixture, the amount of benzo(a)anthracene remaining after 2 
hours is significantly reduced from 65 ± 9.0% to 54 ± 9.1% for the 
benzo(a)anthracene/fluoranthene mixture, however in a tertiary mixture of 
benzo(a)anthracene/fluoranthene/chrysene 64 ± 15% of the benzo(a)anthracene remained after 
the 2 hour exposure.  A significant increase of benzo(a)pyrene partitioned to cellular components 
was observed for solo benzo(a)pyrene exposure (0.23 ± 20) compared to a 
benzo(a)pyrene/benzo(a)anthracene mixture (0.68 ± 0.58).    Exposure to PAH mixtures resulted 
in PAH interactions which affected both metabolism and cellular partitioning.  The PAH 
interactions were PAH dependent and occurred in a limited number of mixtures. The work here 
suggests that PAH mixtures can be a crucial factor for PAH studies examining PAH metabolism 
and PAH partitioning, particularly PAH bioavailability. 
5.3 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are widespread carcinogenic environmental 
contaminants produced worldwide through biogenic, petrogenic and pyrogenic sources (Page et 
al. 1999; Tobiszewski and Namiesnik 2012; Yunker et al. 2002).  PAHs found in the 
environment are present as complex mixtures and the mixture composition is attributed to source 
profile (Tobiszewski and Namiesnik 2012; Yunker et al. 2002). PAHs interact with each other 
from a physiochemical perspective influencing desorption from soil (White et al. 1997; White et 
al. 1999) and from a biochemical perspective by inducing or inhibiting their own metabolism 
(Lampen et al. 2004; Shimada et al. 2003; Shimada and Guengerich 2006; Spink et al. 2008).  
Furthermore, PAHs can competitively bind proteins within the cell as demonstrated by Merchant 
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et al. (1992), where benzo(ghi)perylene out competes benzo(a)pyrene for protein adsorption, 
resulting in higher concentrations of free cellular benzo(a)pyrene. Such physiochemical and 
biochemical interactions likely influence PAH exposure to humans.    
For orally ingested PAHs, the enterocytes of the small intestine form the first tissue 
encountered with the capacity to metabolize PAHs.  After uptake, PAHs are metabolized by CYP 
enzymes, such as CYP1A1, 1A2, 1B1 and 3A4 which creates various metabolites such as 
epoxide, quinone, and hydroxyl molecules (Ding and Kaminsky 2003; Ramesh et al. 2004; 
Shimada and Guengerich 2006).  Whereas CYP3A4 is the dominant enzyme in hepatic tissue, 
CYP1A1, 1A2, and 1B1 are the prominent enzymes in extra-hepatic tissue, such as enterocytes 
of the small and large intestine (Ding and Kaminsky 2003).         
Incorporating the metabolism of PAH mixtures may be a key component in developing 
an in vitro digestion bioaccessibility model to mimic in vivo bioavailability of PAHs.  In vivo 
bioavailability measurements are influenced by metabolism (Juhasz et al. 2014; Ramesh et al. 
2004; Ruby et al. 2016), whereas many in vitro digestion models, such as PBET, FOREhST, and 
SHIME do not contain biotic PAH metabolizing systems (Cave et al. 2010; Ruby et al. 2002).  
Oomen et al. (2001) and Vasiluk et al. (2007) extracted contaminants from soil with simulated 
intestinal fluids using the PBET model and exposed a confluent monolayer of caco-2 (human 
colon carcinoma) cells to a 1:1 mix of simulated and culture media to determine bioaccessibility. 
For Vasiluk et al. (2007), [14C]-labeled B(a)P was used therefore metabolism was not 
influencing the measurements and Oomen et al. (2001) did not believe caco-2 metabolism of 
lindane was significant relative to hepatic metabolism, and thus was not addressed.   
PAH-PAH interactions influence partitioning, bioaccessibility and bioavailability (James 
et al. 2016).  These PAH-PAH interactions can potentially occur by altering chemical adsorption 
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characteristics or chemical metabolic fate.  For example, benzo(a)anthracene spiked into soil 
increased benzo(a)pyrene desorption from soil, thus increasing bioaccessibility (James et al. 
2018) via a chemical competitive adsorption process.  Alternatively, PAHs, and PAH 
metabolites, depending on the specific compound, can induce or inhibit CYP enzymes (Iwanari 
et al. 2002; Shimada et al. 2003; Shimada and Guengerich 2006).   Benzo(a)anthracene inhibits 
human CYP1A1, 1A2, and 1B1 activity (Shimada and Guengerich 2006), suggesting a possible 
biochemical interaction with benzo(a)pyrene co-exposure.  Other PAHs, such as chrysene and 
fluoranthene, induce CYP enzymes (Iwanari et al. 2002; Shimada et al. 2003).  Notably, CYP 
enzyme induction/inhibition is not only PAH dependent, but can be species, tissue and cell 
specific (Iwanari et al. 2002; Shimada et al. 2003; Vondracek et al. 2017), as fluoranthene in fish 
can inhibit CYP1A activity (Willet et al. 2001).    However, little is known about PAH-PAH 
interactions that occur during incidental soil ingestion.  Our previous work demonstrated that 
there were chemical adsorption interactions; this work, explored the biochemical effects of PAH 
mixture ingestion.    
We used an intestinal porcine enterocyte cell line (IPEC-J2) to investigate PAH-PAH 
biochemical interactions and provide results comparable to James et al. (2016) and James et al. 
(2018) which used the juvenile swine model. Within a mammalian cell, a contaminant resides in 
at least two compartments, free and bound (Lesca et al. 1994; Merchant et al. 1992; Raha et al. 
1990), with the amount between these two compartments described by a distribution coefficient 
(Lesca et al. 1994).  Thus, building on the work of Merchant et al. (1992), we investigated how 
the proportion of bound-PAH is influenced by PAH mixture using an intestinal cell line model 
system and hypothesize that PAH mixture will influence the partitioning between compartments 
as well as the relative rate of metabolism. 
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5.4 Materials and Methods 
5.4.1 Chemicals and Reagents 
Dimethyl sulfoxide (DMSO), benzo(a)anthracene (99%), chrysene (98%), and 
fluoranthene (99%) were all obtained from Sigma-Aldrich.  Benzo(a)pyrene was obtained from 
MRI global.  Stock solutions of each PAH were prepared by dissolving PAHs in DMSO.  Stock 
solutions were stored at room temperature and dilutions were made immediately prior to use.  
5.4.2 Intestinal Porcine Enterocyte Cell Line (IPEC-J2)   
The IPEC-J2 cells were graciously donated by Dr. Natacha Hogan, University of 
Saskatchewan, were grown in DMEM/F12 (Dulbecco’s modified Eagle medium/ Ham’s F-12 
mixture), supplemented with 5% fetal bovine serum (v/v), 1% penicillin/streptomycin (v/v), and 
0.1% epidermal growth factor (v/v).  The IPEC-J2 cell cultures were maintained in 250 mL 
tissue culture flasks, in a 5% CO2 incubator at 37°C.  When necessary, cell cultures nearing 
confluency were removed from the flask using TrypLE Express 1X Disassociation Reagent 
(Gibco – Lifetech), an alternative to trypsin, centrifuged and diluted back into culture flasks.  For 
exposure conditions, cell cultures nearing confluency were removed from the flask using TrypLE 
Express 1X Disassociation Reagent, plated onto 96-well plates at a density of 1 × 105 
cells/well, and grown for 48 hours to a density of 1 × 106 cells/well.  At approximately 48 hours 
post plating, the IPEC-J2 cells were treated according to their respective experimental sections. 
5.4.3 PAH Recovery from Glass and Plastic 96-Well Plates 
To determine ideal experimental methodology, the abiotic recovery of PAHs present in 
100 µL of media was determined for 1, 2, 4, 8, and 24 hour incubations with both glass and 
plastic 96-well plates.  Glass and plastic 96-well plates were obtained from ThermoFisher 
Scientific.  To prevent evaporative losses, breathable sterile rayon film is used to seal the 96-well 
 74 
plates. For each endpoint there were three experimental replicates and each experimental 
replicate consisted of six technical replicate samples with the 96-well plate.      
5.4.4 WST-1 Assay 
Cell viability was evaluated using the WST-1 assay that utilizes colorimetric differences 
to determine cytotoxicity.  Metabolically active cells produce NADPH, which triggers the 
cleavage of the WST-1 tetrazolium salt to produce a formazan dye (Berridge et al. 1996).  
Incubations were for 24 hours and treatments consist of 100 µL media, media with DMSO 
(0.01% total volume), or media with PAHs dissolved in DMSO into 200 µL 96-well plates.  
PAH treatments consists of three dose levels (0.2 µM, 1 µM, and 10 µM) for each PAH, 
benzo(a)pyrene, benzo(a)anthracene, chrysene, and fluoranthene.  Previous researchers have 
exposed mammalian cells to PAH concentrations between 0.5-10 µM (Bessette et al. 2005; 
Vakharia et al. 2001; Larrson et al. 2012).  The exposure concentrations for the WST-1 assay 
were chosen as 0.2 µM is an environmental relevant concentration based on bioaccessible PAH 
concentrations from James et al. (2018), 1 µM provides greater statistical power based on 
analytical sensitivity for metabolism and cellular partitioning experiments, and 10 µM is a high 
exposure scenario to purposefully strain IPEC-J2 cells.       
After 24 hours, media was aspirated off and to each well, 100 µL media containing 10% 
(v/v) WST-1 reagent was added.  The plate was incubated for an additional 3 hours and readings 
were taken at 0.5, 1, 2, and 3 hours using a spectrophotometric plate reader at 440 nm and 
background reference wavelength at 620 nm, according to the manufacturer’s instructions.  The 
percentage of viability was calculated relative to a media treatment control wells from triplicate 
observations. For each endpoint there were three experimental replicates and each experimental 
replicate consisted of six technical replicate samples with the 96-well plate. 
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5.4.5 PAH Metabolism by IPEC-J2 
The metabolism of benzo(a)pyrene and benzo(a)anthracene by IPEC-J2 cells was 
determined using 100 µL of treated media in plastic 96-well plates at 1 and 2 hour incubations of 
cells with PAH mixtures.  Cells were plated at a density of 1 × 105 cells/well, and grown for 48 
hours to a density of 1 × 106 cells/well.  Treatment groups consist of 1µM concentrations of: 
benzo(a)pyrene, benzo(a)pyrene/benzo(a)anthracene, benzo(a)anthracene, benzo(a)anthracene/ 
fluoranthene, benzo(a)anthracene/chrysene, and benzo(a)anthracene/fluoranthene/chrysene.   At 
each time interval 100 µL of medium was removed from six replicate wells and samples were 
diluted with 1.7 mL of acetonitrile in 2 mL amber HPLC vials.  Each well was washed with 100 
µL of acetonitrile three times. Samples were stored at -20 °C until analysis, diluted with 1.7 mL 
of acetonitrile in 2 mL amber HPLC vials.    In addition to the six replicates wells per 
experimental unit, there were five experiment units for each treatment.   
PAH metabolism is estimated by measuring parent PAHs remaining after 2 hour 
exposure by HPLC.  To account for PAH losses due to evaporative losses as well as 
absorption/adsorption, the total amount of PAHs recovered is corrected to the recovery of abiotic 
controls (see Section 5.4.8 Quality Assurance Quality Control).  By accounting for the abiotic 
losses, it is assumed that all additional PAH losses is the result of metabolism. 
5.4.6 PAH Binding to Cellular Components 
Measuring benzo(a)pyrene and benzo(a)anthracene binding to cellular components was 
performed similarly to PAH metabolism. Cells were plated at a density of 1 × 105 cells/well, 
and grown for 48 hours to a density of 1 × 106 cells/well.  After the 48 hour growth period, 
cells were killed by removing the media and subsequent 1 hour UV light exposure.  Post UV 
exposure, cells were exposed to 100 µL of media in 96-well plates for incubations of 1 and 2 
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hours with PAH mixtures.  Treatment groups consist of 1µM concentrations of: benzo(a)pyrene, 
benzo(a)pyrene/benzo(a)anthracene, benzo(a)anthracene, benzo(a)anthracene/fluoranthene, 
benzo(a)anthracene/chrysene, and benzo(a)anthracene/fluoranthene /chrysene.  At the designated 
incubation time, media was removed from the well and placed in microtubes.  Each well was 
then incubated with 100 µL of 0.25% TrypLE Express in PBS.  The cell suspension was then 
added to the appropriate microtube and centrifuged at 14,600 g for 10 min.  The supernatant 
media (~200 µL) was diluted with 1.6 mL of acetonitrile in 2 mL amber HPLC vials.  The cell 
pellet was washed with 100 µL of acetonitrile and diluted with 1.7 mL of acetonitrile in 2 mL 
amber HPLC vials.  A diagram of the method is available in Appendix C (Figure C1).  Samples 
were stored at -20 °C until analysis.  For each endpoint there were five experimental replicates 
and each experimental replicate consisted of six technical replicate samples with the 96-well 
plate. 
5.4.7 HPLC 
Prepared PAH samples were analyzed using an Agilent 1260 Infinity High Pressure 
Liquid Chromatography coupled with Fluorescence Detection (HPLC-FD) (Marriott et al. 1993). 
A 10 μL aliquot was injected onto an Agilent PAH Pursuit column (3 μm particle size, 100mm 
length, and 4.6 mm internal diameter) guarded with an Agilent Pursuit C18 MetaGuard (3 μm 
particle size, 2mm internal diameter). The column temperature was maintained at 25°C for the 
duration of the 25 min run.  The mobile phase consists of acetonitrile and water with a flow rate 
of 1.5 mL min-1.  At the start of the run the solvent gradient was 60:40 acetonitrile: water, 
gradually increases to 95:5 acetonitrile: water at 20 m, and was held constant until the end of the 
run.  The fluorescence detector employs a constant excitation wavelength of 260 nm and four 
emission wavelengths of 350, 420, 440, and 500 nm.  Detection limits for fluoranthene was 1.71 
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pg µL, benzo(a)anthracene was 2.45 pg µL, chrysene was 5.27 pg µL, and benzo(a)pyrene was 
13.02. 
5.4.8 Quality Assurance Quality Control  
To account for evaporative losses and adsorption/absorption of PAHs to plate walls, the 
PAH recovery of each experimental unit was corrected to abiotic controls measuring PAHs 
recovered from media without IPEC-J2 cells.  The average recovery of benzo(a)anthracene, 
benzo(a)pyrene, and fluoranthene from abiotic controls throughout all experiments ranged from 
72.6% to 107% with the highest standard deviation of 18.6%.  The maximum difference between 
PAH recovery in a single experimental unit was 13.6%  (86.2% for fluoranthene and 72.6% for 
benzo(a)anthracene)  PAH metabolism and partitioning experiments are corrected to the parallel 
abiotic controls relative to their experimental unit where the average standard deviation was 
8.6%. The average recovery of chrysene ranged from 9.5% to 38.9%.   
5.4.9 Statistical Analysis 
All data that was non-normally distributed typically were log-normally distributed and 
therefore was log-transformed prior to analysis.  Tests of significant difference were performed 
using either one way ANOVA (p < 0.05) or student’s t-test with a Bonferroni correction where 
appropriate (p < 0.05).   
5.5 Results 
Glass and Plastic PAH Recovery 
The abiotic PAH recovery from plastic 96-well plates after 1 and 2 hour incubation 
averages 77.6% to 90.0%, except for chrysene, for which recovery averages 27.7% to 31.3% 
(Table 5.1).  PAH recovery from glass 96-well plates after 1 and 2 hour incubation averages 
54.6% to 89.6%, except for chrysene, for which recovery averages 17.4% to 27.8%.  Incubations 
times of 4 hours and longer had significantly lower PAH recovery (p < 0.05) (Table 5.1). 
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WST-1 Cytotoxicity 
 The PAHs fluoranthene, benzo(a)anthracene, chrysene, and benzo(a)pyrene display no 
overt signs of cytotoxicity to IPEC-J2 cells from doses of 0.2 μM up to 10 μM according to 
WST-1 viability results (Figure 5.1).  Whereas the control cultures of 0.01% and 0.001% triton 
resulted in an average cell viability of under 30% (Figure 5.1).  Triton control groups were 
significantly different from PAH exposure groups, but not from each other (ANOVA, p < 0.05) 
Table 5.1 Recovery of PAHs over 24 hour dosing period in glass and plastic 96-well plates 
 
Time 
Glass (%) Plastic (%) 
FLU1 B(a)A1 CHR1 B(a)P1 FLU1 B(a)A1 CHR1 B(a)P1 
1 hour 
75.4 
(23.5) 
80.0 
(9.37) 
27.8 
(13.1) 
89.6 
(20.0) 
88.6 
(20.4) 
90.0 
(22.6) 
27.8 
(19.2) 
87.3 
(13.6) 
2 hour 
60.9 
(10.9) 
78.2 
(12.3) 
17.4 
(8.00) 
54.6 
(16.0) 
77.6 
(7.25) 
84.3 
(11.5) 
31.3 
(6.82) 
83.4 
(15.4) 
4 hour 
52.9 
(25.4) 
62.4 
(11.5) 
19.3 
(12.0) 
57.3 
(36.9) 
59.4 
(15.8) 
71.1 
(11.6) 
27.7 
(3.98) 
56.9 
(12.9) 
8 hour NA NA NA NA 
29.0 
(4.46) 
74.9 
(7.81) 
13.4 
(1.77) 
69.3 
(15.2) 
24 hour NA NA NA NA 
43.0 
(29.1) 
41.6 
(12.4) 
19.3 
(2.60) 
52.3 
(26.7) 
1Abbreviations are as follows: FLU is fluoranthene, B(a)A is benzo(a)anthracene, CHR is 
chrysene, and B(a)P is benzo(a)pyrene.  Reported value is the average of five replicates with the 
standard deviation in parentheses.  
Recovery was calculated as the total PAH recovered from ~100 µL media divided by the total 
amount of PAH added (1µM).  
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Figure 5.1 WST-1 cytotoxicity of PAHs to IPEC-J2 cells.  Cells were dosed with the 
following treatments 0.2 µM (●), 1 µM (◌), 10 µM (▼), DMSO control ( ), 0.01% triton (□), 
and 0.001% triton (■) (n = 3 and each treatment consists of six replicate samples). ANOVA 
tables indicate that 0.01% triton (□) and 0.001% triton (■) are significantly different from the 
other treatment groups, but not from each other.    
 
PAH Metabolism 
 The amount of benzo(a)anthracene remaining from the benzo(a)anthracene/fluoranthene 
mixture at 2 hours was the only mixture that was significantly different (P<0.05) from solo 
benzo(a)anthracene exposure (Figure 5.2).The remaining benzo(a)anthracene after 2 hour 
exposure was 65 ± 9.0% (mean ± standard deviation) for solo benzo(a)anthracene, 54 ± 9.1% for 
benzo(a)anthracene/fluoranthene, 64 ± 13% for benzo(a)anthracene/chrysene, 59 ± 18% for  
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benzo(a)anthracene/fluoranthene/chrysene and 64 ± 15% for 
benzo(a)anthracene/benzo(a)pyrene. The remaining benzo(a)pyrene after 2 hour exposure was 71 
± 6.9% for solo benzo(a)pyrene exposure and 69 ± 12% for benzo(a)pyrene/benzo(a)anthracene 
mixture.  Notably, the total PAH recovered has been corrected to PAH recovery from parallel 
abiotic control experiments.   
PAH Binding to Cellular Components 
 Three PAH mixtures, benzo(a)anthracene/fluoranthene, benzo(a)anthracene/chrysene, 
and benzo(a)anthracene/fluoranthene/chrysene at 2 hours resulted in significantly (P<0.05) less 
binding to cellular components than solo benzo(a)anthracene (Figure 5.3).  The average 
partitioning of benzo(a)anthracene into cellular components (amount in cells divided by amount 
in media) after 2 hour incubation was 0.74 ± 0.46  for solo benzo(a)anthracene, , 0.47 ± 0.13for 
benzo(a)anthracene/fluoranthene, 0.36 ± 0.16  for benzo(a)anthracene/chrysene, 0.45 ± 0.17  for  
benzo(a)anthracene/fluoranthene/chrysene, and 0.64 ± 0.43. Benzo(a)pyrene/benzo(a)anthracene 
mixture was significantly different from solo benzo(a)pyrene after 2 hour incubation (Figure 
5.3). The average partitioning of benzo(a)pyrene into cellular components after 2 hour incubation 
was 0.23 ± 0.20 for benzo(a)pyrene solo and 0.68 ± 0.58 for benzo(a)pyrene/benzo(a)anthracene.  
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Figure 5.2 Percentage of benzo(a)pyrene (left) or benzo(a)anthracene (right) remaining in cells and media after 2 hour incubation.  
`*`denotes a significant difference using Students t-test with Bonferroni correction (p < 0.05) compared to single compound exposure.  
Comparisons were made to the recovery of single compound mixtures at the given time point.   Small symbols represent the value of 
individual replicates while the large symbols represents the mean (n = 15) and error bars are the standard deviation of this mean. The 
percentage of PAH remaining was calculated as the total amount recovered divided by the total dose.  The total amount recovered was 
corrected to parallel abiotic control experiments. .Abbreviations are as follows: Flu is fluoranthene, B(a)A is benzo(a)anthracene, Chr 
is chrysene, and B(a)P is benzo(a)pyrene. 
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Figure 5.3 Partitioning of benzo(a)pyrene (left) and benzo(a)anthracene (right) between cells and media based on PAH mixture 
after 2 hour incubation. `*`denotes a significant difference using Students t-test with Bonferroni correction (p < 0.05) compared to 
single compound exposure.  Significant difference was compared the partitioning of single a compound at the given time point.  Small 
symbols represent the value of individual replicates while the large symbols represents the mean (n = 15) and error bars are the 
standard deviation of this mean.    The total amount recovered was corrected to parallel abiotic control experiments. Abbreviations are 
as follows: Flu is fluoranthene, B(a)A is benzo(a)anthracene, Chr is chrysene, and B(a)P is benzo(a)pyrene. 
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5.6 Discussion 
The original goal was to determine if cellular exposure to simple PAH mixtures can help 
explain the differences in bioaccessibility and bioavailability reported by James et al. (2016) and 
James et al. (2018).  Whereas, the statistical modelling by James et al. (2018) predicted that 
increased free fluoranthene would increase benzo(a)anthracene bioavailability, here it was found 
that fluoranthene co-exposure with benzo(a)anthracene decreased the amount of remaining 
benzo(a)anthracene (Figure 5.2), thus not likely to increase the bioavailable fraction of parent 
compound.  Notable, when cells were exposed to a fluoranthene/chrysene/benzo(a)anthracene 
mixture, benzo(a)anthracene metabolism is not significantly different from solo 
benzo(a)anthracene exposure (Figure 5.2).  The results here suggest that PAH kinetics and 
dynamics may not be confidently predicted with simple mixtures of one to three compounds.  
Larsson et al. (2012) investigated the differences in the relative potency of individual PAHs to 
PAH mixtures with as many as 15 PAHs mixed together for a luciferase bioassay.  Larsson et al. 
(2012), found good agreement in most PAH mixtures using a concentration addition model of 
individual PAHs but noted that as the number of PAHs in the mixture increased, predictions had 
a higher tendency to deviate from predicted values. Although researchers have acknowledged the 
influence of PAH interactions, the mixtures are oftentimes limited to a binary (Merchant et al. 
1992; Tarantini et al. 2011) or trinary scale (Chun et al. 2002).  
PAH interactions were unique to the mixture they were in.  For example, while a 
benzo(a)pyrene/benzo(a)anthracene mixture resulted in an increase of benzo(a)pyrene 
partitioning to cellular components, the mixture does not affect partitioning of 
benzo(a)anthracene to cellular components (Figure 5.3).  In contrast, benzo(a)anthracene 
mixtures with either or both fluoranthene and chrysene resulted in a significant decrease of 
partitioning to cellular components, although only a benzo(a)anthracene/fluoranthene mixture 
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resulted in a significant increase in benzo(a)anthracene metabolism (Figure 5.2).  Notably, PAH 
binding affinity to receptors and receptor induction are both PAH dependent (Bosveld et al. 
2002; Kamps and Safe 1987; Larsson et al. 2012; Piskorskapliszczynska et al. 1986; Topinka et 
al. 2008).    
There are many complicating factors for PAH exposure to organisms.  Exposure to 
environmental PAHs typically occurs as mixture of PAHs, of which there are numerous parent, 
akly-, nitro-, and oxidative-PAHs, as well the metabolites of the aforementioned PAHs that will 
influence PAH exposure through the numerous potential interactions with either each other 
(White et al. 1997; White et al. 1999) or with cellular responses (Shimada et al. 2008).Species, 
tissue and cell specificity for induction of metabolism and cell binding may further influence the 
unique cellular response (Iwanari et al. 2002; Shimada et al. 2003; Vondracek et al. 2017).  In an 
attempt to minimize these complications only simple PAH mixtures of 1-3 parent PAH 
compounds were used in this study.  Ideally, PAH mixtures would be dominated by primary 
interactions, i.e. one or two other PAHs as predicted by James et al. (2018).  However this ideal 
scenario does not appear to be the likely for biochemical responses. An intestinal porcine 
enterocyte cell line (IPEC-J2) was used to generate comparable results to previous research by 
James et al. (2016) and James et al. (2018), where bioavailability was determined from landrace 
female juvenile swine, 8-9 weeks old.  Notably, IPEC-J2 cells were isolated from the jejunum of 
unsuckled newborn mixed breed piglets (Berschneider 1989; Vergauwen 2015).  The 
discrepancy between mixed breed vs landrace swine, as well as newborn (< 1 day) vs juvenile 
(8-9 weeks) may also contribute to varying results. Lastly, whereas a swine jejunal cell line was 
used to measure metabolism of PAHs, whole organism exposure may also have significant 
 95 
 
 
metabolic contributions from the liver, duodenal, ileal and colon cells which likely influence 
PAH exposure.   
Exposure time was limited to 2 hours and plastic 96-well plates were favored over glass 
96-well plates. Exposure of 4 hours led to PAH recovery at best of 71 ± 11 % but typically 
between 50 -60% (Table 5.1).  Although 2 hour exposure time may not be optimum for 
metabolic activation, Barranco et al. (2017) found that 6 hours was enough to illicit maximum 
response from CYP1A1 in zebrafish embryos.  Intestinal transit times through the stomach and 
small intestine average approximately 5 hours (Madsen et al. 1992) and PAH bioaccessibility 
models are based on physiological conditions transit times range between 4 to 18 hours (Oomen 
et al. 2002; Van de Wiele et al. 2007).  Although longer exposure likely result in greater relative 
metabolism, they may not be representative of mammalian exposure.  
Disappearance of parent PAHs is primarily due to three processes: metabolism by IPEC-
J2 cells, evaporation, and adsorption/absorption to the sides of the walls.  To account for the 
evaporative losses and adsorption/absorption of PAHs in 96-well plates, all PAHs were corrected 
to the relative recovery of PAHs from 100 µL media.  Theoretically, metabolism of PAHs by 
IPEC-J2 cells should be the primary process responsible for the disappearance of each PAH.  
Direct measurement of PAH metabolites would be ideal, however PAHs typically undergo 
multiple steps of metabolism, see review by Ramesh et al. (2004), and there are numerous 
individual metabolites which further complicates measuring rates of PAH metabolism.  One 
method to simplify the measurement of multiple metabolites is to conjugate groups of 
metabolites with sulfate or glucuronic acid and simply measure for the entire group (Autrup 
1979).  In the present study we attempted to use physiological relevant concentrations of parent 
PAH, 0.2 µM, and although cytotoxicity and recovery at 0.2 µM was acceptable (data not 
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shown), the analytical sensitivity would not allow for detection of significant differences 
between metabolism at such low concentrations, thus a concentration of 1 µM was used.  
PAH binding to cellular components and PAH metabolism can be significantly affected 
by PAH mixture. In support of the hypothesis, a benzo(a)anthracene/benzo(a)pyrene mixture 
increased the amount of free benzo(a)pyrene.  In contrast, various mixtures of fluoranthene, 
chrysene, and benzo(a)anthracene does not increase the available benzo(a)anthracene as 
predicted by James et. (2018). Unfortunately, simple PAH mixtures of 2-3 PAHs are unlikely to 
predict the interactions from complex PAH mixtures present in environmental matrixes.   Our 
work supports previous findings (Larsson et al. 2012), where although simple mixtures can be 
reliably predicted, predictions deviate as mixture complexity increases.  Future work 
investigating cellular responses to PAHs should consider a variety of complex mixtures to attain 
a more accurate biochemical response. 
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6 SYNTHESIS 
Human health risk assessment for oral absorption of soil-borne PAHs currently use a 
default conservative estimate of 100%.  This default estimate naturally leads to overestimation of 
human risk.  Estimating oral PAH soil bioavailability from animal models are costly, time 
consuming and ethically impractical, hence the development of in vitro bioaccessibility models 
to circumvent these challenges.  Currently, the major issue with using in vitro bioaccessibility 
models is that they have not been validated to accurately predict the bioavailability across many 
soils from across the world, therefore leading to inaccurate estimates of human exposure.  
Without in vitro or in vivo models, PAH soil absorption, exposure assessment and subsequent 
risk assessment are likely to be overestimated.  These overestimations may cause unnecessary 
concern for the public as well as unnecessary remediation goals.  Therefore, the primary goal of 
this research was to develop an in vitro bioaccessibility model that improves the prediction of in 
vivo bioavailability.   The principle goals of this research was to further investigate factors 
influencing PAH bioavailability as it relates to PAH soil desorption, PAH interactions, energetic 
input of in vitro models, and cellular responses to PAH mixtures.  Overall the global objective 
was improving in vitro predictions of in vivo bioavailability.  
6.1 Principle Findings 
The PAH bioavailability varied significantly across soils, while it was found that PAH 
mixture will influence desorption of PAHs from soil and relative rates of metabolism, affecting 
exposure via bioavailability of parent compound.   From 14 soils, individual PAH concentrations 
ranged from ~1-750 µg g-, bioavailability was as high 87% and in contrast, bioavailability from 
some soils/PAHs was undetectable, i.e. 0% (Table 3.1 and Table A1).  The average 
bioavailability of all PAHs was between ~1-15%, while the median bioavailability was ~2-30% 
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(Table 3.1 and Table A1).  Although partitioning, as measured by fugacity, could not explain 
exposure between soils (Figure 3.2), it does explain exposure between PAHs (Figure 3.3).  
When accounting for energetic input and PAH interactions within an in vitro digestion model, in 
vitro bioaccessibile predictions of in vivo bioavailability were improved to significant 
correlations (p < 0.05) with r2 values of ~ 0.65 (Figure 4.3).  Although the observed effects of 
PAH mixture on PAH metabolism does not support statistical predictions, metabolism due to 
PAH mixture was a significant factor that affects parent PAH bioavailability (Figure 5.2).  The 
overall research demonstrates that PAH interactions were an integral aspect to PAH partitioning, 
metabolism, bioaccessibility, and bioavailability. 
A major obstacle for determining factors for PAH soil bioavailability is that many soil 
properties inter-correlate, particularly to PAH soil concentration (Figure 3.1 and Figure 3.2).  
PAH soil concentration is typically the denominator for calculating bioavailability, therefore any 
property correlated to PAH bioavailability may simply be a result of correlating to soil 
concentration.  To analyze the numerous inter-correlations SEM was used to illuminate the 
relationships between the multiple predictor variables (Figure 3.2; Table 3.2).  SEM revealed 
that benzo(a)pyrene was the only PAH where fugacity capacity and organic carbon content 
predict benzo(a)pyrene exposure (AUC48) independent of benzo(a)pyrene soil concentration 
(Figure 3.2).  PAH exposure averaged across soils can be predicted by fugacity with a slope of 
0.33 and r2 of 0.66 (p <0.005) (Figure 3.3). 
Energetic input and PAH interactions were essential components to creating an in vitro 
bioaccessibility to mimic in vivo bioavailability. By introducing a new shaking method which 
has a lower kinetic energy input, PAH desorption from soil was significantly reduced (Figure 
4.2).  Furthermore, the high energy FOREhST model had moderate correlations (r2’s ~0.4-0.6) to 
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PAH soil concentration (Figure 4.1), but as stated previously, correlating to soil concentration 
typically does not correlate to bioavailability.  Through a series of statistical analysis performed 
by COIA, SEM, and general linear modeling, improved predictions of in vivo exposure of 
benzo(a)pyrene and benzo(a)anthracene were made with the in vitro FOREhST model. PAH 
partitioning from PAH mixtures was not influenced uniformly, as Figure 4.4 demonstrates how 
PAH mixtures (up to 4 PAHs) influence partitioning of various PAHs. The general linear model 
predicting benzo(a)pyrene exposure was B(a)PAUC48 ~ B(a)AFOR + B(A)PFOR, while the general 
linear model for benzo(a)anthracene exposure was B(a)AAUC48 ~ B(a)AFOR + FLUFOR + CHRFOR 
(Figure 4.3).  Confirming the statistical modelling, spiked benzo(a)anthracene in FOREhST 
fluids with soil resulted in increased bioaccessbile benzo(a)pyrene, while in contrast spiked 
fluoranthene in FOREhST fluids with soil did not result in any significant difference of 
bioaccessible benzo(a)anthracene (Figure 4.5).   Interestingly, spiked benzo(a)anthracene 
influenced bioaccessible benzo(a)pyrene, whereas exposure of IPEC-J2 cells to a mixture of 
benzo(a)anthracene and benzo(a)pyrene does not alter metabolism of benzo(a)pyrene (Figure 
5.2).  Conversely, where spiked fluoranthene did not affect bioaccessible benzo(a)anthracene, 
IPEC-J2 cells exposed to a mixture of fluoranthene and benzo(a)anthracene resulted in a 
significant increase of benzo(a)anthracene metabolism (Figure 5.2). 
In summary, improved predictions of in vivo PAH bioavailability from in vitro PAH 
bioaccessibility can be made by accounting for the interactions of PAH mixtures.  In the research 
presented here, benzo(a)pyrene partitioning, bioaccessibility and bioavailability was primarily 
influenced by benzo(a)anthracene.  In contrast, while statistical modelling predicted that 
fluoranthene would affect benzo(a)anthracene bioavailability/bioaccessibility, no experimental 
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evidence was found to improve predictions, however fluoranthene did affect the metabolism and 
cellular partitioning of benzo(a)anthracene. 
6.2 Future Directions  
The results generated here indicate that PAH interactions will influence exposure, and by 
accounting for PAH interactions improved predictions of exposure can be made. To further 
improve in vitro predictions of in vivo bioavailability research regarding the complexities of 
PAH metabolism as it relates to PAH mixtures consisting of numerous, i.e. 10-plus, PAH 
compounds is needed.  To further complicate complex PAH mixtures is co-exposure of PAHs 
with other environmental contaminants, such as metals, pesticides, dioxins, petroleum 
hydrocarbons, and PCBs.  The aforementioned contaminants may further interact and influence 
PAH exposure and are routinely found in soil.  Determining the myriad of contaminants present 
in every single soil is a nigh impossible task and therefore is not an enviable option.  However, 
cell exposure to bioaccessible extracts, as performed by Oomen et al. (2001) and Vasiluk et al. 
(2007), may provide a realistic exposure scenario to ascertain the unique interactions between 
numerous contaminants.  The work of Oomen et al. (2001) and Vasiluk et al. (2007) used the in 
vitro PBET model, which is similar to the FOREhST model, to extract contaminants from soil 
and expose caco-2 cells to measure the absorption from cells.  Although Oomen et al. (2001) and 
Vasiluk et al. (2007) were only looking at a single contaminant, the cell line was exposed to the 
entirety of soil components solubilized into PBET fluids.  Thus any potential biochemical 
interactions influencing metabolism, transportation and binding were accounted for. 
Metabolic contributions from additional cell lines derived from varying species and 
tissues could be used to further understand PAH exposure.  The research here investigated 
bioavailability/exposure to juvenile swine, as a model for human exposure, and compared to 
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porcine jejunal cells (IPEC-J2) to investigate the biochemical PAH interactions.  To further 
explore PAH biochemical interactions, additional relevant and high priority species include 
swine, rodent and human.  The majority of in vivo bioavailability research has been performed 
with rodents (Culp et al. 1998; Juhasz et al. 2014b; Ramesh et al. 2004; Roberts et al. 2007), 
while in this thesis, swine was the model organism (Casteel et al. 1997).  As metabolism is 
known vary between species, it is imperative to differentiate and evaluate the extent of 
differences between species.  If differences between species are evaluated, identifying patterns 
and trends between multiple studies across species would provide a larger database which can 
potential clarify any observed disparity. For example, the mouse AhR is 10 times more sensitive 
than the human Ahr to TCDD (Flaveny and Perdew 2009) while the swine AhR is comparable to 
the human AhR for benzo(a)pyrene and TCDD (Lesca et al. 1994).   
In terms of tissue discrepancy, CYP enzyme induction has also been found to be 
dependent upon both tissue and cell type (Iwanari et al. 2002; Shimada et al. 2003; Vondracek et 
al. 2017).  In this thesis, jejunal cells were used to investigate PAH interactions influecning 
partitioning and metabolism.  For PAHs that are orally absorbed, the foremost tissues of concern 
include the liver, small intestines and large intestines.  The liver has the largest capacity for 
metabolism of PAHs, while the small and large intestines are the first tissues in contact that have 
an apprepeciable ability to metabolize PAHs (Ding and Kaminsky 2003).  Given that PAHs 
mixtures influence PAH partitioning, the partitioning may illicit a different biochemical response 
based on tissue type. Therefore, the relative partitioning/metabolic response from multiple 
tissues would likely provide a more holistic view to further our understanding of PAH exposure. 
 Overall, fututre directions to improve in vitro predictions of in vivo PAH soil 
bioavailability include evaluating complex chemical mixtures naturally present in soil, 
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differences between animal models regarding exposure to mixtures and lastly, differenes 
between tissue/cell types to PAH mixtures. 
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APPENDIX A 
CHAPTER 3 SUPPLEMENTAL INFORMATION 
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Figure A1. Comparison between Area under the Curve (μg PAHs recovered in plasma per gram of soil over a 48 hour time period) 
and soil fugacity capacity of five PAHs.  Data points represent the average (n = 6) and error bars represent the standard error of the 
mean for Area under the Curve. 
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Figure A2. Comparison of the bioavailability for 5 PAHs against partitioning into simulated fluids for 14 soils historically 
contaminated with petroleum hydrocarbons.  Data points represent the mean (n =6) of mammalian bioavailability and (n=3) estimates 
of Ksim.  Bioavailability was calculated as the quotient of Area under the Curve (μg PAHs recovered in plasma per gram of soil over a 
48 hour time period) divided by the total amount of PAHs in the dosed soil. Error bars represent the standard error of the mean and 
were obscured for Ksim.  
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Figure A3.  Comparison between Area under the Curve (μg PAHs recovered in plasma per gram of soil over a 48 hour time period) 
and fugacity of five polyaromatic hydrocarbons.  Fugacity units are reported in nano-fugacity or 10-9 Pa and was calculated from soil 
concentration and soil fugacity capacity. Data points represent the average (n = 6) and error bars represent the standard error of the 
mean for Area under the Curve. 
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Figure A4. Correlation between bioavailability and (Silt + Clay)/TOC in soils for five PAHs. Bioavailability was calculated as the 
quotient of Area under the Curve (μg polyaromatic hydrocarbons recovered in plasma per gram of soil over a 48 hour time period) 
divided by the total amount of polyaromatic hydrocarbons in the dosed soil.  
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Figure A5.  Time course of PAH plasma concentration following oral ingestion of three PAH contaminated soils over 48 hours  
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Table A1. Physiochemical properties and additional PAH bioavailability of soils used in this study 
Soil 
Soil Concentration (μg/g) Bioavailability (%) 
ANT1 FLU1 PYR1 DIB1 B(g)P1 IND1 ANT1 FLU1 PYR1 DIB1 B(g)P1 IND1 
BGS1 1.6 1.2 2.7 ND 3.1 1.0 16 12 13 - 20 0 
BGS2 11 53 76 47 48 35 1.7 0.3 0.07 0 0.06 0 
BGS3 11 69 77 40 37 35 5.2 1.0 0.5 9.9 - 0 
BGS4 11 149 125 61 64 48 55 3.9 4.1 1.5 2.0 3.2 
BGS5 5.7 88 53 20 23 22 31 4.2 14 2.7 2.2 4.1 
BGS6 4.9 63 56 21 25 20 33 2.5 5.3 0.1 0.6 4.3 
BGS7 3.3 28 23 14 18 18 38 30.9 25 9.9 0.7 2.1 
BGS8 4.1 121 76 24 28 30 87 2.5 10 0.1 0.9 17 
BGS9 2.7 30 32 20 25 19 14 0 9.7 0.8 1.1 0 
BGS10 17 289 300 32 49 37 16 1.7 2.3 0.06 0.3 0.3 
BGS11 11 136 184 41 46 39 16 2.6 2.2 1.8 2.2 0.1 
BGS12 140 758 582 170 166 125 0.2 0 0.2 0 0.07 0 
WP1 27 213 117 7.0 5.7 5.6 24 0.3 1.2 9.3 14 2.6 
GW2 1 5.5 4.6 7.4 4.3 2.2 85 39.7 7.4 0 30 16 
COT1 0.01 ND 0.02 ND 0.04 ND 100 - 100 - 100 - 
COT2 0.01 0.01 0.02 ND ND ND 100 100 100 - - - 
COT3 ND ND 0.05 ND ND ND - - 100 - - - 
COT4 0.01 0.01 <LOQ ND 0.01 ND 100 0 - - 100 - 
COT5 0.01 ND ND ND 0.01 ND 100 - - - 0 - 
Average2 18 143 122 39 39 31 30 7.3 6.8 2.8 6.3 3.5 
Geometric 
Mean2 7 62 59 27 24 19 15 3.0 3.0 1.1 1.6 2.5 
Standard 
Deviation2 36 195 154 43 41 31 27 12 7.1 4.0 14 5.6 
1Abbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, DIB is dibenzo(ah)anthracene, B(g)P is 
benzo(ghi)perylene, and IND is indeno(123-cd)pyrene 
2The average, geometric mean and standard deviation values for bioavailability do not include the 5 COT soils 
ND indicates a non-detection of PAH in soil 
<LOQ indicates a value below the limit of quantification 
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Table A2. Log Soil-Water Partitioning Coefficients (Kd) of PAHs between Soils 
Soil ANT1 FLU1 PYR1 B(a)A1 CHR1 B(b)F1 B(k)F1 B(a)P1 DIB1 B(g)P1 IND1 
BGS 1 
2.24 
(0.06) 
1.65 
(0.03) 
1.74 
(0.03) 
1.51 
(0.03) 
1.49 
(0.02) 
1.55 
(0.03) 
1.52 
(0.02) 
1.55 
(0.03) 
NA 
1.68 
(0.04) 
1.66 
(0.02) 
BGS 2 
3.96 
(0.11) 
3.87 
(0.11) 
3.09 
(3.27) 
3.17 
(0.09) 
3.31 
(1.09) 
3.57 
(0.09) 
3.39 
(0.12) 
3.72 
(0.18) 
4.08 
(0.02) 
4.02 
(0.18) 
3.45 
(0.04) 
BGS 3 
1.28 
(0.04) 
1.76 
(0.09) 
4.81 
(0.09) 
4.57 
(0.07) 
4.59 
(0.06) 
4.53 
(0.13) 
4.50 
(0.07) 
4.27 
(0.07) 
1.05 
(0.16) 
4.60 
(0.05) 
4.23 
(0.14) 
BGS 4 
3.78 
(0.21) 
4.82 
(0.01) 
4.71 
(0.02) 
5.38 
(0.12) 
4.84 
(0.28) 
4.79 
(0.15) 
5.22 
(0.07) 
4.52 
(0.04) 
NA 
5.37 
(0.11) 
4.17 
(1.13) 
BGS 5 
2.92 
(0.04) 
2.62 
(0.01) 
2.51 
(0.05) 
2.66 
(0.02) 
2.66 
(0.04) 
2.84 
(0.03) 
2.76 
(0.06) 
2.88 
(0.03) 
3.00 
(0.09) 
2.85 
(0.01) 
2.83 
(0.02) 
BGS 6 
0.66 
(0.03) 
4.44 
(0.07) 
4.58 
(0.11) 
4.39 
(0.01) 
4.30 
(0.01) 
4.25 
(0.08) 
4.41 
(0.11) 
4.07 
(0.13) 
NA 
4.67 
(0.13) 
4.20 
(0.36) 
BGS 7 
2.98 
(0.12) 
2.53 
(0.09) 
2.21 
(0.09) 
2.27 
(0.09) 
2.45 
(0.09) 
2.52 
(0.08) 
2.51 
(0.10) 
2.42 
(0.12) 
2.76 
(0.11) 
2.72 
(0.09) 
2.64 
(0.06) 
BGS 8 
3.33 
(0.23) 
3.40 
(0.08) 
3.34 
(0.06) 
3.29 
(0.10) 
3.33 
(0.10) 
3.16 
(0.24) 
3.12 
(0.29) 
3.22 
(0.34) 
4.29 
(0.54) 
3.92 
(0.39) 
3.54 
(0.23) 
BGS 9 
3.49 
(0.30) 
3.30 
(0.12) 
3.32 
(0.15) 
2.76 
(0.23) 
2.76 
(0.21) 
3.02 
(0.14) 
2.91 
(0.13) 
2.97 
(0.10) 
3.13 
(0.11) 
3.22 
(0.11) 
3.17 
(0.09) 
BGS 10 
4.11 
(0.16) 
4.67 
(0.16) 
4.47 
(0.16) 
4.08 
(0.23) 
4.08 
(0.22) 
4.01 
(0.21) 
4.06 
(0.16) 
3.88 
(0.07) 
4.55 
(0.15) 
4.56 
(0.04) 
0.72 
(0.06) 
BGS 11 
4.19 
(0.16) 
4.59 
(0.07) 
4.63 
(0.08) 
4.77 
(0.11) 
4.84 
(0.12) 
5.27 
(0.14) 
5.24 
(0.14) 
5.05 
(0.13) 
NA 
0.40 
(0.15) 
NA 
BGS 12 
5.94 
(0.57) 
5.32 
(0.09) 
5.35 
(0.14) 
5.53 
(0.11) 
5.39 
(0.11) 
4.75 
(0.09) 
4.89 
(0.14) 
4.61 
(0.26) 
5.00 
(0.28) 
5.09 
(0.26) 
5.44 
(0.50) 
WP1 
4.46 
(0.08) 
3.02 
(0.04) 
5.53 
(0.06) 
5.12 
(0.26) 
4.94 
(0.22) 
4.49 
(0.35) 
4.55 
(0.43) 
4.55 
(0.23) 
NA NA NA 
GW5 
4.02 
(0.06) 
0.65 
(0.07) 
0.52 
(0.03) 
0.58 
(0.03) 
0.48 
(0.02) 
1.25 
(0.16) 
1.35 
(0.14) 
1.34 
(0.15) 
0.96 
(0.20) 
0.44 
(0.02) 
1.99 
(0.25) 
1Abbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is 
benzo(a)anthracene, CHR is chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is 
benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, B(g)P is 
benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
Values in parentheses indicate the standard deviation from 3 measurements 
NA – No estimate available 
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Table A3. Log Soil-Simulated Fluid Partitioning Coefficients (Ksim) of PAHs between Soils 
Soil ANT1 FLU1 PYR1 B(a)A1 CHR1 B(b)F1 B(k)F1 B(a)P1 DIB1 B(g)P1 IND1 
BGS 1 
2.89 
(0.36) 
0.74 
(0.43) 
1.96 
(0.03) 
2.30 
(0.06) 
2.20 
(0.04) 
2.84 
(0.10) 
2.77 
(0.08) 
2.84 
(0.56) 
NA 
2.93 
(0.05) 
NA 
BGS 2 
2.38 
(0.06) 
2.24 
(0.08) 
2.30 
(0.04) 
2.63 
(0.05) 
2.67 
(0.05) 
2.80 
(0.03) 
2.78 
(0.03) 
2.78 
(0.04) 
2.96 
(0.04) 
2.96 
(0.03) 
2.87 
(0.06) 
BGS 3 
2.37 
(0.10) 
2.28 
(0.11) 
2.35 
(0.14) 
2.67 
(0.15) 
2.65 
(0.17) 
2.79 
(0.16) 
2.80 
(0.14) 
2.83 
(0.018) 
3.07 
(0.16) 
2.99 
(0.15) 
2.84 
(0.15) 
BGS 4 
2.22 
(0.17) 
2.13 
(0.21) 
2.22 
(0.19) 
2.53 
(0.18) 
2.53 
(0.18) 
2.82 
(0.17) 
2.73 
(0.17) 
2.87 
(0.016) 
3.03 
(0.16) 
3.00 
(0.14) 
2.92 
(0.16) 
BGS 5 
2.01 
(0.09) 
1.86 
(0.12) 
1.74 
(0.13) 
2.28 
(0.10) 
2.26 
(0.11) 
2.65 
(0.09) 
2.54 
(0.10) 
2.76 
(0.10) 
2.84 
(0.06) 
2.90 
(0.10) 
2.74 
(0.15) 
BGS 6 
2.27 
(0.10) 
2.10 
(0.11) 
2.17 
(0.11) 
2.41 
(0.14) 
2.45 
(0.14) 
2.69 
(0.15) 
2.60 
(0.11) 
2.70 
(0.16) 
2.77 
(0.12) 
2.79 
(0.12) 
2.70 
(0.11) 
BGS 7 
2.73 
(0.15) 
1.96 
(0.14) 
2.08 
(0.14) 
2.32 
(0.12) 
2.31 
(0.14) 
2.68 
(0.10) 
2.56 
(0.13) 
2.97 
(0.012) 
2.80 
(0.09) 
2.87 
(0.07) 
2.94 
(0.18) 
BGS 8 
2.25 
(0.15) 
2.11 
(0.10) 
2.09 
(0.11) 
2.57 
(0.08) 
2.52 
(0.08) 
2.84 
(0.05) 
2.78 
(0.06) 
2.90 
(0.04) 
2.98 
(0.09) 
2.95 
(0.06) 
3.01 
(0.11) 
BGS 9 
2.40 
(0.29) 
1.93 
(0.25) 
2.10 
(0.21) 
2.37 
(0.14) 
2.34 
(0.15) 
2.68 
(0.12) 
2.57 
(0.10) 
2.78 
(0.16) 
2.71 
(0.06) 
2.87 
(0.10) 
2.75 
(0.08) 
BGS 10 
2.30 
(0.10) 
2.33 
(0.14) 
2.23 
(0.04) 
2.58 
(0.04) 
2.57 
(0.04) 
2.86 
(0.05) 
2.76 
(0.006) 
2.91 
(0.06) 
3.04 
(0.10) 
3.04 
(0.08) 
2.91 
(0.10) 
BGS 11 
2.07 
(0.03) 
2.01 
(0.11) 
2.08 
(0.11) 
2.39 
(0.13) 
2.39 
(0.13) 
2.67 
(0.14) 
2.60 
(0.013) 
2.67 
(0.13) 
2.84 
(0.12) 
2.87 
(0.14) 
2.80 
(0.14) 
BGS 12 
2.32 
(0.34) 
2.23 
(0.13) 
2.24 
(0.10) 
2.56 
(0.06) 
2.60 
(0.07) 
2.82 
(0.04) 
2.74 
(0.034 
2.77 
(0.04) 
2.88 
(0.03) 
2.93 
(0.03) 
2.83 
(0.04) 
WP1 
1.08 
(0.20) 
1.51 
(0.07) 
1.38 
(0.08) 
1.74 
(0.012) 
1.77 
(0.12) 
2.01 
(0.12) 
1.99 
(0.0311 
1.59 
(0.58) 
2.15 
(0.18) 
2.15 
(0.13) 
2.17 
(0.12) 
GW5 
2.36 
(0.10) 
2.06 
(0.23) 
2.09 
(0.08) 
2.38 
(0.11) 
2.50 
(0.12) 
2.58 
(0.35) 
2.58 
(0.08) 
2.84 
(0.17) 
NA 
2.73 
(0.21) 
NA 
1Abbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is 
benzo(a)anthracene, CHR is chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is 
benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, B(g)P is 
benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
Values in parentheses indicate the standard deviation from 3 measurements 
NA – No estimate available
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Table A4. Summary of Collinear Data from Structure Equation Modelling 
PAH1 
Model Parameters 
Significant 
Relationship2 
P 
value 
Coefficient 
Standardized 
Coefficient 
 
 
Chi-
square 
DF P-
Value 
ANT 3.3 2 0.20 
Zsoil predicts [Soil] 0.010 0.17 0.51 
TOC predicts [Soil] 0.022 0.71 0.45 
[Soil] predicts AUC 0.087 -0.17 -0.45 
Zsoil predicts AUC 0.79 0.008 0.064 
Ksim predicts AUC 0.002 -1.055 -0.61 
TOC predicts AUC 0.87 0.023 0.037 
FLU 4.8 2 0.10 
Zsoil predicts [Soil] 0.001 0.31 0.71 
TOC predicts [Soil] 0.18 0.49 0.24 
[Soil] predicts AUC 0.24 0.29 0.41 
Zsoil predicts AUC 0.047 -0.2 -0.66 
Ksim predicts AUC 0.19 0.14 0.41 
TOC predicts AUC 0.45 -0.35 -0.24 
PYR 2.7 2 0.25 
Zsoil predicts [Soil] 0.001 0.31 0.83 
TOC predicts [Soil] 0.034 0.53 0.28 
[Soil] predicts AUC 0.33 0.30 0.49 
Zsoil predicts AUC 0.41 -0.090 -0.39 
Ksim predicts AUC 0.17 0.25 0.4 
TOC predicts AUC 0.26 -0.43 -0.37 
B(a)A 3.4 2 0.18 
Zsoil predicts [Soil] 0.001 0.26 0.80 
TOC predicts [Soil] 0.035 0.51 0.30 
[Soil] predicts AUC 0.14 0.25 0.65 
Zsoil predicts AUC 0.39 -0.046 -0.37 
Ksim predicts AUC 0.25 0.056 0.33 
TOC predicts AUC 0.072 -0.38 -0.57 
CHR 3.2 2 0.20 
Zsoil predicts [Soil] 0.001 0.25 0.79 
TOC predicts [Soil] 0.004 0.60 0.37 
[Soil] predicts AUC 0.069 0.44 0.86 
Zsoil predicts AUC 0.21 -0.090 -0.22 
Ksim predicts AUC 0.31 0.62 0.31 
TOC predicts AUC 0.078 -0.58 -0.70 
B(b)F 3.7 2 0.15 
Zsoil predicts [Soil] 0.001 0.24 0.69 
TOC predicts [Soil] 0.001 0.81 0.55 
[Soil] predicts AUC 0.41 -0.13 -0.30 
Zsoil predicts AUC 0.009 0.12 0.82 
Ksim predicts AUC 0.04 0.043 0.42 
TOC predicts AUC 0.12 -0.27 -0.44 
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Table A4 continued.     
B(k)F 3.0 2 0.22 
Zsoil predicts [Soil] 0.001 0.20 0.69 
TOC predicts [Soil] 0.001 0.66 0.50 
[Soil] predicts AUC 0.96 0.014 0.02 
Zsoil predicts AUC 0.33 0.063 0.34 
Ksim predicts AUC 0.67 -0.016 -0.10 
TOC predicts AUC 0.14 -0.39 -0.46 
B(a)P 3.0 2 0.23 
Zsoil predicts [Soil] 0.001 0.24 0.67 
TOC predicts [Soil] 0.001 0.74 0.51 
[Soil] predicts AUC 0.91 0.019 0.024 
Zsoil predicts AUC 0.001 0.21 0.78 
Ksim predicts AUC 0.88 0.004 -0.029 
TOC predicts AUC 0.010 -0.51 -0.46 
DIB 7.9 2 0.02 
Zsoil predicts [Soil] 0.52 0.014 0.14 
TOC predicts [Soil] 0.002 0.79 0.65 
[Soil] predicts AUC 0.43 -0.26 -0.25 
Zsoil predicts AUC 0.085 -0.045 -0.43 
Ksim predicts AUC 0.095 0.12 0.43 
TOC predicts AUC 0.70 -0.16 -0.13 
B(g)P  9.5 2 0.01 
Zsoil predicts [Soil] 0.024 0.11 0.46 
TOC predicts [Soil] 0.012 0.68 0.51 
[Soil] predicts AUC 0.93 -0.0.24 -0.031 
Zsoil predicts AUC 0.65 -0.035 -0.20 
Ksim predicts AUC 0.31 0.070 0.44 
TOC predicts AUC 0.90 -0.046 -0.045 
IND 6.7 2 0.04 
Zsoil predicts [Soil] 0.89 0.006 0.033 
TOC predicts [Soil] 0.006 0.61 0.65 
[Soil] predicts AUC 0.23 -0.48 -0.40 
Zsoil predicts AUC 0.24 0.083 0.36 
Ksim predicts AUC 0.041 0.10 0.71 
TOC predicts AUC 0.75 -0.13 -0.12 
1Abbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is 
benzo(a)anthracene, CHR is chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is 
benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, B(g)P is 
benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
2Abbreviations are as follows: Zsoil  is the soil fugacity capacity, [Soil] is the soil PAH 
concentration, OC is the soil organic carbon, and AUC is the area under the curve (exposure) 
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Table A5. P-values from ANOVA comparison of IV AUC`s for weeks one, three, four and 
five 
PAH1 
Week vs 
Week 
P value 
B(a)A 
One-Three 0.99 
One-Four 0.91 
One-Five 0.98 
Three-Four 0.98 
Three-Five 0.99 
Four-Five 0.98 
CHR 
One-Three 0.99 
One-Four 0.94 
One-Five 0.98 
Three-Four 0.99 
Three-Five 0.93 
Four-Five 0.63 
B(b)F 
One-Three 0.83 
One-Four 0.84 
One-Five 0.96 
Three-Four 0.87 
Three-Five 0.53 
Four-Five 0.96 
B(k)F 
One-Three 0.97 
One-Four 0.93 
One-Five 0.66 
Three-Four 0.99 
Three-Five 0.47 
Four-Five 0.14 
B(a)P 
One-Three 0.99 
One-Four 0.93 
One-Five 0.80 
Three-Four 0.99 
Three-Five 0.97 
Four-Five 0.98 
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Table A6. P-values from ANOVA comparison of WP1 soil AUC`s for weeks one, four and 
five. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAH1 
Week vs 
Week 
P value 
B(a)A 
One-Four 0.58 
One-Five 0.80 
Four-Five 0.93 
CHR 
One-Four 0.5 
One-Five 0.92 
Four-Five 0.30 
B(b)F 
One-Four 0.90 
One-Five 0.64 
Four-Five 0.88 
B(k)F 
One-Four 0.0001 
One-Five 0.0001 
Four-Five 0.97 
B(a)P 
One-Four 0.26 
One-Five 0.12 
Four-Five 0.88 
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Table A7. Soil Locations 
Soil Site 
BGS1 Isle of Wight, UK 
BGS2 Near Stonehouse, UK 
BGS3 Near Stonehouse, UK 
BGS4 Isle of Wight, UK 
BGS5 Isle of Wight, UK 
BGS6 Isle of Wight, UK  
BGS7 Isle of Wight, UK 
BGS8 Isle of Wight, UK 
BGS9 Isle of Wight, UK 
BGS10 Sheffield, UK 
BGS11 Sheffield, UK 
BGS12 Gasworks site, UK 
WP1 Holmsund, Sweden 
GW2 Gothenburg, Sweden 
COT1 Saskatchewan, Canada 
COT2 Saskatchewan, Canada 
COT3 Saskatchewan, Canada 
COT4 Saskatchewan, Canada 
COT5 Saskatchewan, Canada 
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APPENDIX B 
CHAPTER 4 SUPPLEMENTAL INFOMRATION 
 
 
 
Figure B1. Diagram of the low energy FOREhST massaging method.  In the method, 2-1.5” 
rotating spherical balls move up and down the length of 5 modified polytetrafluoroethylene 
(PTFE) bags  (5”x4”).   
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Figure B2. Comparison between low energy FOREhST PAH release and soil concentration of five PAHs in 14 soils historically 
contaminated with hydrocarbons.  Data points represent the mean (n=3) for FOREhST PAH release and error bars represent the 
standard error of this mean.   
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Figure B3. Comparison of Area Under the Curve (AUC) against Low energy FORE(h)ST PAH release (top) and high energy 
FOREhST release (bot) of 5 PAHs in 14 soils historically contaminated with hydrocarbons. Data points represent the mean (n = 6) of 
mammalian exposure (AUC48) measured in µg PAH per gram of soil and (n=3) estimates of in vitro FORE(h)ST PAH release.  Error 
bars represent the standard error of the mean.
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Figure B4.  Comparison of phenanthrene and benzo(a)pyrene solubility in both bile (top 2 
panels) and water (bottom 2 panels) from single compound to multiple compound mixtures.  
Significant difference is indicating by ‘*’ at p < 0.05.    Abbreviations are as follows: Phen is 
phenanthrene, Pyr is pyrene, BkF is benzo(k)fluoranthene, and B(a)P is benzo(a)pyrene.
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Figure B5.  Output of co-inertia analysis.   A)  Components of the standardized principal 
component analysis of the PAH bioavailability data set projected on to the co-inertia axes.   B) 
Components of the standardized principal component analysis on the predictor variable (PAH 
bioaccessibility and soil properties) data set projected on to the co-inertia axes.  C) Histogram of 
the eigenvalues. D) Standardized co-inertia scores of the bioavailability (A) and predictor 
variable data sets (B) projected on to the co-inertia axes.  E) Canonical weights of predictor 
variables F) canonical weights of PAH bioavailability  
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Figure B6.   SEM diagram of the relationships between Soil Organic Carbon, FOREhST release 
of multiple PAHs, and PAH exposure.  Single headed arrows indicate that a change in the 
variable at the tail causes a direct change to the variable at the head.  Double headed arrows 
indicate non-directed causality.  Dashed lines indicate a non-significant (P>0.05) path, whereas 
black arrows indicate a positive relationship and red arrows indicate a negative relationship.  
Arrow width corresponds to the strength of the relationship between variables with standardized 
coefficients provided for significant paths. 
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Table B1. Physiochemical properties of 14 soils used in this study 
 Particle Size (%)   Soil Concentration (μg/g) 
 Sand Silt + Clay OCa pH ANTb FLUb PYRb B(a)A
b 
CHRb B(b)Fb B(k)Fb B(a)Pb DIBb B(g)Pb INDb 
BGS1 84 16 1.3 6.7 1.6 1.2 2.7 1.5 1.4 3.7 2.0 2.5 ND 3.1 1.0 
BGS2 77 23 8.8 6.7 11 53 76 23 27 84 22 56 47 48 35 
BGS3 54 46 8.2 6.5 11 69 77 19 24 86 22 35 40 37 35 
BGS4 67 33 6.8 n/a 11 149 125 50 49 101 33 61 61 64 48 
BGS5 57 43 3.3 n/a 5.7 88 53 18 18 46 16 18 20 23 22 
BGS6 59 41 12 6.5 4.9 63 56 19 26 40 14 17 21 25 20 
BGS7 49 51 7.8 6.6 3.3 28 23 6.8 11 22 8 10 14 18 18 
BGS8 70 30 13 2.0 4.1 121 76 32 39 80 19 25 24 28 30 
BGS9 38 62 3.9 6.2 2.7 30 32 16 16 36 13 22 20 25 19 
BGS10 90 10 4.8 6.3 17 289 300 75 86 77 32 41 32 49 37 
BGS11 39 61 4.9 6.3 11 136 184 54 60 73 29 48 41 46 39 
BGS12 63 37 33 n/a 140 758 582 390 340 410 160 290 170 166 125 
WP1 42 58 2.4 5.7 27 213 117 51 45 39 15 18 7.0 5.7 5.6 
GW2 59 41 4.6 6.7 1 5.5 4.6 3.7 4.0 5.7 2.2 4.5 7.4 4.3 2.2 
aOrganic carbon reported as percent (w/w). 
bAbbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene,  B(a)A is benzo(a)anthracene, CHR is 
chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, 
B(g)P is benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
ND indicates a non-detection of PAH in soil 
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Table B2. PAH bioavailability (%) of 14 soils used in this study 
Soil ANTa FLUa PYRa B(a)Aa CHRa B(b)Fa B(k)Fa B(a)Pa B(a)Aa DIBa B(g)Pa INDa 
BGS1 16 12 13 21.0 5.8 56.6 10.2 0.8 21.0 - 20 0 
BGS2 1.7 0.3 0.07 1.5 5.4 2.5 0.0 0.6 1.5 0 0.06 0 
BGS3 5.2 1.0 0.5 6.4 5.9 3.5 2.5 2.2 6.4 9.9 - 0 
BGS4 55 3.9 4.1 3.2 5.0 3.2 0.3 2.6 3.2 1.5 2.0 3.2 
BGS5 31 4.2 14 12.4 16.8 5.0 3.1 0.7 12.4 2.7 2.2 4.1 
BGS6 33 2.5 5.3 3.2 3.9 7.8 0.6 2.7 3.2 0.1 0.6 4.3 
BGS7 38 30.9 25 17.9 16.6 6.0 1.5 6.1 17.9 9.9 0.7 2.1 
BGS8 87 2.5 10 7.5 12.6 4.7 4.7 0.2 7.5 0.1 0.9 17 
BGS9 14 0 9.7 5.3 9.2 3.7 0.7 2.2 5.3 0.8 1.1 0 
BGS10 16 1.7 2.3 6.2 6.5 5.5 5.2 9.0 6.2 0.06 0.3 0.3 
BGS11 16 2.6 2.2 0.7 6.1 3.2 0.2 9.5 0.7 1.8 2.2 0.1 
BGS12 0.2 0 0.2 0.1 0.004 0.1 0.01 0.1 0.1 0 0.07 0 
WP1 24 0.3 1.2 2.4 3.2 8.0 22.9 33.0 2.4 9.3 14 2.6 
GW2 85 39.7 7.4 19.2 46.7 14.3 3.9 1.0 19.2 0 30 16 
aAbbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene,  B(a)A is benzo(a)anthracene, CHR is 
chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, 
B(g)P is benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
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Table B3. Soil PAH release in the low energy FOREhST model across 14 soils 
Soil ANTa FLUa PYRa B(a)Aa CHRa B(b)Fa B(k)Fa B(a)Pa DIBa B(g)Pa INDa 
BGS1 
0.0062 
(0.0035) 
0.10 
(0.0040) 
0.035 
(0.0047) 
0.015 
(0.0023) 
0.023 
(0.0066) 
0.0037 
(0.00003) 
NA 
0.017 
(0.030) 
0.00076 
(0.0013) 
NA 
0.00018 
(0.00032) 
BGS2 
0.25 
(0.060) 
2.1 
(0.62) 
2.4 
(0.68) 
0.61 
(0.21) 
0.56 
(0.19) 
1.26 
(0.45) 
0.36 
(0.13) 
0.67 
(0.19) 
0.63 
(0.16) 
0.40 
(0.16) 
0.34 
(0.13) 
BGS3 
0.17 
(0.11) 
1.9 
(0.98) 
1.4 
(0.69) 
0.48 
(0.29) 
0.51 
(0.32) 
0.88 
(0.49) 
0.25 
(0.15) 
0.47 
(0.34) 
0.52 
(0.33) 
0.32 
(0.20) 
0.25 
(0.14) 
BGS4 
0.11 
(0.026) 
5.1 
(1.2) 
3.2 
(0.85) 
0.84 
0.28) 
0.77 
(0.27) 
0.86 
(0.34) 
0.43 
(0.22) 
0.37 
(0.15) 
0.53 
(0.22) 
0.38 
(0.16) 
0.33 
(0.14) 
BGS5 
0.33 
(0.044) 
9.2 
(2.5) 
3.2 
(2.6) 
1.8 
(0.48) 
1.8 
(0.51) 
2.3 
(0.65) 
0.87 
(0.26) 
1.1 
(0.12) 
1.5 
(0.33) 
1.2 
(0.29) 
0.97 
(0.30) 
BGS6 
0.11 
(0.033) 
3.0 
(0.95) 
2.3 
(0.81) 
0.62 
(0.26) 
0.79 
(0.35) 
0.85 
(0.42) 
0.31 
(0.16) 
0.46 
(0.27) 
0.50 
(0.26) 
0.43 
(0.23) 
0.38 
(0.20) 
BGS7 
0.021 
(0.012) 
1.5 (0.57) 
0.92 
(0.37) 
0.21 
(0.083) 
0.37 
(0.16) 
0.41 
(0.18) 
0.15 
(0.071) 
0.11 
(0.060) 
0.24 
(0.11) 
0.25 
(0.11) 
0.18 
(0.081) 
BGS8 
0.045 
(0.028) 
2.3 
(0.83) 
1.1 
(0.52) 
0.38 
(0.19) 
0.55 
(0.25) 
0.58 
(0.28) 
0.19 
(0.098) 
0.31 
(0.16) 
0.31 
(0.16) 
0.22 
(0.114) 
0.19 
(0.088) 
BGS9 
0.040 
(0.0059) 
1.4 
(0.12) 
0.98 
(0.082) 
0.41 
(0.032) 
0.42 
(0.032) 
0.55 
(0.042) 
0.20 
(0.014) 
0.27 
(0.039) 
0.31 
(0.026) 
0.23 
(0.017) 
0.20 
(0.015) 
BGS10 
0.364 
(0.096 
13 
(2.3) 
0.00099 
(0.0017) 
2.2 
(0.54) 
2.3 
(0.59) 
1.33 
(0.40) 
0.59 
(0.19) 
0.52 
(0.16) 
0.58 
(0.18) 
0.52 
(0.17) 
0.48 
(0.14) 
BGS11 
0.15 
(0.081) 
6.9 
(0.20) 
0.043 
(0.019) 
1.5 
(0.29) 
1.7 
0.17) 
1.3 
(0.27) 
0.59 
(0.099) 
0.41 
(0.27) 
0.60 
(0.15) 
0.52 
(0.12) 
0.53 
(0.096) 
BGS12 ND ND ND 
0.012 
(0.013) 
2.4 
(3.5) 
0.74 
(0.47) 
0.16 
(0.20) 
0.078 
(0.0013) 
5.0 
(1.3) 
3.7 
(1.2) 
3.3 
(1.0) 
WP1 
0.37 
(0.65) 
4.0 
(6.9) 
0.029 
(0.050) 
0.70 
(0.95) 
3.3 
(1.2) 
1.7 
(0.83) 
0.68 
0.29) 
0.75 
(0.49) 
0.24 
(0.12) 
0.14 
(0.085) 
0.15 
(0.082) 
GW2 
0.083 
(0.081) 
3.0 
(4.7) 
1.8 
(2.8) 
0.78 
(1.1) 
1.3 
(2.1) 
1.1 
(1.7) 
0.51 
(0.80) 
0.10 
(0.067) 
0.74 
(1.1) 
0.37 
(0.54) 
0.38 
(0.60) 
aAbbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is benzo(a)anthracene, CHR is 
chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, 
B(g)P is benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
Values in parentheses indicate the standard deviation from 3 measurements 
NA – No estimate available
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Table B4. Soil PAH release in the high energy FOREhST model across 13 soils 
Soil ANTa FLUa PYRa B(a)Aa CHRa B(b)Fa B(k)Fa B(a)Pa DIBa B(g)Pa INDa 
BGS1 
4.9 
(3.0) 
3.3 
(2.2) 
2.0 
(2.1) 
1.4 
(1.0) 
1.5 
(0.89) 
1.9 
(1.3) 
0.84 
(0.53) 
0.88 
(0.92) 
1.3 
(0.87) 
1.3 
(0.79) 
1.0 
(0.64) 
BGS2 
29 
(6.4) 
24 
(5.9) 
25 
(6.6) 
6.8 
(1.7) 
6.0 
(1.5) 
25 
(6.0) 
7.1 
(1.7) 
17 
(4.2) 
19 
(4.5) 
16 
(3.7) 
12 
(2.6) 
BGS3 
25 
(2.9) 
15 
(1.9) 
24 
(2.7) 
5.4 
(0.69) 
5.5 
(0.62) 
18 
(2.4) 
4.7 
(0.63) 
11 
(1.3) 
13 
(1.9) 
11 
(1.5) 
8.7 
(1.1) 
BGS4 
39 
(34) 
26 
(23) 
24 
(21) 
8.7 
(7.5) 
8.1 
(7.0) 
14 
(12) 
5.1 
(4.4) 
7.7 
(6.7) 
9.4 
(6.4) 
8.5 
(7.4) 
6.5 
(5.5) 
BGS5 
34 
(4.4) 
23 
(2.9) 
12 
(2.0) 
6.0 
(0.85) 
6.3 
(0.84) 
7.9 
(1.1) 
3.4 
(0.43) 
2.8 
(0.70) 
5.1 
(0.60) 
4.9 
(0.63) 
3.9 
(0.54) 
BGS6 
30 
(3.6) 
14 
(1.2) 
4.1 
(5.5) 
0.42 
(0.66) 
9.0 
(0.99) 
8.2 
(0.83) 
3.1 
(0.28) 
0.26 
(0.064) 
6.4 
(0.65) 
5.5 
(0.54) 
4.5 
(0.39) 
BGS7 
22 
(20) 
12 
(9.8) 
0.98 
(1.7) 
1.7 
(1.6) 
6.6 
(5.8) 
5.9 
(4.7) 
2.8 
(2.4) 
0.19 
(0.17) 
4.1 
(3.1) 
4.2 
(2.7) 
3.4 
(2.2) 
BGS8 
25 
(14) 
14 
(6.9) 
1.6 
(1.4) 
2.8 
(3.3) 
8.0 
(4.1) 
7.4 
(37) 
3.4 
(1.7) 
0.64 
(0.80) 
5.0 
(2.0) 
4.5 
(1.6) 
3.7 
(1.3) 
BGS9 
10 
(1.8) 
6 
(1.1) 
3.7 
(0.84) 
2.9 
(0.72) 
3.2 
(0.52) 
5.1 
(1.2) 
2.2 
(0.41) 
1.8 
(1.0) 
3.4 
(0.74) 
3.6 
(0.73) 
2.8 
(0.62) 
BGS10 
82 
(8.5) 
74 
(9.0) 
28 
(21) 
17 
(2.5) 
18 
(2.1) 
14 
(1.9) 
6.1 
(0.66) 
6.9 
(2.1) 
8.8 
(1.3) 
8.4 
(1.1) 
7.3 
(0.78) 
BGS11 
55 
(2.6) 
57 
(2.6) 
33 
(1.6) 
17 
(0.75) 
16 
(0.70) 
19 
(0.83) 
7.9 
(0.33) 
14 
(0.66) 
13 
(0.62) 
12 
(0.34) 
10 
(0.40) 
BGS12 NA NA NA NA NA NA NA NA NA NA NA 
WP1 
149 
(14) 
96 
(9.2) 
113 
(17) 
34 
(4.0) 
31 
(3.3) 
23 
(3.0) 
9.5 
(1.2) 
8.5 
(1.8) 
5.9 
(0.74) 
5.6 
(0.82) 
3.1 
(0.39) 
GW2 
2.3 
(1.1) 
1.4 
(0.68) 
2.6 
(1.7) 
0.98 
(0.52) 
0.87 
(0.45) 
1.2 
(0.69) 
0.60 
(0.32) 
0.78 
(0.50) 
1.3 
(0.76) 
1.1 
(0.61) 
0.28 
(0.30) 
aAbbreviations are as follows: ANT is anthracene, FLU is fluoranthene, PYR is pyrene, B(a)A is benzo(a)anthracene, CHR is 
chrysene, B(b)F is benzo(b)fluoranthene, B(k)F is benzo(k)fluoranthene, B(a)P is benzo(a)pyrene, DIB is dibenzo(ah)anthracene, 
B(g)P is benzo(ghi)perylene, and IND is indeno(123,cd)pyrene 
Values in parentheses indicate the standard deviation from 3 measurements 
NA – No estimate available
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Table B5. PCA of PAH exposure (AUC48) 
 PC1 PC2 PC3 PC4 PC5 PC6 
Phenanthrene -0.12 -0.17 -0.09 0.20 -0.79 -0.36 
Anthracene -0.29 0.07 0.55 0.091 0.065 0.15 
Fluoranthene -0.28 -0.12 -0.33 0.29 0.039 0.70 
Pyrene -0.42 -0.19 -0.20 -0.0056 -0.10 0.11 
Benzo(a)anthracene -0.41 0.053 -0.053 -0.031 -0.25 0.071 
Chrysene -0.41 0.0076 -0.18 -0.15 0.14 -0.26 
Benzo(b)fluoranthene -0.38 0.30 0.071 -0.037 0.13 -0.26 
Benzo(k)fluoranthene -0.19 0.16 0.62 0.25 -0.12 0.12 
Benzo(a)pyrene -0.18 0.08 -0.22 0.60 0.43 -0.40 
Dibenzo(ah)anthracene 0.035 0.62 -0.21 -0.0018 -0.17 0.21 
Benzo(ghi)perylene 0.061 0.64 -0.15 -0.06 -0.13 -0.016 
Indeno(123-cd)pyrene -0.31 -0.05 -0.00071 -0.64 0.11 -0.032 
Standard deviation 2.12 1.48 1.31 1.10 1.06 0.800 
Proportion of Variance 0.376 0.183 0.144 0.101 0.093 0.053 
Cumulative Proportion 0.376 0.559 0.702 0.803 0.897 0.949 
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Table B6. PCA of predictor variables, including PAH bioaccessibility and soil properties 
 PC1 PC2 PC3 PC4 PC5 
FOREhST Phenanthrene -0.077 -0.26 -0.32 0.018 -0.066 
FOREhST Anthracene -0.053 -0.35 0.13 -0.0076 0.076 
FOREhST Fluoranthene -0.038 -0.30 0.26 0.11 -0.24 
FOREhST Pyrene -0.068 -0.047 -0.093 0.55 0.28 
FOREhST Benzo(a)anthracene -0.048 -0.32 0.20 0.10 -0.22 
FOREhST Chrysene 0.098 -0.30 -0.034 -0.20 -0.16 
FOREhST Benzo(b)fluoranthene -0.014 -0.38 -0.064 0.066 0.091 
FOREhST Benzo(k)fluoranthene -0.046 -0.38 -0.038 0.070 -0.077 
FOREhST Benzo(a)pyrene -0.058 -0.33 -0.032 0.14 0.29 
FOREhST 
Dibenzo(ah)anthracene 0.24 -0.037 -0.055 0.0047 0.098 
FOREhST Benzo(ghi)perylene 0.24 -0.050 -0.050 0.018 0.080 
FOREhST Indeno(123-cd)pyrene 0.24 -0.047 -0.050 0.0032 0.051 
Soil Phenanthrene 0.19 -0.11 0.29 -0.034 -0.17 
Soil Anthracene 0.25 -0.013 -0.049 -0.092 0.044 
Soil Fluoranthene 0.24 -0.073 0.042 -0.074 -0.047 
Soil Pyrene 0.24 -0.081 0.094 -0.057 -0.13 
Soil Benzo(a)anthracene 0.25 -0.014 -0.013 -0.065 -0.013 
Soil Chrysene 0.25 -0.021 0.0072 -0.057 -0.041 
Soil Benzo(b)fluoranthene 0.25 0.0012 -0.024 0.021 0.071 
Soil Benzo(k)fluoranthene 0.25 -0.0086 -0.021 -0.0062 0.022 
Soil Benzo(a)pyrene 0.25 0.0067 -0.031 0.0053 0.046 
Soil Dibenzo(ah)anthracene 0.24 0.0054 -0.036 0.10 0.048 
Soil Benzo(ghi)perylene 0.24 -0.0011 0.0089 0.11 0.0063 
Soil Indeno(123-cd)pyrene 0.24 -0.0045 -0.0056 0.11 0.017 
Soil organic carbon 0.23 0.085 -0.068 0.087 0.010 
Log Soil organic carbon 0.19 0.085 -0.090 0.25 -0.081 
Sand 0.028 0.048 0.54 0.14 0.14 
Silt and Clay -0.027 -0.050 -0.54 -0.13 -0.14 
As 0.042 -0.24 -0.16 -0.036 0.46 
Cr -0.047 0.071 -0.11 0.37 -0.35 
Cu 0.054 -0.099 -0.14 -0.0031 -0.45 
Pb 0.051 0.068 -0.095 0.55 -0.14 
Standard deviation 3.98 2.53 1.68 1.49 1.27 
Proportion of Variance 0.494 0.201 0.088 0.070 0.0500 
Cumulative Proportion 0.494 0.695 0.783 0.853 0.903 
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Table B7.  Summary of Canonical Weights from Co-Inertia Modelling 
Predictive Factor X Canonical Weight Y Canonical Weight Strengtha 
FOREhST Chrysene -0.181 0.407 0.446 
FOREhST Fluoranthene -0.396 -0.144 0.421 
FOREhST Anthracene -0.308 0.235 0.388 
FOREhST Benzo(a)anthracene  -0.356 -0.136 0.381 
Soil [As] -0.092 0.348 0.360 
FOREhST Pyrene -0.0162 -0.349 0.349 
FOREhST Benzo(k)fluoranthene -0.299 0.0815 0.310 
Soil [Cr] -0.0380 -0.285 0.287 
Soil [Anthracene] 0.165 0.232 0.285 
FOREhST Benzo(a)pyrene -0.281 0.0376 0.284 
FOREhST Benzo(b)fluoranthene  -0.258 0.112 0.281 
Log Soil Organic Carbon 0.114 -0.252 0.277 
Soil [Cu] 0.0855 0.259 0.273 
Soil [Pb] 0.0756 -0.202 0.216 
Soil [Benzo(a)anthracene] 0.134 0.163 0.211 
Soil [Benzo(a)pyrene] 0.176 0.109 0.207 
Soil Organic Carbon 0.180 -0.0476 0.186 
FOREhST Dibenzo(ah)anthracene 0.160 0.0902 0.184 
Soil [Chrysene] 0.114 0.142 0.182 
Soil [Fluoranthene] 0.0323 0.179 0.182 
Soil [Benzo(k)fluoranthene] 0.140 0.0987 0.171 
FOREhST Phenanthrene -0.161 0.0556 0.170 
FOREhST Indeno(123-cd)pyrene 0.146 0.0839 0.168 
Soil [Dibenzo(ah)anthracene] 0.158 0.0103 0.159 
FOREhST Benzo(ghi)perylene 0.139 0.0647 0.153 
Soil [Benzo(b)fluoranthene] 0.137 0.0589 0.149 
Soil [Pyrene] 0.0216 0.132 0.134 
Soil [Benzo(ghi)perylene] 0.130 -0.0143 0.130 
Soil [Indeno(123-cd)pyrene] 0.103 -0.0622 0.120 
Sand -0.0509 -0.0913 0.105 
Silt and Clay 0.0496 0.0891 0.102 
Soil [Phenanthrene] -0.0750 0.0541 0.0925 
a Strength calculated as the square root of the sum of the squares for the X and Y canonical 
weights (Strength = √(X canonical weight2 + Y canonical weight2).
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Table B8. Summary of Collinear Data from Structure Equation Modelling 
PAH 
Model Parameters 
Significant Relationship 
P- 
value 
Coefficient 
Standardized 
Coefficient 
 
 
Chi-
square 
DF P-Value CFI RMSE 
B(a)A 4.5 2 0.11 0.96 0.30 
B(a)AFOR predicts AUC 0.01 -4.1 -1.8 
CHRFOR predicts AUC 0.088
gl 
-0.45 -0.29 
FLUFOR predicts AUC 0.001 1.1 2.5 
OC predicts AUC 0.62 0.014 0.075 
 OC predicts B(a)AFOR 0.40 -0.004 -0.048 
B(a)AFOR -FLUFOR covariance 0.01 2.1 0.98 
B(a)P 2.3 1 0.13 0.93 0.31 
B(a)PFOR predicts AUC 0.03 -4.1 -0.56 
B(a)AFOR predicts AUC 0.001 3.5 1.0 
OC predicts AUC 0.62 0.021 0.075 
OC predicts B(a)PFOR 0.74 -0.003 -0.070 
 B(a)PFOR -B(a)AFOR covariance 0.05 0.112 0.62 
Abbreviations are as follows: FLU is fluoranthene, B(a)A is benzo(a)anthracene, CHR is chrysene, B(a)P is benzo(a)pyrene, FOR 
represents the bioaccessible fraction of a PAH from low energy FOREhST model, and OC is the soil organic carbon 
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APPENDIX C 
CHAPTER 5 SUPPLEMENTAL INFOMRATION 
 
Figure C1.  Diagram of PAH recovery from plastic 96-well plates.  After incubation, media was 
removed into microtube.  To each well, 100 µL of 0.25% TrypLE Express was added and 
incubated for 10 minutes.  TrypLE Express was removed and added to corresponding mircotube 
prior to centrifugation.  
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Figure C2. Percentage of benzo(a)pyrene (left) or benzo(a)anthracene (right) remaining in cells and media after incubation 1 hour incubation.  
`*`denotes a significant difference at p <0.05.  Comparisons were made to the recovery of single compound mixtures at the given time point.   
Small symbols represent the value of individual replicates while the large symbols represents the mean (n = 15) and error bars were the standard 
deviation of this mean. The percentage of PAH remaining was calculated as the total amount recovered divided by the total dose.  The total 
amount recovered was corrected to parallel abiotic control experiments. .Abbreviations are as follows: Flu is fluoranthene, B(a)A is 
benzo(a)anthracene, Chr is chrysene, and B(a)P is benzo(a)pyrene. 
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Figure C3.  Partitioning of benzo(a)pyrene (left) and benzo(a)anthracene (right) between cells and media based on PAH mixture after 1 hour 
incubation. `*`denotes a significant difference at p <0.05.  Significant difference was compared the partitioning of single a compound at the given 
time point.  Small symbols represent the value of individual replicates while the large symbols represents the mean (n = 15) and error bars were 
the standard deviation of this mean.    The total amount recovered was corrected to parallel abiotic control experiments. Abbreviations are as 
follows: Flu is fluoranthene, B(a)A is benzo(a)anthracene, Chr is chrysene, and B(a)P is benzo(a)pyrene.  
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